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As an initial step in the investigation of ininunoglobulin 
synthesis in human lymphoid cell lines over one hundred of these 
lines were screened for the secretion of imunoglobulins using 
a sensitive haemaggluti nation inhibition assay. The vast majority 
of cell lines showed a monoclonal pattern of immunoglobulin secretion 
with 1gM as the predominant class of secreted imunoglobulin. All 
the cell lines derived from cord blood secreted only 1gM. No 
polyclonal immunoglobulin secretion was observed in established cell 
lines which had been in culture for some time. Several cell lines 
were identified which secreted no detectable imunoglobulin or 
secreted only a single type of imunoglobulin polypeptide (presumptive 
variants). 
In order to establish variant clones from a known immunoglobulin 
secreting cell line for comparison, cloning and mutagenesis experiments 
were carried out. A semi-solid agarose cloning technique was developed 
and used in conjunction with "Meiphalan", a human anti-tumour drug 
which is an established mutagen of immunoglobulin synthesis in mouse 
myeloma cells. No variant patterns of irmiunoglobulin synthesis were 
detected in over two thousand clones of untreated and Melphalan-treated 
cells analysed for the secretion of both heavy and light chains, nor 
were any variants detected in over one hundred previously established 
clones from cultures of other cell lines which had been treated with 
the mutagens EMS and MNNG. 
Further analysis of the imunoglobulins secreted by normal 
B lymphoblastoid cell lines and the presumptive variant cell lines were 
undertaken.: SDS PAGE profiles, under reducing and non-reducing 
conditions, of unfractionated biosynthetically radiolabelled culture 
supernatants suggested that some imrnunoglobulin polypeptides could be 
directly identified and might be present in different forms among the 
secreted proteins. However this analysis also demonstrated that, in 
general, a large number of diverse proteins were synthesised so that 
fractionation of the secreted products was necessary to study further 
the immunoglobulins present. 
Serological and SDS PAGE analyses of radiolabelled culture 
supernatants from an IgM-synthesising cell line fractionated by sucrose 
gradient velocity sedimentation in the presence of a detergent 
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demonstrated that the 1gM was secreted as a 19S pentarner which 
could be readily isolated from the other secreted proteins. Similar 
analyses of the secreted proteins of other lyM-synthesising cell lines 
demonstrated that; imunoglobulin can account for a very large 
proportion of the secreted proteins; there is type specific migration 
of human light chains in SDS gels; in addition to intact imunoglobulin 
molecules excess free light chains are secreted in varying amounts 
by different lines. The application of sucrose gradient velocity 
sedimentation to the investigation of secreted imunoglobulins from 
the presumptive variant cell lines showed that the single detectable 
polypeptides secreted by these lines were not present as components 
of larger otherwise unidentified molecules. This also suggested 
however, that isolation, and so further investigation, of these 
polypeptides was unlikely to be achieved in this way. 
As an alternative to purification by physical means such as 
velocity sedimentation, imunoglobulins were isolated from cell culture 
supernatants by imunoprecipitation. Several methods and reagents 
were evaluated for imunoprecipitation using isolated 19S 1gM for 
comparison to give optimal results. SOS PAGE analysis of imunoprecipitates 
from the radiolabelled culture supernatants of presumptive variant cell 
lines showed that the light chains secreted by these cell lines were of 
normal molecular weight with the exception of three cell lines which 
synthesised apparently structurally abnormal light chains. 
Normal and presumptive variant cell lines were serologically 
analysed for intracellular and cell surface ininunoglobulin. The normal 
cells contained, expressed on the cell surface and secreted the same 
single heavy chain class and light chain type whereas the presumptive 
variant lines showed an array of different combinations of heavy and 
light chain synthesis and expression. 
The experimental observations outlined above are discussed and 
the principal conclusions formed can be summarised as follows: The 
pattern of immunoglobulin synthesis shown by established human 
lymphoblastoid cell lines suggests that they are derived from a 
subpopulation of blood lymphocytes which is principally characterised 
by the active secretion of imunoglobulin. The production of light 
chains in relative excess of heavy chains in human lymphoblastoid cell 
lines derived from normal B lymphocytes is consistent with this being 
a feature of normal immunoglobuliri synthesis. In contrast to the 
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labile properties attributed to immunoglobulin genes in other systems 
the lack of cloned mutants from human lymphoid cell lines suggests 
that instability is not a feature of ininunoglobulin genes per se but 
of the system in which they are expressed. The patterns of 
iriunoglobulin synthesis and expression in the presumptive variant 
lines suggest that some of these may be mutants of imunoglobulin 
synthesis but others represent early stages of B lymphocyte 
differentiation and indicate that p chain synthesis precedes light 
chain synthesis in B lymphocyte ontogeny. The implications of these 
conclusions for our current understanding of immunoglobulin synthesis 
are also discussed. 
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I1UNOGLOBULIN SYNTHESIS IN HUMAN LYMPHOID CELL LINES 
INTRODUCTION 
OVERVIEW 
One of the most remarkable features of the vertebrate immune 
system is the ability to recognise an enormous range of different 
antigenic molecules. Antibodies, which belong to a class of proteins 
known as imunoglobulins,are a major component in the molecular 
recognition system of the immune response and over the past two 
decades or so there has been intense study towards understanding 
their structure, synthesis and genetics. 
The biochemical and serological characterisation of imunoglobulin 
molecules from blood serum has been a source of extensive information 
about antibodies. However these studies have been superseded in the 
investigation of the molecular and genetic basis of irwnunoglobulin 
production by the use of cultured imunoglobulin synthesising cells. 
In this field there are two major systems, the mouse myeloma tumours 
(together with the cell lines which are derived from them) and human 
lymphoid cell lines. To date, studies have been almost exclusively 
limited to the former of these sources yet human lymphoid cell lines 
offer several advantages in studying imunoglobulins and the cells 
which synthesise them. 
IMMUNOGLOBLJLINS AND THE IMMUNE RESPONSE 
Antibodies are not isolated components in the immune system 
but participate in a continuum of cellular and molecular events. 
To illustrate this, several features of the immune response are 
mentioned here. A more complete and detailed account can be obtained 
from recent immunology text books (See Golub 1977, Roitt 3rd Edition 1977). 
The introduction into the vertebrate body of an antigenic 
determinant, usually a macromolecule or composite of macromolecules, 
in immunogenic form and dose provokes a specific immune response. 
This response involves a complex series of events which can be loosely 
divided into those aspects involving antibody formation and those 
involving tissue reactions. These two types of response are termed 
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"humoral" and "cell-mediated" immunity. As a rule, free soluble 
antigen stimulates humoral immunity while membrane and tissue 
bound antigens promote cell-mediated immunity. There are however 
a great many exceptions to this generalisation and prediction must 
wait until the molecular basis of immunogenicity and antigenicity 
are better understood. The antibody molecules synthesised in a 
humoral response to an antigenic determinant belong to a group of 
proteins called imniunoglobulins and bind specifically to that 
determinant or to similar structures. The combination of antibody 
and antigen is the first step in the elimination of that complex 
from the organism by the phagocytic action of macrophages and/or 
specific enzymic destruction. Both mechanisms involve the interaction 
of the antibody component in the antigen/antibody complex with one 
or a number of sequentially acting protein components of the blood 
serum collectively called "complement". 
Although in vivo it requires the co-operation of at least two 
types of cells, the thymus derived 1-lymphocyte and the bone marrow 
or bursa-derived B lymphocyte to produce immunoglobulin, the synthesis 
and secretion of large amounts of immunoglobulin is the exclusive 
property of the B cell lineage (Fig. 1). Constitutive receptor 
immunoglobulin molecules on the outer membrane of a circulating 
peripheral B-lymphocyte recognise an antigen and subsequent binding 
of that antigen to the B-lymphocyte cell surface immunoglobulin 
receptors induces the B-lymphocyte to proliferate and differentiate 
into a plasma cell rapidly synthesising and secreting irrinunoglobulin. 
Each plasma cell in tha clone derived from a given antigen-sensitised 
B-lymphocyte produces a single molecular species of antibody which 
binds that antigen. 
The complete role of 1-lymphocytes is less well understood but 
as a class they have several subsets which can have effector or 
regulator functions. Effector T-lymphocytes are the agents of 
cell-mediated immune reactions and regulator subsets of T-lymphocytes 
modulate the response to most antigens controlling, among other things, 
imunoglobulin production by B-lymphocytes (Fig. 1). 1-lymphocytes 
are also known to be antigen specific in their responses and there is 
evidence demonstrating that the 1-lymphocyte receptor which mediates 
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Fig. 1 	A diagramatic overview of J and B lymphocyte development 
and function 
(Adapted from broder et al., 1978) 
"Bursal Equivalent" refers to the Avian Bursa of Fabricius which 
is the organ of B lymphocyte development in that species. No similar 
organ has been found in other vertebrates but historically a "Bursal 
Equivalent" is inferred in non- AvianB lymphocyte ontogeny. 
Ag 	: antigen 
infers a pathway of cellular development 
indicates cell interaction 
synthesised by the T-lymphocyte itself (Krawinkel et al., 1979) and 
that regulator molecules produced by T-lymphocytes may also be in 
some part imunoglobulin-like (Sy et al., 1980). In addition, 
another family of immunologically important molecules, the classical 
transplantation or histocompatibility antigens have some structural 
similarities with the imunoglobulins (Orr et al., 1979). However, 
while accepting the importance of these related molecules, the 
immunoglobulins themselves are central to the functioning of the 
immune system. 
THE STRUCTURE OF IMMUNOGLOBULINS 
There is an extensive background of information on imunoglobulin 
structure, which has been described in detail in many reviesand 
texts (see for example Secher 1979 and Nisonoff et al., 1975). 
However a brief account of the principal aspects of iniiiunoglobulin 
structure and nomenclature together with some reference to their 
relationship to function is appropriate here. 
Malignant disorders of B-lymphocytes such as multiple myeloma 
in humans lead to abnormally high levels of homogeneous immunoglobulin 
molecules in the serum and urine of affected individuals. The study 
of these niye1oma  proteins" together with the earlier analysis of 
pooled normal rabbit immunoglobulin (Porter 1959) established the basic 
polymeric composition of ininunoglobulin molecules. Furthermore, 
detailed comparisons of the aminoacid sequences of polypeptides from 
various myeloma proteins yielded the characteristic primary structural 
organisation of the major imunoglobulin polypeptides (Edelman et al., 
1969). 
The major polypeptides of irnunoglobulins; heavy chains and light chains 
The basic imunoglobulin model for all vertebrates studied to 
date is the symmetrical four chain polypeptide unit shown in Fig. 2. 
(Nisonoff et al., 1975). This unit occurs singly in most immunoglobulins 
but can be present as a dinier or pentamer in some immunoglobulin 
classes (See Table 1). However, in every immunoglobulin the monomer 
Fig. 2 	A generalised IgG molecule slowing the basic tetrapeptide 
chain structure of the monomeric iniriunoglobulin unit 
(Adapted from Milstein and Svasti 1971) 
The left hand part of the diagram shows the various regions within 
the molecule; the right hand side shows the orientation of the heavy 
and light chains and the arrangement of disulphide bridges. 
-S-S- : disulphide bridge 
CHO 	: carbohydrate 
H 	 hinge 
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Table 1 	Some properties of human imunoglobulins 
Adapted from Nisonoff et al., (1975) and Turner (1977) 
TABLE 1 
Heavy chain Number of 
Sedimentation Molecular molecular heavy chain Carbohydrate Normal serum 
Ininuenoijlotial in Heavy Oialii StruLture coefficient weight 
(x10 3 ) 
weight 
(x10 3 ) 




IgG 1 Y l 2 - 3 monomer 7 146 51 4 9 
IqG2 y 2 monomer 7 146 51 4 2 - 3 3 
19G  y3 monomer 7 165 60 4 2 - 3 
ttjC. 4 monomer 7 146 51 4 2 - 3 0.5 
lqH p Pentamer 19 970 72 5 9 - 	12 1.5 
+ J chain 
IijA 1 monomer 7 160 52 - 56 4 7 	- 	11 3 
7 160 52- 58 4 IgA 9 
" 2 
monomer 7 	- 	11 0.5 
dlmer 
i J chain 
11 380 - 390 52 - 58 4 7 	- 	If 0.05 SIi)A or 02 
4 secretory 
component 
hi0 A monomer 7 172 - 200 60 - 69 
4 or 5 9 - 	11 0.03 
IgL monomer 8 188 - 196 72 - 76 4 12 
0.0003 
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unit consists of two identical heavy chains (51,000 - 76,000 mol. wt.) 
and two identical light chains (21,600 mol. wt.). On the basis of 
comparisons of exact aminoacid sequences of imunoglobulin polypeptides, 
both heavy and light chains have been divided into two regions, an 
N-terminal "variable" region of about 110 - 120 aminoacid residues 
and a C-terminal "constant" region which comprises the remainder of 
each polypeptide. (Milstein et al., 1967, Putman 1974). 
Constant regions and variable regions 
This constant (C) regions of itmiunoglobulin polypeptides do 
not vary in aminoacid sequence except at a number of residues 
reflecting isotypic and allotypic variation (Milstein and Munro 1973). 
In humans there are five isotypes or classes of heavy chain a 6 c y 
and i-i , with subclasses among the a and y chains and, as throughout 
the vertebrates, there are two light chain types; K and A . Immunoglobulin 
molecules are differentiated from each other by their heavy chain class, 
an cx heavy chain containing molecule belonging to the IgA class of 
ininunoglobulins, a 	heavy chain the IgG class and so on (See Table 1). 
An Ig molecule of any class may have light chains of either K or A 
type though not a hybrid mixture. 
Inriunoglobulin C region allotypes are alternative forms of 
isotypes present in only some individuals of a species. These serologically 
detected markers are of great significance when studying immunoglobulin 
genetics (Natvig and Kunkel 1973). However despite correlation of many of 
these markers with variations in aminoacid sequence, allotypes are 
not a major source of classification in imunoglobulin structure. 
Thevariable (V) regions of immunoglobulin heavy and light chains 
are not uniformly variable but have distinct groups of "hypervariable" 
residues. There are three such hypervariable segments in the V regions 
of light chains (Wu and Kabat, 1970) and three or four in the V regions 
of heavy chains. The hypervariable regions of a heavy chain together 
with the corresponding sequences of the associated light chain fold 
together in the antibody molecule to form an antigen combining site 
(Poljak 1974). This gives the antibody molecule, in its monomeric 
form, two identical combining sites. In contrast to the hypervariable 
residues, the non-antigen binding portions of an immunoglobulin 
chain V region are conserved and are referred to as the V region 
"framework" sequences (Wu and Kabat 1970, Capra and Kehoe 1975). 
Imunoglobulin domains 
Irtinunoglobulin molecules show a high degree of internal 
homology in primary structure (Edelman 1972). Both heavy and light 
chains can be divided into contiguous regions of homology of about 
110 - 120 aminoacids in length: Two in the light chains, V  
(variable light) and CL  (constant light) and four or five depending 
upon class in heavy chains, V   (variable heavy), C H  1 (constant heavy 1), 
C H  2 (constant heavy 2) etc. (See Fig. 2 and table 1). The V region 
sequences are homologous with each other but not with the C regions; 
each of the CH regions are homologous to each other and to CL. 
Intrachain disulphide bonds are located, one in each homology region, 
enclosing a peptide loop of about 60 - 70 aminoacid residues in 
each case. 
The linear periodicity in primary sequence and disulphide 
bond arrangement shown by immunoglobulin molecules underlies a 
similarly ordered tertiary and quaternary structure. The "domain 
hypothesis proposed by Edelman (1970) suggested that each homologous 
region is folded into a compact globular structure (domain) and 
linked to neighbouring domains by more loosely folded stretches of 
polypeptide. Electron microscopic and X-ray crystalographic evidence 
have confirmed the existance of domains as independant three-dimentional 
entities (Pojak 1975) and in addition it has been shown that there is 
a characteristic "immunoglobulin fold" which, to date, has been found 
with only minor modifications in every immunoglobulin domain studied 
(Feinstein & Beale 1977). Edelman (1970, 1972) has further suggested 
that each homologous region has evolved as an active site mediating 
a function of the imunoglobulin molecule. There is evidence to 
support this concept in the function of the V region domains being 
antigen binding and in the location of certain effector functions of 
immunoglobuliri molecules within specific heavy chain C region domains 
e.g. Cl q (the first complement factor) binding to the C 
H 
 2 domain in 
human 1gM and IgG classes and monocyte membrane binding by the C H 3 
domain of human IgG (Turner 1977). 
The hinge region 
The interdomain segment known as the "hinge region" (See Fig. 2 
occurs in humans in the centre of the linear sequence of cx , 	, and y 
heavy chains (Edelman 1970, Liu et al., 1976, Spiegelberg 1977) 
and contains most or all of the interchain disulphide bonds. 
Immunoglobulin sequence homology is at its lowest in the hinge 
region (Michealsori et a]., 1977) which is rich in proline residues 
and is particularly susceptible to enzymic cleavage. It has been 
suggested that the role of the hinge may be in providing a flexible 
or specific angle between the two binding sites of the monomer 
molecule which, when antigen is bound, co-ordinates the action of the 
antigen binding (Fab) and effector (Fc) portions of the molecule 
(Huber et al., 1976). 
The terms Fab and Fc (Fig. 2) are used in describing all 
imunoglobulins but originate from the proteolysis of rabbit IgG 
by the plant protease papain (Porter 1959): Fab - Fragment antigen 
binding; Fc - Fragment crystalline which was subsequently shown to 
be associated with the effector functions of the molecule. 
Other polypeptide components 
In addition to heavy chains and light chains there are two 
other polypeptides found in certain imunoglobulins: The J chain is 
a 15,000 Dalton polypeptide synthesised by antibody forming cells 
but which has no structural homology to other immunoglobulin 
polypeptides. It is invariably found in association with 1gM pentamers 
and IgA dimers (Koshland 1975). Although no role other than its 
structural one has been forwarded for the human J chain, it has been 
proposed that the J chain has a controlling influence in the 
polymerisation of murine 1gM (Della Corte and Parkhouse 1973). The 
secretory component (SC) is a 60,000 Dalton polypeptide structurally 
unrelatedto other immunoglobulin polypeptides (Mestecky et al., 1971) 
and associated with sIgA which is the IgA dimer of external secretions 
(gut, saliva and milk). The secretory component is not synthesised 
by antibody forming cells but by epithelial cells and is attached 
during the secretion process (Poger and Lamm 1974). 
Carbohydrate moiety 
Besides polypeptides, immunoglobulins also contain oligosaccharides; 
infact all immunoglobulins are glycoproteins. The carbohydrate content 
in immunoglobulins varies between the different classes (See table 1) 
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and there is a wide variation in the sugar groups present (Clamp and 
Johnson 1972). Heavy chains always have covalently attached 
carbohydrate; in human a , 6 and -y chains there is only one 
carbohydrate side chain in each case attached immediately N-terminal 
to the C 
H 
 2 domain (Edelman 1970, Pink 1970, Spiegelberg 1977), but 
chains can have up to five oligosaccharide units all at different 
positions in the C region (Putman 1973). 
The secretory component and the J chain are also glycopeptides 
but light chains in general have no carbohydrate content. However 
oligosaccharide attachment to light chains has been reported at 
aspartic acid or asparagine residues in the light chain V region. 
In each case the light chains have been free Bence-Jones proteins 
of murine and human origin (Knope et al., 1975, Keifer et al., 1980). 
No satisfactory explanation has yet been offered as to the biological 
role of the oligosaccharide substituants of ininunoglobulin molecules. 
It has been suggested that the attachment of carbohydrate facilitates 
the secretion of certain classes of inriunoglobulin in murine myelomas 
but this observation excludes mouse IgG which can be secreted with or 
without its oligosaccharide groups (Hickman and Kornfield 1978). A 
structural role for immunoglobulin carbohydrate has been put forward 
in a human IgG myeloma protein where it prevents close contact of the 
CH1 and C 
H 
 2 domains which is important in the interaction of the Fab 
and Fc regions of the molecule (Silverton 1977). 
Although the oligosaccharides of immunoglobulins are interesting, 
such relationships between carbohydrates and proteins are common, 
however, the nature of immunoglobulin polypeptide chains especially 
in terms of the relationship between their structure and the genes 
which encode 	them is far from common and perhaps unique to those proteins. 
THE GENETICS OF IMMUNOGLOBULINS 
This is another well reviewed topic especially from the point 
of view of the classical genetics of polypeptide allotypes and sequences 
(Milstein and Munro 1973, Sogn and Kindt 1977) but also more recently 
at the nucleic acid level (Rabbitts 1979). The latter of these two 
approaches using new DNA technology continues to make rapid inroads 
on imunoglobulin genetics and it is this field which forms the 
greater part of the following short account. 
There are two crucial observations from imunoglobulin structure 
which have influenced the study of ininunoglobulin genetics - The 
striking variable/constant nature of heavy chains and light chains 
and the extensive non-random diversity of V region sequences. To 
resolve the genetic problem of two structurally distinct regions within 
one polypeptide Dreyer and Bennet (1965) hypothesised that separate 
genes were required to code for the V and C regions of each chain. 
Furthermore, their hypothesis offered an explanation of antibody 
diversity by proposing that a single C region gene can be expressed 
in conjunction with any one of a battery of V region genes, each 
coding for a different V region, by somatic recombination. These 
arguments have been shown to be relevant to several features of 
antibody gene organisation and expression. 
Separate V and C genes and their integration 
Sequence studies and genetic analysis of the V and C regions of 
both heavy and light chains of myeloma and normal serum inriunoglobulins 
have been consistant with the "two genes one polypeptide" argument of 
Dreyer and Bennet (1965). For example aminoacid sequence analysis of 
several human K light chains has revealed three basic groups of V region 
sequences (Milstein 1967) defined by characteristic residues and shared 
sequence insertions or deletions. It is generally accepted that if 
the groups of sequences are well defined, as in the case of human 
K chains V regions, they represent the expression of multiple non-allelic 
genes (for a more detailed explanation see the section on V region 
diversity). Since, in addition, the allotypes of human K  chain C regions 
segregate in a true allelic fashion (Mage et al., 1973) suggesting 
that there is only one K c gene per haploid set of chromosanes 
separate V and C genes and their integration must be postulated. Analysis 
of aminoacid sequences and of the segregation of markers in other human 
inriunoglobulin polypeptides and the immunoglobulins of the mouse and 
rabbit, where V region markers are also available (Milstein and Munro 1973, 
and Sogn and Kindt 1977) have given similar results and shown the 
following general lay-out of antibody genetics; The immunoglobulin 
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genes reside in three unlinked groups, one codes for the heavy chains 
another for the K chains and the third for A chains. Within each 
family there are separate clusters of V and C genes (the number of 
V genes being greater than the number of C genes) which are closely 
linked to each other but are clearly distinct since several 
recombinants have been detected in mice and rabbits (Mage et al.., 
1973, Leiberman et al., 1974). 
Having established that for heavy chains and each of the light 
chain types there are separate V and C coding sequences the question 
then arises of the stage at which the information from the separate 
genes is combined to produce a complete heavy or light polypeptide 
chain. Evidence against this happening at either the transcriptional 
or translational levels comes from the contiguous translation of V 
and C regions from the same light chain messenger RNA isolated from 
a mouse myelorna tumour cell line grown in tissue culture (Milstein 
et al., 1974) and from the absence of V and C region scrambling in 
the immunoglobulins synthesised by hybrid myeloma cells (Kohler and 
Milstein 1975). Both these observations conform with a hypothesis that 
the V and C genes are rearranged and joined together at the DNA level. 
Direct evidence for separate V and C genes in undifferentiated 
DNA (representing the germline) and their subsequent rearrangement or 
translocation in differentiated tissue has been presented by Hozumi 
and Tonegawa (1976). They demonstrated that the treatment of mouse 
embryonic DNA with a restriction endonuclease produced two fragments 
which showed significant hybridisation with a labelled K light chain 
rnRNA whereas the similar treatment of mouse myeloma DNA produced 
only one such fragment. In the same way a similar rearrangement 
was shown for the mouse Ày and C genes (Tonegawa et a]., 1976). 
However although these experiments demonstrated the rearrangement of 
light chain V and C genes such that theyauld be detected on a single 
DNA fragment, they had not shown that the V and C genes were joined 
into a continuous coding sequence in that fragment. In fact the 
susceptibility of nucleic acid hybrids between KcDNA (Rabbitts and 
Forster 1978) and K mRNA (Mathyssens and Tonegawa 1978) to a single-
strand specific nuclease suggested that the rearranged V and C genes 
were not contiguous. Furthermore, duplexes between mouse A mRNA 
and a cloned myelorna V+C gene seen under the electron microscope formed 
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loops of intervening sequences between the V and C coding segments 
(Brack and Tonegawa 1977). The non-contiguous nature of the 
rearranged A chain V and C genes was confirmed by the complete 
nucleotide sequence of a mouse myeloma A gene which together with 
the sequence of the corresponding germline gene (Bernard et a]., 1978) 
also revealed other interruptions in the gene structure and identified 
the site of integration of the V and C genes (See Fig. 3a). The 
germline sequence consisted of 45 base pairs (b.p.) coding for the 
leader (L) or signal peptide (an N-terminal peptide present in the 
unsecreted A chain precursor), 93 b.p. of untranslated intervening 
sequence 1, 306 b.p. coding for the V region up to aminoacid 
residue 102 (V), about 4,500 b.p. of undefined DNA, a 39 b.p. sequence 
coding for the remainder of the V region (J), an untranslated 
intervening sequence of about 1,200 b.p. (1 
2 )and finally the 
uninterrupted C region coding sequence (C). In the myeloma DNA the 
two partial V region coding sequences were covalently linked together 
eliminating the large undefined segment of DNA from the gene; the rest 
of the gene structure remaining unchanged. A comparison of the germline 
and myeloma sequences shows that integration of the mouse A chain 
coding segments does not occur at the V/C junction but between a 
foreshortened V region gene and a segment of DNA (which has been termed 
the J or joining segment) encoding the final V region sequences. 
Siedman and colleagues (1979) have reported a similar gene structure and 
analogous joining mechanism in a mouse K light chain. Further sequence 
analysis (Max et al., 1979, Sakano et al., 1979) has shown the K 
arrangement to be more complicated than the single A J segment revealing 
a cluster of five J segments identified by homology to K chain aminoacid 
sequences. 
Murine immunoglobulin heavy chain genes are also interrupted 
by non-coding sequences and show somatic rearrangement. The hybridisation 
of mouse V   and  CH cDNA with embryonic and myeloma DNA has shown the 
V genes to be distant from the cluster of C genes in the germline 
and rearranged in the differentiated tissue (Maki et a]., 1980, 
Gough et al., 1980). 
Comparisons of the DNA sequence of a germline V  gene and the 
corresponding rearranged sequence expressed in an ct chain (Early et al., 
1980a)and a Y 2b (subclasses of the mouse -y chains are 1, 2a, 2b and 
3) chain (Sakano et a]., 1980) have shown that the germline V   sequence 
Fig. 3 	Arrangement, rearrangment and transcription of murine 
imunoglobulin genes 
Horizontal lines are introns or non-transcribed sequences in DNA 
and untranslated portions of RNA; raised boxes are exons in DNA and 
translated sequences in RNA. 
Murine 	light chain genes in embryonic or germline 
(undifferentiated DNA) and plasma cell DNA. 
Murine K  light chain genes in embryonic or germline 
(undifferentiated DNA) and plasma cell DNA showing also the transcription 
of the plasma cell gene and the splicing of that transcript. 
Murine heavy chain genes in embryonic or germline 
(undifferentiated DNA) and in the DNA of i-' and Y2b synthesising cells as 
a demonstration of the heavy chain switch; this diagram also shows the 
transcription of P5 or im mRNA. 
Fig  
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ends at the sequence coding for the third hypervariable region i.e. 
before the end of the expressed V   sequence. By analogy with the 
light chain genes this suggested that the missing sequences should 
be found in the J segments associated with a C gene and in both 
cases the authors sought and found, by hybridisation, a cluster of 
J segments close to the CP gene. However, sequencing of the J segments 
revealed that in neither case did the sum of the V   and J H  germline 
sequences equal that of the intact expressed V gene. In the case 
of the V region expressed in an a chain, the coding gap coincided 
with 14 aminoacid residues of the third hypervariable region and 
with the nucleotides encoding 6 aminoacid residues constituting the 
centre of the third hypervariable region in the case of the V region 
expressed in an 2b chain. These observations have prompted the 
conclusion that the missing nucleotides originate from one or more of 
a third type of germline V gene segment termed the "D" or diversity 
segment, the complete gene being assembled by recombination of V, 0 
and J segments. The existence of 0 segments in mouse heavy chain 
gene construction has also been predicted on the basis of aminoacid 
sequence data (Rao et al., 1979, Schilling et al., 1980). 
Each coding region specifies a domain 
The rearranged and expressed murine heavy chain V gene, in 
common with its light chain counterpart, is continuously coded but 
is itself separated from the constant region by a non-coding sequence 
(Early et al., 1980a, Sakano et al., 1980, Gough et al., 1980). In the 
case of murine light chains the constant region coding DNA is also 
uninterrupted (Bernard et al., 1978, Seidman et al., 1979) so that the 
entire rearranged light chain gene can be seen as being constructed from 
separate segments of DNA coding for each homology region or domain. 
Mouse heavy chain genes show the same fundamental structure as, in 
addition to the separately encodedV region domain, DNA sequence and 
hybridisation studies have shown that in the a (Early et al., 1979), 
i (Sakano et al., 1979, Honjo et al., 1979), Y2b (Kataoka et al., 
1979), p(Gough et al., 1980, Calame et al., 1980, Kawakami et al., 
1980) and 5(Tucker et al., 1980) C region genes the individual domains 
(and hinge regions where present) are each encoded in separate segments 
of DNA (exons) divided from one another by non-coding intervening 
sequences (introns). 
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The Heavy Chain Switch 
The existence of a number of different heavy chain C regions 
in any individual (e.g. nine in man, eight in mice) sharing the 
same set of V regions complicates the expression of heavy chain genes. 
Several studies in different species have shown that at an early 
stage of B lymphocyte differentiation an individual B lymphocyte 
initially expresses the 1gM class of inriunoglobulin, (Cooper et al., 
1976). Later, although light chain expression remains unaltered, 
there is a "heavy chain switch" when the same B lymphocyte, or its 
clonal progeny changes the class of heavy chain it secretes while 
retaining the same heavy chain V region, (Gearhart et al., 1975, 
Wang et al., 1977, Abney et al., 1978). 
In the mouse germline DNA the heavy chain J segments which mark 
the site of V gene integration in the heavy chain gene complex are 
located next to the Cp gene which lies at the start of a cluster 
containing all the heavy chain C region genes (Early et al., 1980a, 
Sakano et al., 1980). It has been suggested that from this germline 
configuration two separate somatic rearrangements are required to 
generate complete iniiiunoglobulin heavy chains other than those of 
the p class (See Fig. 3). The first joins the V, D and J segments of 
the V coding sequences and the second replaces the Cp coding sequences 
with those of another heavy chain class or subclass i.e. mediates the 
heavy chain switch. Direct evidence that DNA rearrangement is the 
mechanism of CH  switching has been presented from the examination 
by hybridisation and sequence studies of rearranged a (Davis et al., 
1980a), y 1 (Kataoka et al., 1980) and 12b  (Sakano et al., 1980) 
genes from mouse myeloma tumours expressing those respective classes 
of heavy chain. In each of these cases the expressed gene contains, in 
addition to a fused V gene and the appropriate CH  gene, a portion of 
the sequences which flank the Cii gene on the J segment side. This 
suggests that the VH  gene was initially associated with the CP gene 
and that a later DNA rearrangement then replaced the Cu gene with the 
subsequent CH  gene by linking together their respective flanking 
sequences. The point at which the flanking sequences join in the 
rearranged gene and the corresponding breakpoints in the germline DNA 
are termed the "switch sites". The sequence analysis of three different 
Cu - Ca switching sites (Davis et al., 1980b) has shown that the 
sequences surrounding those sites are highly conserved blocks of thirty 
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nucleotides which may serve as a recognition sequence. These sequences 
are unlike those thought to mediate V-D-J joining in V   genes 
(Sakano et al., 1979, Early et al., 1980a, Max et al., 1979) and they 
lack homology with the sequences reported for the C1 1 (Kataoka et al., 
1980) and Cy2b  (Sakano et al., 1980), switching sites which in turn 
suggests that heavy chain switching is mediated by class specific 
recognition sequences. The y 1 gene sequence of mouse rnyeloma MC101 
(Kataoka et al., 1980) as analysed by Davis et al., (1980b) contains 
Ca and C11 flanking sequences in that order between the VH 
and Cy1 gene segments indicating that switching progressed from Ci 
to Ca and subsequently from Cw to C -r1 and so it may be a multistep process. 
Alternatively, successive complex switching may be an aberration 
characteristic of myeloma cell lines. 
In any case, the order of events contrasts with that of the 
simple deletion model for switching proposed by Honjo and Kataoka (1978). 
They employed hybridisation kinetics to determine the number of CH  genes 
in mouse myeloma tumours producing different classes of immunoglobulin 
and concluded that a V   gene is combined with a second CH  gene by 
deletion of the intervening DNA between the V   and second CH  genes. 
Based on this model their data fit a heavy chain gene order of 
a. The use of cloned cDNA CH  probes to demonstrate 
that C1.1 genes were not present in the fractionated DNA of IgG and IgA 
secreting mouse myelomas although each retains a full complement of Ca 
genes (Cory and Adams 1980) and similar experiments using different 
combinations of CH  probes and myeloma lines expressing different 
imunoglobulins (Cory et al., 1980, Coleclough et al., 1980, Rabbitts 
et al., 1980a) have supported Honjo and Kataoka's mechanism and order 
of CH  switching. However, in contrast to Honjo and Kataoka (1978) these 
later reports have shown that CH  switching was often not confined to one 
allelic set of heavy chain genes and even took different forms within 
a single cell line, presumably varying on different homologous 
chromosomes. That different gene arrangements in the same cell do not 
result in the synthesis of two different heavy chain polypeptides is 
due to "allelic exclusion" in immunoglobulin gene expression. 
Allelic Exclusion 
Each normal antibody secreting cell and its progeny from an 
individual heterozygous for immunoglobulin C region markers expresses only 
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one of either of the two available allotypes (Pernis et al., 1955, Davie 
et al., 1971) and this phenomenon has been termed "allelic exclusion". 
Despite having been established for some time, mechanisms have not 
readily been put forward to explain allelic exclusion in irTrunoglobulins. 
However during the studies of irmiunoglobulin gene structure allelic 
exclusion is another property of irrinunoglobul ins which has been linked 
with the rearrangement of their genes. 
Several authors have suggested that allelic exclusion operates by 
the expressed allele being rearranged while the imunoglobulin genes 
remain in their germline configuration on the excluded chromosome. This 
argument has been complicated by the frequent failure to detect 
unrearranged heavy chain (Cory and Adams 1980, Coleclough et al., 1980) 
and light chain (Lenhard-Schuller et al., 1978, Perry et al., 1980) 
genes in mouse myeloma cells. However, only one rearranged gene is 
expressed, others are non-functional or "abortive" rearrangements which 
may result, for example, in a reading frame shift producing a stop 
codon (Altenberger et al., 1980) or an erroneous splicing pattern of 
the primary transcript (Siedman and Leder 1980, Choi et al., 1980). 
Following these observations the first argument has been modified to 
suggest that allelic exclusion may be the result of a multistep process 
(Perry et al.., 1980, Coleclough et al., 1980) with different V gene 
rearrangements taking place until one functional V-J or V-D-J integration 
has been formed, after which further rearrangements are inhibited by an 
unknown mechanism. The occurrence of K mRNA's and rearranged K genes 
in A producing mouse myelomas has prompted the proposal that the same 
mechanism that mediates allelic exclusion is responsible for ensuring the 
synthesis of only one light chain type by each B lymphocyte and its 
progeny (Alt et al., 1980a) i.e. genic or isotypic exclusion. This would 
be achieved by exclusion of the formation of complete A chain genes in 
cells already expressing K chains while, following a "pecking order", A 
genes would only be rearranged if the joining of K gene segments failed to 
produce a functional light chain gene. In the case of heavy chains, 
more than one class is expressed in the same B lymphocyte during 
differentiation but these will all originate from the same allelic set 
of heavy chain genes, as the successful integration of a VH  gene will 
inhibit the same event on the other allele or that allele will previously 
have formed a non-functional V  gene which will prevent the expression of 
C  genes from that allelic cluster. 
Alternatively the mechanism of allelic exclusion may be, as first 
thought based simply on the joining of iriununoglobulin genes on one 
homologous chromosome only, for, in contrast to the reports on mouse 
myelomas in which more than one allele is rearranged, Joho and 
Weissman (1980) have reported that in normal mouse spleen cells 
expressing Kchains about 50% of theK alleles are unchanged, indicating 
that non-functional rearrangements may occur rarely or not at all in 
normal lymphoid cells. If this is the case non-functional rearrangements 
can be explained as an abnormal feature related to the malignant nature 
of the mouse myeloma cells. However, the question has been raised 
whether the technique of Joho and Weissman (1980) has sufficient 
resolution to detect cells with both chromosomes rearranged if they are 
in a minority (Altenberger et al., 1980, Molgaard 1980). Therefore 
it is still open to question whether both inyeloma  cells and normal 
B lymphocytes have more than one V gene joining event per expressed 
heavy chain or light chain. However in addition to being thought of 
as a mechanism of allelic/genic exclusion, non-functional inriunoglobulin 
gene rearrangements have been seen as part of the process of generating 
diversity in variable region genes. 
V region Diversity 
The hypothesis of Dreyer and Bennet (1965) on the molecular 
basis of antibody formation explained V region diversity in terms of 
each V region being coded for by a different V gene, all such genes 
being present in the germline DNA and this argument has become known 
as the "germline theory" of antibody diversity. Alternatively, somatic 
models (Gally and Edelman 1972) proposed that V region variation could 
be generated from a small V gene pool by somatic mutation or recombination 
during the development of the individual. As the gerinline theory 
predicts that all V regions are coded for in the germline whereas 
according to somatic models only a few basic V genes will be present, 
an evaluation of the number of germline V genes should determine which 
hypothesis is likely to be correct. The aminoacid sequences of V regions 
and nucleic acid hybridisation data have both been used to estimate 
the number of gernline V genes. 
The analysis of spontaneous human myeloma proteins established 
the classification of V region aminoacid sequences in to distinct groups 
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in both light chains and heavy chains (Hood and Talmage 1970, Capra 
and Kehoe 1975). There are four defined groups of human K light chain 
V region aminoacid sequences and the same number in the A light chain 
V regions, while among the human heavy chains there are three reasonably 
well defined groups of V region sequences. It has been argued that 
if a single gene coded for all the V regions belonging to a given 
imunoglobulin chain, multiple identical somatic mutations would be 
required to produce the observed ordered array of aminoacid sequences. 
As this was considered an unlikely event, it was inferred that the 
different basic sequences of a given V region are coded for by separate 
germline genes. (Milstein et al., 1967, Hood et al., 1967). Furthermore, 
the presence of different V region groups in all individuals implies 
that they do not represent alleles of a single locus, for if they did 
they would segregate (Milstein et al., 1969, Tischendorf et al., 1971, 
Wang et al., 1971). These studies on human irmiunoglobulins supported 
the idea that both heavy chain and light chain V regions are coded for 
by tandem non-allelic genes. Aminoacid studies in the mouse myeloma 
system have extended and refined these initial conclusions and in the 
same system the study of V region diversity has been pursued using 
imunoglobulin mRNA and cDNA probes. 
Mouse K chains, which constitute 95% of light chains in the mouse, 
show extensive variation in V region aminoacid sequences in both the 
hypervariable and framework residues. This pattern of variability can 
be explained in part by multiple germline genes since, from partial 
N-terminal aminoacid sequence data, the number of K V region groups 
(and so the minimum number of V genes) has been estimated to be about 
fifty for either Balb/c or NZB mice (Hood et al., 1976). 
The extensive study of one K V region group V21 has stressed 
the importance of multiple germline V genes but has also suggested 
that antibody diversity may be increased by somatic means. The V21 
group, on the basis of almost complete aminoacid sequences, may be 
further divided into six subgroups by related sequence patterns 
(McKean et al., 1978, Weigert et al., 1978) indicating that within that 
single group there are at least six germline genes. It is possible 
that additional V21 subgroups may be found but nucleic acid hybridisation 
data (Valbuenna et al., 1978) have suggested that the number of V21 
germline genes is the same as the number of subgroups. This would avour 
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there being a somatic source of variation in this group as the entire 
group consists of nearly thirty different sequences. 
In contrast to K light chains the pattern of variability in the 
V regions of mouse A light chains (which make up only 5% of mouse 
light chains) has been shown to be a simple one. (Weigert and Riblet 
1976). In twenty one A chains produced by myelomas induced in inbred 
Balb/c and NZB mice, twelve V region sequences were identical and 
the remaining nine differed by only one - three aminoacid substitutions 
all of which were present in hypervariable regions. Such a simple 
pattern of diversity is consistent with there being one germline V A 
gene and variants arising by a somatic mechanism. This interpretation 
is supported by nucleic acid hybridisation studies which suggest that 
mouse A V regions are coded for by one or a few germline genes 
(Tonegawa 1976). 
The aminoacid sequence data on mouse heavy chain V regions are 
neither as extensive nor as revealing as the light chain sequences. 
The available sequences can be divided into four groups with the 
largest of them being further divisible into at least 5 subgroups 
(Barstard et al., 1974). This pattern of diversity suggests that the 
variable regions of mouse heavy chains are under multigene control 
encoded in at least eight germline genes. Hybridisation of mouse 
germline DNA using V   probes has shown that there are at least 50 and 
probably many more V   genes (Cory and Adams 1980, Rabbi tts et al., 
1980b). These estimates of the total number of germline V genes on 
their own do little to explain the generation of antibody diversity. 
However, together with the same information from other imunoglobulin 
chains it is possible, assuming that most light chains may combine 
with mostheavy chains, to calculate the number of different antibody 
molecules that could be formed using germline sequences only. For 
example, using estimates of 350 V   geniiline genes and 200 VH  germline 
genes compounded from mouse protein and nucleic acid data (Weigert et al., 
1978), one can propose that 7 x 10 different antibody molecules could 
be formed. However, as estimates of the mammalian antibody repertoire 
are currently running at about 2 x 10 (Kohler et al., 1976, C an ro 1978) 
the difference between these two figures suggests that there must be 
some somatic mechanism involved in the generation of diversity. 
Several authors have suggested the possibility that V-J joining 
in light chains and V-D-J joining in heavy chains may generate V region 
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sequence diversity by random combination of the coding segments 
involved (Weigert et al., 1978, Seidman et al., 1979) and codon 
variation at the joins between the segments (Bernard and Gough 1980, 
Max et al,, 1979, Sakano et al., 1979). If the flexibility in the 
exact position of V gene joining necessary for this latter mechanism is 
accompanied by the generation of missence genes (Max et al., 1980), 
such a mechanism could account for the large number of non-functional 
gene rearrangements in myeloma cells. 
Certainly V gene somatic rearrangement is a defined molecular 
mechanism which does lead to V region sequence differences and could 
generate considerable diversity. Nevertheless not all the variations 
in V region aminoacid sequence attributed to somatic diversity can 
be accounted for by these mechanisms. None of the sequence differences 
in mouse A V-regions can be explained by V-J joining and there are 
20 - 30 K  V-region aminoacid residues which show more variation than 
residue 96 whose codon coincides with the V-J join (Dunnick 1979). 
In general the antigen complementarity of an antibody molecule depends 
on all the hypervariable regions and not just those in the vicinity 
of V-J, V-D-J joining. The significance, in terms of antigen specificity 
of aminoacid sequence changes which can be attributed to joining and 
the mechanism(s) responsible for non-germline V region diversity in 
parts of immunoglobulin molecules not concerned with V region joining 
has yet to be demonstrated. 
Human immunoglobulin gene structure; evidence from variant imunoglobulin 
polypepti des 
Analysis of aminoacid sequences and the segregation of markers 
have shown' that separate V and C genes code for both heavy chains and 
light chains in man and other species in addition to mice. However, 
there are, at the moment, only murine immunoglobulin nucleic acid 
probes and the greater detail of immunoglobulin gene structure and 
expression which has come from the study of immunoglobulin genes 
at the nucleic acid level has been confined to that species. Nevertheless 
there are several deletion mutants which occur in both murine and 
human immunoglobulins whose structure can be correlated with the known 
organisation of mouse imniunoglobulin genes and so imply a similar 
organisation of human imunoglobulin genes. 
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The human ininunoglobulin chains with internal deletions for 
which enzymic degradation can be excluded and a genetic basis implied 
in their origin have been summarised by Franklin (1979). In these 
variant immunoglobulin polypeptides an entire domain or hinge region 
is often deleted and it is an interesting feature of the deletions 
that they begin or end at or near what would be a germline exon/intron 
boundary if human imniunoglobulin genes were similarly organised to 
those of the mouse. The majority of human heavy chain variants have 
been isolated from the serum of individuals with a rare lymphoproliferative 
disorder called "heavy chain disease" (Franklin 1964) and are referred 
to as heavy chain disease (H.C.D.) proteins; the remainder are from 
myeloma proteins. (See Fig. 4a). Five Y, and one Y H.C.D. variants 
show a deletion which encompasses part of the variable region and 
all of the C 
H  1 domain of the constant region with resumption of the 
normal sequence at the beginning of the hinge region. A further three Y l 
variants have an exact and complete deletion of the hinge region itself. 
In three y3  variants, one shows a deletion of part of the V region 
and all of the C 
H  1 domain similar to those variants in the Y and 
class; a second shows the same deletion but extended into the hinge 
region (which in 	chains is replicated three times) ending exactly 
before the final replicate of the hinge; the third has all of the CH  
domain and a large internal portion of the V region missing but has 
retained, between the two deletions, a last part of the V region 
sequence which could be analogous to the murine heavy chain J segment. 
Similarly in an abnormal A chain from a human myeloma the internal 
V region deletion ends at residue 99 which corresponds exactly to the 
position of V-J joining in murine A light chains (Fig. 4b). A second 
abnormal human A type myeloma light chain has a V region deletion 
which ends at a position (aminoacid residue 110) corresponding to the 
start of the murine J-C intron (Fig. 4b). 
There are murine and human immunoglobulins whose heavy chains 
have hybrid C regions, that is they are composed of domains from 
different heavy chain classes. (Birshtein et al., 1980, Tsuzukida 
et al., 1979). These cases have been used to argue that there are 
separately encoded domains in immunoglobulin genes as shuffling of 
individual domain coding regions, for example by recombination, is a 
likely mechanism to account for such hybrid molecules. Human and mouse 
Fig. 4 	Variant human imunoglobulin polypeptides together with the 
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imunoglobulin gene structure have also been equated by comparison 
of a peptide spanning the V/C junction in human S chains with the 
homologous region in other human heavy chain classes and subclasses 
which indicated the presence of a short J type sequence. (Milstein 
and Dêverson 1980). 
In summary one might propose that, from the characterisation of 
variant human immunoglobuljn polypeptides, human light chain C regions, 
heavy chain C region domains and hinge regions are separately encoded 
as exons in an imunoglobulin transcription unit and furthermore that 
the V regions of both heavy chains and light chains in humans are 
formed by the fusion of at least two germline segments. 
THE BIOSYNTHESIS OF IT1UNOGLOBULINS 
A complete account of the biosynthesis of a polymeric glycoprotein, 
which all imunoglobulins are, must consider transcription, translation, 
glycosylation, assembly and secretion. All these topics will be 
briefly considered here together with the regulation of irnmunoglobulin 
production. For a further account the reader is directed to extensive 
reviews by Williamson (1973) and Parkhouse (1977) although these do 
not include an account of the processing of an immunoglobulin primary 
RNA transcript nor of the role of the N-terminal signal peptide in 
irnmunoglobulin secretion. 
Transcription of Immunoglobulin genes 
Even in their integrated forms, active immunoglobulin genes 
are not contiguous in the genome. Recent studies on other genes of 
eukaryotes and their viruses have revealed several more cases of this 
split gene structure where coding segments of DNA (exons) alternate 
with non-co0ing intervening sequences (introns). In general the 
introns are excised from a large nuclear transcript to give a 
continuously coding mRNA, (for a review see Crick 1979). The 
immunoglobulins are no exception to this and Rabbitts (1978) and 
Gilmore-Hebert and Wall (1978) have demonstrated in mouse myeloma 
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cells that the smallest light chain coding nuclear RNA fragment is 
of a similar size to the cytoplasmic message. They concluded that 
light chain rnRNA is processed from a larger nuclear transcript. 
(See Fig. 3b). 
In both mouse myeloma and human lymphoid B cells membrane-bound 
and secretory 1gM iiheavy chains have different carboxytermini which 
is reflected in their being coded for by separate species of mRNA 
that differ at their 3' ends, (Alt et al., 1980b, Singer et al., 1980). 
Although there is a single uC gene in the mouse (Cory and Adams 1980) 
apparently there are two separate 3' terminal sequences for p RNA 
encoded in the genome so that mRNAs coding for either membrane bound 
chains (pm) or secretory p chains (us) may be created by alternative 
nuclear RNA processing (Early et al., 1980b) as shown in Fig. 3c. A 
similar system would appear to operate in the 6 chain of IgD molecules 
the other major class of membrane bound inhTiunoglobulin (Tucker et al., 
1980). 
However, despite differential processing of a primary transcript 
operating at this level the lack of detectable p or a transcripts in 
the nuclei of y producing mouse myeloma cells (Marcu et al., 1979) 
and the absence of V and C region scrambling in hybrid mouse nyeloma 
cells producing two different classes of heavy chain (Schulman and 
Kohler 1978) argue against such a mechanism in heavy chain class 
determination. 
Translation of inriunoglobulin mRNA 
There are no mechanisms peculiar to immunoglobulin translation 
and in common with all other proteins imunoglobulin polypeptides 
are synthesised in an N-terminal to C terminal direction from a 
single initiation point (Fleishman 1967, Lennox et a]., 1967) which is 
the codon for methionine tRNAF (Milstein et al., 1972) the general 
initiator for eukaryotic proteins. 
The heavy chains and light chains of mouse myeloma immunoglobulins 
are synthesised on separate polyribosomes on the membrane of the 
endoplasmic reticulum (Williamson and Askonas 1967, Cioliar,d Lennox 
1973). The membrane bound character of the heavy and light chain 
synthesising polyribosomes ensures that transport of the nascent 
polypeptides into the cisternae of the endoplasmic reticulum which 
predetermines the addition of carbohydrate and ultimate secretion of 
the completed immunoglobul -in molecules. 
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Glycosylation of imnunoglobulins 
The addition of sugars to imunoglobulin chains and the subsequent 
modification of those sugars (as studied in mouse B lymphoid cells) 
occurs in three main steps which are common to glycosylated proteins 
in general. First, the addition of core sugars to the nascent 
polypeptides as they emerge into the cisternae of the endoplasmic 
reticulum (Bergman and Kuehl 1977), second the partial trimming of 
these oligosaccharjdes in the endoplasmic reticulum (Tabas et al., 
1978) and finally the addition of terminal sugars in the Golgi complex 
(Melchers 1973). Carbohydrate addition is not required for monomer 
assembly, polymerisation (when it occurs) or secretion since completely 
unglycosylated irmiunoglobulins can be assembled and secreted (Hickman 
and Kornfield 1978, Tartakoff and Vassallj 1979). 
The Assembly of Immunoglobulin molecules 
The nascent heavy and light chain polyptides are assembled into 
H 2 L2  immunoglobulin monomers in the cisternae of the endoplasmic 
reticulum. Assembly occurs between nascent heavy chains and a pool 
of free light chains (Williamson and Askonas 1968) initially by 
noncovalent interactions prior to covalent linkage by interchain 
disulphide bonds. There are several pathways of interchain disulphide 
bond formation but the two major intermediates are H 2 and HL (Bevan et al., 
1972). Completion of the fourchain monomer then takes place by addition 
of light chains to H 2 or by dimerisation of HL. 
Several studies on the assembly of Inurine polymeric immunoglobulins 
have shown that the conversion of (H 2 L2 ) subunits into J chain 
containing polymers occurs just before or simultaneously with secretion 
from the cell (Buxbaum and Scharff 1973, Bargellesi et al. , 1972, 
Parkhouse 1973). However, Tartakoff and Vassalli (1979) have found 
that 1gM pentamers are rapidly assembled while still in transport 
through the endoplasmic reticulum before entry into the Golgi complex and 
so not immediately prior to secretion. Furthermore Howell-Saxton 
and Wettstejn (1978) have demonstrated an intracellular pool of 19S 
(pentameric) 1gM in a human lymphoblastoid cell line and Buxbaum 
et al., (1971) have shown that whereas some human lymphocytes and 
plasmacytes may accumulate intracellular pentameric 1gM others may not. 
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The Secretion of Immunoglobul ins 
Normally, completely assembled imunoglobuljn molecules are 
either secreted from the cell or incorporated into the plasma membrane. 
Both these events are predestined by the site of synthesis of 
ir-inunoglobulin polypeptides being on membrane bound polyribosomes. 
The discussion of a mechanism to determine the secretory fate of 
inrnunoglobulins and other proteins raises the question of how certain 
mRNA molecules come to be selectively translated as part of a membrane 
bound polyribosome complex. One explanation postulated a non-translated 
nucleotide sequence in mRNAs coding for secretory proteins which had 
an affinity for membranes. However, the finding that immunoglobulin 
light chains are synthesised in a precursor form favoured an alternative 
idea which invoked the nascent polypeptide in the formation of membrane 
bound polyribosomes. Milstein and co-workers (1972), during a study 
of the cell-free translation of K light chain mRNA isolated from mouse 
myeloma cells, observed that the light chain was synthesised in 
precursor form with an additional N terminal oligopeptide. They 
proposed that the extra sequence provided a "signal" for attaching 
the growing chain to the membrane of the endoplasmic reticulum. Later, 
the same group demonstrated that during protein synthesis membrane 
fragments can convert the precursor to the ultimate product, (Cowan et al., 
1973). Several other murine and human immunoglobulin polypeptides 
have been shown to be synthesised in cell free systems as large 
precursors (Tonegawa and Baldi 1973, McCune et al., 1980) and exons 
coding for the precursor or signal peptide have been identified in 
the DNA sequences of both murine heavy chains and light chains. The 
primary structure of the N-terminal extra pieces of several mouse K and A 
chains have been shown to differ extensively (Burstein and Schechter 
1978) yet they all have a high percentage of hydrophobic aminoacids; 
a property that would fit the proposed attachment of the sequence to 
the membrane. Many other secreted proteins, in both eukaryotes and 
prokaryotes, have been shown to be synthesised as a large precursor 
with an additional hydrophobic N terminal signal sequence that is 
cleaved by a membrane bound enzyme (Davis and Tai 1980), establishing 
the "Signal hypothesis". 
Although the signal hypothesis has suggested a mechanism for 
the selection of secretory proteins and their passage across intracellular 
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membranes into the lumen of the endoplasinic reticulum in eukaryotic 
cells, the way in which imunoglobulins are ultimately transported 
via the Golgi apparatus to the outside of the cell or into the 
plasma membrane remains poorly understood. In general when proteins 
are secreted from the Golgi apparatus they are packaged into secretion 
vesicles or granules which move to the plasma membrane, fuse with it 
and release their contents to the outside of the cell. However, in 
the case of immunoglobulin secretion there is no apparent dense 
packaging of the molecules prior to secretion which in contrast appears 
to be a steady continuous process (Palade 1975). 
As well as passing through the E.R. the eventual insertion or 
secretion of imunoglobulins at the plasma membrane may be controlled 
by membrane/peptide interaction. For example, membrane-bound 
imunoglobulins in both mice and humans have a different C terminal 
from their secreted counterparts (Alt et al., 1980b, McCune et al., 1980). 
and structurally mutant mouse myelorna A light chains which possess a 
cleavable signal remain unsecreted in hybrids where the normal light 
chain of the other parent is secreted (Mossman and Williamson 1980). 
Regulation of IrTlilunoglobulin Synthesis 
There are several events which can influence imunoglobulin 
synthesis at different stages. At the transcription level the manner 
in which imunoglobulin coding DNA segments are joined determines 
whether that imrnunoglobulin coding DNA can function as a transcription 
unit or not. The mechanisms of allelic exclusion and the heavy chain 
switch are both thought to function in this way (see section on 
imunoglobulin genetics) and as both the initial constitutive production 
of iffinunoglobulin and the maturation of the humoral immune response 
from 1gM production to immunoglobulin of another class are important 
events in B lymphocyte differentiation they must be subject to 
developmental regulation. 
Another event under similar control occurs at the RNA processing 
level where, during differentiation, B lymphocytes express oredominantly 
membrane bound 1gM or secreted 1gM, the mRNAs for which are transcribed 
from a single p gene and produced by alternative nuclear RNA processing 
pathways. 
Little is known about the transport of processed RNA from the 
nucleus to the cytoplasm and even less about the regulation of such 
events. Some attention, however has been paid to the control of the 
translation of imniunoglobulin mRNAs as translational control is thought 
to be important in regulating the intracellular concentrations of 
heavy chains, light chains and assembled immunoglobulin molecules 
(Stevens and Williamson 1973). However, the orthodox view, from 
studies of normal rnurine lymphoid tissue and myelonia tumour has been 
that balanced intracellular concentrations of heavy chains and light 
chains are maintained by the rapid turnover of a pool of light chains 
which, due to their shorter length compared to heavy chains, are 
completed and released from their polyribosomes faster than heavy 
chains (Askonas and Williamson 1967). 
In cases of unbalanced production of heavy chains and light 
chains the tendancy has always been found to be towards an increased 
light chain to heavy chain ratio. In fact, although Askonas and 
Williamson (1967) concluded that excess light chain synthesis is a 
consequence of neoplasia, Baumal and Scharff (1973) argued that while 
the synthesis of heavy chains and light chains can be balanced in 
normal lymphoid tissue there is almost invariably some excess light 
chain produced. In addition the consistant finding of excess light 
chain synthesis in immature human B-lymphocytic neoplasns has led 
Gordon et al., (1978) to suggest that this is a pattern of imunoglobulin 
synthesis related to normal cells. Kohler (1980) has also suggested 
that this may be the case because free heavy chain is toxic to 
immunoglobulin-synthesising cells. His evidence comes from the pattern 
of loss of heavy chain or light chain expression in hybrid mouse 
myeloma cells; chain loss was random only in lines with an excess of 
active light chain genes over heavy chain genes and in all other 
combinations preferential heavy chain loss was observed. The subsequent 
conclusion, that heavy chain synthesis is dependant upon prior light 
chain synthesis, is consistent with the findings that spontaneous loss 
of heavy chain expression but with maintenance of light chain 
expression is a frequent event in mouse myelonia cell lines (Milstein 
et al., 1975, Morrison et al., 1974) whereas the opposite is a very 
rare occurrence. Where heavy chains have been found to be the only 
expressed immunoglobulin polypeptide of a mouse myeloma cell line 
they appear always to be defective (Cowan et al., 1974, Wilde and 
Milstein 1980) as is the case in the cells which synthesise the variant 
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human heavy chain disease proteins in the absence of light chain 
synthesis (Buxbaum et al., 1978). Variant clones of a mouse myelorna 
cell line which synthesise apparently normal heavy chains and no 
light chains have been isolated after mutagenesis (Morrison and Scharff 
1975) but all of the variant clones produced the lone heavy chain 
at a vastly reduced level. Recently some authors have reported free p 
chain synthesis by pre-B lymphocytes (Burrows et al., 1979, Levitt 
and Cooper 1980) however, it is not known whether the heavy chains 
are variant or normal and if they are synthesised at a low level 
or not. 
CULTURED CELL LINES; 
MODELS FOR THE STUDY OF IMMUNOGLOBULIN SYNTHESIS 
The analyses of human serum immunoglobulins together with those 
from other species provided important insights into the structure 
synthesis and genetics of iniunoglobu1ins. However, as the published 
work cited throughout this introduction has shown, mouse myeloma 
tumours and the cell lines derived from them have provided an excellent 
source of material for the direct study of ininunoglobulins at the 
level of the gene and in synthesis, assembly and secretion. During 
this intense study of mouse myeloma tumours and cell lines there 
has been no similar development of any other system although it is 
well known that immunoglobulin synthesis is a stable characteristic 
of human lymphoma, lymphoblastoid and myeloma cell lines. In fact 
human lymphoid cell lines (as these lines are collectively known) are 
the only other major source of immunoglobulin synthesising cells established 
in culture. Furthermore and regardless of the species difference, 
human lymphoid cell lines differ from mouse myeloma cell lines in 
several potentially important ways. 
The cells of mouse myeloma lines are malignant and abnormal 
so great care must be taken in relating imunoglobulin synthesis in these 
cells to the same process in normal lymphocytes. One example of 
contention in this respect is excess production of light chains frequently 
observed in mouse myeloma cell lines which, it has been argued, is either 
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a normal feature of lymphoid tissue or a consequence of neoplasm 
(Parkhouse 1977). Concern has also been expressed that the frequent 
absence of unrearranged imunoglobulin genes in mouse myelorna lines 
may be a consequence of the maintenance or re-expression of the 
gene-rearranging enzymes after the malignant transformation of the 
cells (Max et al., 1980). In addition the malignancy process in 
mouse myeloma selects in a non-random manner the lymphocytes to be 
transformed. Hapten binding and sequence analysis of myeloma proteins 
(Loh et al., 1979) have shown that mouse myeloma cell lines represent 
only a subset of the total lymphocyte repertoire. This has an obvious 
bearing on estimates of V region diversity from myeloma aminoacid 
sequence data although this is less important now that such estimates 
can be tackled at the nucleic acid level. However, this may still 
influence studies of the mode of expression of different V region 
genes and in the somatic generation of diversity. It should also be 
noted that having once demonstrated that the myeloma process in mice 
is selective, several features may in fact be selected for. 
Among the human lymphoid cell lines the leukaemia, lymphoma 
and myeloma derived lines are of undoubted malignant descent however 
those lymphoblastoid lines established from normal B lymphocytes by 
the use of Epstein-Barr virus (EBV) are of presumed non-neoplastic 
origin (Nilsson and Pontein 1975). As EBV is thought to be a po1yclon1 
B lymphocyte activator (Bird and Britton 1979) this suggests that 
it is not selective in its transformation of B lymphocytes. Even in 
cases where it has been argued that EBV preferentially transforms a 
subpopulation of B lymphocytes (Steel et al., 1977) that subpopulation 
has been outlined as those cells already synthesising ininunoglobulin 
which is a developmental stage open at some time to all normal B lymphocytes. 
The stages of B lymphocyte differentiation represented by the 
cells which comprise mouse myeloma lines and human lymphoid lines 
show important differences between the two systems. The cells of the 
mouse myeloma lines represent plasma cells which are the terminally 
differentiated state of an immunoglobulin producing cell. The 
comparisons which have been made to elucidate the events of immunoglobulin 
gene expression have been made at the gene level using DNA from 
twelve-day-old mouse embryos or sperm. Clearly what is missing is a 
developmental context in which to place the differences observed between 
these two extremes. This may become more essential in a search for 
31 
somatic mechanism(s) generating V region diversity which cannot be 
accounted for by the somatic recombination of V region genes (see 
section on V region diversity) and for the signals which trigger 
such events in B lymphocyte differentiation. Intermediate stages of 
B lymphocyte differentiation are not easily accessible in the mouse 
although the use of Abelson virus transformed mouse cells (Baltimore 
1979) or hybridoma technology (Burrows et al., 1979, Levitt and 
Cooper 1980) may solve this problem. Alternatively there is an 
abundant source of intermediate developmental stages among human 
lymphoid cell lines which represent clonl expansions of cells at 
several discrete stages of B lymphocyte and (for a smaller number 
of cell lines) I lymphocyte development (See Table 2). These lines 
should allow an analysis of the particular aspects of imunoglobulin gene 
rearrangement and expression that occur during lymphocyte ontogeny. 
Another feature of mouse myeloma cells in culture which may 
prove a drawback in understanding the molecular basis of imunoglobuliri 
synthesis is that their chromosome complements are abnormal, unstable 
and difficult to identify. (Moriwaki and Irnai 1978). The changing 
nature of the DNA content of mouse myeloma cells could be related to the 
multiple non-functional rearranged genes (Perry et al., 1980) and 
deleted coding sequences (Cory and Adams 1980) which appear common in 
mouse myeloma cells and have been implicated in the normal processes of 
allelic exclusion, the generation of diversity and the heavy chain switch 
(see section on imunoglobulin genetics). In contrast to mouse myeloma 
cells the karyotypes of human lymphoid cell lines are often diploid 
or near diploid, stable and readily identifiable by chromosome banding 
(Steel et al., 1980) so that they provide an opportunity to study 
immunoglobulin gene expression in a stable, recognisable genetic 
background. 
As human lymphoid lines and mouse myeloma cells are both mammalian 
in origin, one does not expect to see any fundamental differences 
emerge in the normal organisation and expression of their respective 
immunoglobulin genes. Therefore, any use of the species difference 
between the two systems in determining how immunoglobuljn genes work 
will only arise when both have been studied to the same detailed level. 
The two light chain types, K and A , present a well documented difference 
Table 2 	A tentative morphological and functional classification of 
normal human B lymphocyte differentiation; its relationship 
to lymphoproliferative disorders and human B lymphoid cell lines 
Adapted from Nilsson (1978) 
TABLE 2 
Normal 
B lymphocyte Multipotent Lymphoid Immature Lympho- 
lineage stem cell stem cell B lymphocyte B lymphocyte B lymphoblast plasmacyte 	Plasma cell 
Morphology No polyribosomes. Abundant free polyribosomes. Numerous free Abundant endoplasmic 
No endoplasmlc Sparse endoplasmlc polyribosomes. reticulum. 
reticulum. reticulum. Some endoplasmic Few free polyribosornes. 
Minute golgi Minute golgi 	apparatus. reticulum. Well 	developed golgi 
apparatus. Moderately apparatus. 





imunoglobulin - - + (+) + ++ 
Surface 
immunoglobulin - - (+) +++ ++ + 	 (+) 
Secreted 
Inununoglobulin - - - - - + ++ 
Representative -- Non 1, Mon B EBV positive EBV positive Plasma 
human ("Null") B lymphoma B lymphoblastoid cell 	lines 
lymphoid lymphoid EBV negative 
cell 	line lines B lymphoid 
Origins Leukaemia Burkltt lymphoma EBV transformed Myeloma 




between the species which may be represented in their gene systems. 
In mice K chains account for 95% of light chains and the greater 
part of light chain diversity whereas murine A chains are far less 
diverse and constitute only 5% of light chains (Hood et al., 1976). 
A comparison of the gene systems of mouse light chains with the K 
and A systems of humans where the two light chain types are about 
equally represented and equally diverse (Secher et al., 1979) may 
clarify the role of V genes, J regions and their interaction in the 
generation of light chain diversity. In general the overall 
determination of the structure and organisation of human immunoglobulin 
genes together with the current knowledge of these genes in the mouse 
would allow a comparison in a gene system which has undergone rapid 
evolution over a relatively short period of time. 
The belief also exists that in studying the complex nature of 
imunoglobulin synthesis a better understanding of gene organisation 
and expression in other eukaryotic systems will follow. This has, 
to some extent, already proved to be the case in that imunoglobulin 
genes were the first in eukaryotes for which somatic changes in 
gene rearrangement were characterised at the molecular level (Max et al., 
1979, Sakano et al., 1979). The 'transposable elements" in yeasts 
and Drosophila have also been detailed in their movements within the 
somatic DNA of those oganisms (Cabs and Miller 1980) and it is 
thought that such transpositions in the higher eukaryotes may be 
important in the origin of cancer and in the developmental process. 
The rearranged mouse light chain genes were among the first genes to 
be seen to have a "split" structure which is now considered a general 
feature of gene organisation in eukaryotes and their viruses (Crick 1979). 
It was also the study of the expression of an immunoglobulin polypeptide 
which founded the signal hypothesis in protein secretion (Milstein et al., 
1972). As the imunoglobulins are as yet far from fully understood 
work on this system should continue to have implications for all 
aspects of the biology of multicellular organisms. 
One area to which a study of human immunoglobulin synthesis 
is particularly relevant is medical science. This is true not only 
generally in that the immune system is important in infectious and 
neoplastic diseases but also specifically in conditions effecting 
the immune system itself. In humans there is a wide variety of 
inherited disorders of the immune system (Stanworth 1977) for example 
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the class-specific immunodeficiency diseases. These conditions may 
provide an insight into the genetic elements and cellular events 
that are required for normal immunoglobulin expression and so an 
opportunity to study the aetiology of a genetic disease at the 
molecular level. 
In addition to their specialist capacity to synthesise 
iniiiunoglobulins, established human lymphoid lines are also of 
general biomedical interest. As both human fibroblasts (Hayflick 
1965) and normal glia cells (Ponten and Maclntyre 1968) have a 
limited life in culture, human lymphoblastojd cells are the only 
major source of permanent cultures derived from normal human tissue. 
These lymphoblastoid cultures together with human lymphoid lines from 
neoplasms constitute a convenient system which can be used not only 
to study the biology of normal cells but also to compare that with 
similar material of malignant origin. 
THE AIMS AND APPROACH OF THE RESEARCH PROJECT 
Spontaneous and induced mutations have been used to investigate 
the sequence and control of events in the synthesis of many biologically 
important molecules. Although this is particularly true in 
prokaryotes a similar approach has been made possible with mammalian 
eukaryotic cells through developments in cell culture. (Siminovitch 
1976). This project investigates iniliunoglobulin synthesis in human 
lymphoid cells which has a number of advantages as a system for this 
type of study: The structure and chemistry of ininunoglobulins are 
well understood, there are several interesting features in the 
expression of immunoglobulin genes and the cells which make up these 
different lines represent various stages of differentiation. 
To identify variation in the patterns of imunoglobulin synthesis 
in human lymphoid cell lines it was intended to begin by screening 
the large number of lines available in the laboratory for secreted 
imniunoglobulin and to examine in a similar way clones of mutagenised 
and untreated cultures. The initial screening was to be based on 
simple rapid serological test systems such as the haemagglutin:ation 
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inhibition technique of Evans et al., (1974) and the antibody overlay 
of Scharff et a]., (1975). Any variants arising in this manner would 
have been identified serologically and so in order to confirm which 
polypeptides were being secreted and the nature of those that were it 
would be necessary to fractionate, characterise and identify the 
proteins produced by the lines in question and by normal cells. The 
amount of protein produced by cells in vitro is insignificant in 
comparison to the large concentration of proteins in the form of 
foetal calf serum required for cell survival and growth so that any 
detailed investigation of cell line products was envisaged as involving 
the biosynthetic radiolabelling of secreted cell line proteins. 
The absence of secreted imunoglobulin does not imply that 
synthesis of imunoglobulin has ceased, thus it was intended to extend 
the analysis to any intracellular and surface irTvlunoglobuljn of cell 
lines or clones of lines shown to be deficient or otherwise abnormal 
in their secreted imunoglobulin, together with apparently normal 
imunoglobulin-synthesising cells. 
In summary, the aims of the project are to identify and characterise 
normal and abnormal imunoglobulin synthesis in human lymphoid cell 
lines. The results of these studies may then be used to interpret 
and clarify certain aspects of our current understanding of imniunoglobulin 
genetics and synthesis as described in the introduction to this work. 
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ABBREVIATIONS 
Bis NN'-Me thy lenebisa cry lamjcje 
BSA Bovine Serum Albumin 
Dirnethyl 	POPOP 4- C 2-(4-methyl-5-phenyloxazolyl) 
] -benzene 
EMS Ethylmethane suiphonate 
FCS Foetal calf serum 
9av Centrifugal force at the average rotor radius 
MNNG N-methyl-N-nitro-N-nitrosoguaniciine 
MOPS 2(N-rnorpholino) propanesuiphonic acid 
NP-40 Nonidet P-40 
PAGE Polyacrylamide gel electrophoresis 
PBS Phosphate buffered saline 
PMSF Phenylmethylsuiphonyl fluoride 
PPO 5-Diphenyloxazole 
RNAase A Ribonuclease A 
Sarkosyl N-Lauryl sarcosine 
SDS Sodium dodecyl sulphate 
SRBC Sheep red blood cells 
TCA Trichioroacetic acid 
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MATERIALS 
These materials were obtained as 	follows: 
Acrylamide BDH Chemicals Ltd 
Antisera As several commercial 	antisera, raised 
in different animals were used, each is 
described as it occurs in the Methods 
or Results Section. 
Bis Bio Rad Laboratories 
BSA Sigma Chemical Company Ltd 
Coomassie Blue Sigma Chemical Company Ltd 
14 C valine The Radiochemical Centre Amersharn 
D19 developer Kodak Ltd 
FCS Gibco Bio-Cult Ltd 
Ham's FlU medium Gibco Bio-Cult Ltd 
Human IgA and 1gM The American National 	Red Cross 
Blood Research Laboratory 
Human IgG Miles Laboratories 
i25 Protein A The Radiochemical Centre Amersham 
Melphaian Burroughs Wellcome Ltd 
Microtest Plates Sterilin Ltd 
MOPS Hopkin and Williams Ltd 
Nigrosin BDH Chemicals Ltd 
NP-40 Shell Chemicals Ltd 
Ovalbumin Sigma Chemical Company 
PBS Oxoid Ltd 
Penicillin Glaxo Laboratories Ltd 
Phosphorylase b Sigma Chemical Company 
PMSF Sigma Chemical Company 
Protein A Pharmacia Fine Chemicals 
Protein A-Sepharose Pharmacia Fine Chemicals 
RNAase A Sigma Chemical Company 
RP X-Omat film Kodak Ltd 
Standard human serum Behringwerke 
Staphylococcus aureus 
bacterial 	immunoabsorbant CAMR Microbial Products 
Streptomycin Glaxo Laboratories Ltd 
All other chenicals were reagent grade 
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METHODS 
The principal methods used in this project are described below. 
Exceptions and additions to these procedures are given in the Results 
section with the experiments to which they apply. 
CELL CULTURES 
Most of the human lymphoid lines used in this study had been 
established in the laboratory where this project was carried out and 
their establishment has been previously described (Steel 1972). 
Other lines, obtained from elsewhere had been cultured in this 
laboratory for some months or years. 
All lymphoid cultures were maintained in Ham's FlO medium 
Supplemented with 10% FCS, penicillin (100,000 u/i) and streptomycin 
(100mg/1) at 370C in a 5% CO  atmosphere, or without gassing and with 
the addition of 12.5 mM MOPS to the culture medium. Each culture 
was subcultured once a week to maintajna viable cell density of 
about 0.5 - 1 x 10 6  cells/mi. The viability and cell density of 
cultures were determined by exclusion of the vital dye nigrosin at 
a concentration of 0.2% (Kaltenbach et al., 1958). Lymphoid cultures 
were screened at regular intervals for mycoplasma as a service 
facility of the laboratory and any positive cultures detected were 
discarded. 
Human embryonic skin fibroblasts, human embryonic lung fibroblasts 
and the human fibroblast cell line Wi38 (Hayflick and Moorhead 1961) 
were obtained from cultures routinely established and maintained in 
the laboratory. They were cultured under the same conditions as the 
lymphoid lines and were subcultured at confluence to a density of 
about 2.5 x 10 5  cells/mi. 
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THE HARVESTING OF CELL CULTURES AND THEIR PRODUCTS 
Culture supernatants 
The medium in which cells had been growing, referred to throughout 
as culture supernatant, was collected by centrifugation. Small 
volumes of culture were spun initially at 12,800g 
a  for 30 secs in 
an Eppendorf microcentrifuge (which has a fixed speed setting) at 4 °C 
and the supernatants carefully drawn off and centrifuged again under 
the same conditions for 5 mins to remove any remaining debris. The 
supernatant from this second spin was collected and NP-40 added to 
a final concentration of 0.5%. Large samples were collected in the 
same way but Lysuccessive centrifugation at 500 	for 15 mins and at 
3,000g av for 15 mins at 4 °C in an M.S.E. Chilspin refrigerated bench 
centrifuge. If collected supernatants were not used immediately they 
were stored at -20 °C and thawed rapidly at room temperature before use. 
Cells 
Cells were harvested immediately before use by centrifugation 
at 750g 
a  for 15 mins at 4°C in an M.S.E. refrigerated bench centrifuge 
and washed 3x in cold PBS. Alternatively smaller cultures were 
harvested by centrifugation at 12,800g 
av  for 30 sec in an Eppendorf 
microcentrifuge at 4 °C and washed 3x in cold PBS. 
Cell lysates 
Collected cells were lysed by suspending a washed cell pellet 
in cold lysis buffer (PBS, 0.5% NP-40, 1 mM PMSF) using 0.5mls of 
buffer for up to 2.5 x 106  cells and standing the suspension on ice 
for 5 mins. The resulting lysates were cleared by centrifugation at 
12800 	for 15 mins at 4 °C in an Eppendorf microcentrifuge to 
remove cellular fragments and nuclei. 
CLONING 
Lymphoid cell lines were cloned in agarose after the technique 
originally outlined by MacPherson (1965). Cells were plated out at 
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250 per dish in a lml layer of 0.25% agarose over a 2.5m1 base layer 
of 0.30% agarose, all in normal culture medium without MOPS, in 
60m diameter plastic petri dishes. (Several different commercial 
preparation of agarose were evaluated, see Results section). After 
plating, agarose cultures were incubated at 37 °C in a humid 5% CO  
atmosphere and were overlaid with imi of medium 24 hrs after plating 
and at weekly intervals thereafter. 
Cells could be cloned in this way without a feeder layer but 
where a feeder layer was used the petri dishes were inoculated with 
2.0 x 1O 5 fibroblasts 24 hrs before plating. A variety of feeder 
layers were used (See Results section). 
Under these conditions microscopic colonies were visible 2 - 3 
weeks after plating, and at 4 - 6 weeks colonies were macroscopic. 
At this latter stage colonies were picked from the agar in a sterile 
manner in a volume of 5l with a Gilson pipetman micropi'ette. 
Each colony was then dispensed into 3001 of culture medium in one 
well of a microculture plate. 
THE TREATMENT OF CELLS WITH A MUTAGEN 
Se veral cultures of a lymphoid line were exposed to the 
L-phenyl alanine mustard "Meiphalan" for 24 hrs at concentrations 
of up to bug/ml by addition of aliquots of a stock solution of 
1mg/mi in propylene glycol. These cultures together with others to 
which only propylene glycol had been added were examined for viable 
cells and the concentration of Melphalan giving about 10% cell survival 
after treatment (see Results) was used in further experiments. 
THE SEROLOGICAL DETECTION OF IMMUNOGLOBULINS 
Culture supernatants, cell lysates and sucrose gradient fractions 
A passive haemaggl uti nation inhibition assay was used to 
determine the presence of the major classes of human imunoglobulin 
heavy chains ( a , y , ) and both types of light chain in culture 
supernatants, cell lysates and sucrose gradient fractions. The 
technique used was that adapted for human lymphoid cell lines by 
Evans et a]., (1974) with some modifications. 
Antigen coated red blood cells were prepared in the following 
manner. Erythrocytes from defibrinated sheep blood were washed 3x 
in PBS and stored in Alsevers solution for up to one month before 
use. The sources of antigen, human imunoglobulin in this case, were 
sera from myeloma patients obtained from the Haematology Departments 
of the Western General Hospital, Edinburgh and The Royal Infirmary, 
Edinburgh. In order to coat SRBC with a sample of myeloma serum 
they were first fixed by mixing a 5% suspension of washed SRBC in 
PBS with gluteraldehyde to a final concentration of 0.25%. The 
gluteraldehyde was added to the SRBC suspension slowly with stirring 
over a 15 min period and stirring continued for a further 45 mins at 
room temperature. The fixed SRBC were then washed 3x in PBS and 
gluteraldehyde fixed for a second time in the same way but with the 
addition of imi of myeloma serum in every lOmls of SRBC/gluteraldehyde 
mixture. The antigen coated SRBC were then washed 3x in PBS and 
stored in PBS containing 0.1% NaN 3 at 4°C. Only one myeloma serum 
was used for each aliquot of fixed SRBC so that each batch of coated 
SRBC was sensitised for one particular heavy chain and/or light chain. 
To carry out the haemagglutination inhibition assay doubling 
dilutions of goat antihuman a, y and v antisera (Technicon) and 
rabbit antihuman K and A antisera (Behringwerke) were prepared in 
PBS containing 1.0% FCS and 0.1% NaN 3 . Aliquotes of 25i.l from each 
doubling dilution of an antiserum were dispensed into separate wells 
in a row on a V-section microtest plate with the exception of the 
final well in each row to which a 25il aliquot of PBS 1% FCS containing 
no antiserum was added. The test range of serial dilutions used 
varied for each antiserum and to a lesser extent for each batch of 
myeloma serum-coated SRBC (See Results). An equal volume of the 
sample to be tested was added to each well of one row and into the 
wells in the last row of each plate a control sample was added to 
establish the end point of the uninhibited agglutination reaction. 
The control samples were unused fresh culture medium containing 
0.5; NP-4C, lysis buffer, or 10% sucrose in 0.5 PBS 0.5% NP-40 
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depending upon the source of the test samples. The dilutions of 
antiserum and aliquots of test or control samples were mixed together 
by shaking the plates for 2 mins on a microtest plate shaker and then 
leaving them to stand for at least 15 mins at room temperature. 	A 251 
aliquot of a 0.25% (V/V) suspension of the appropriate ininunoglobulin 
coated SRBC was added to each well after which the plates were again 
shaken for 2 mins and then left at 4 0  C overnight before analysis. The 
presence of a particular imunoglobuljn heavy chain or light chain was 
recognised when the test sample inhibited agglutination by more than 
2 wells, that is greater than a 4 fold difference in end point compared 
with the control row. 
Cell surface ininunoglobulin 
Cell surface irTriunoglobulin was identified by an i125 protein A 
assay of cell surface bound rabbit antihuman irrinunoglobulin antibodies. 
A sample of 1 x 106  cells from a culture to be tested were harvested 
and transferred into an Eppendorf microcentrifuge tube. The washed 
cell pellet was resuspended in lOOpi of a 1 : 20 dilution in PBS of 
the relevant antihuman immunoglobulin antiserum (Behringwerke) and 
then incubated at 4 °C for 30 mins with mixing. The cells were then 
washed 3x in cold PBS and resuspended in lOOi.tl of a solution of Protein A 
at a concentration of 2.5pg/ml in PBS and containing 1 125 labelled 
protein A at 0.5uCi/ml. This mixture was incubated for a further 30 mins 
at 4 0  C with mixing when the cells were washed 3x in cold PBS and the 
final cell pellet counted in a Packard automatic gamma counter which 
has a 65% counting efficiency for I 125 	Control assays without the 
addition of antiserum and with non-immune normal rabbit serum in place 
of antiserum were carried out for each cell culture tested. 
THE BIOSYNTHETIC RADIOLABELLING OF PROTEINS PRODUCED BY CELLS 
IN CULTURE 
Cell culture protein products were biosynthetically radiolabel led 
using uniformly 14C-labelled valine added at lOuCi/ml to the normal 
culture medium. The 14C valine was supplied as an aqueous solution 
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and the required amount was evaporated to dryness in an empty sterile 
culture vessel which was then re-sterilised by placing directly 
under a tissue culture room U.V. bench light for 15 mins. The 
appropriate volume of culture at 1 x 106 viable cells/ml, taken from 
a stock culture 24 hrs after the last medium change, was then dispensed 
into the culture vessel containing the dried 14C valine. The 
radioactive culture was then incubated for 48 hrs under normal culture 
conditions and the supernatant or cells were harvested as described 
previously. 
THE DETECTION OF RADIOACTIVITY IN CULTURE SUPERNATANTS 
AND SUCROSE GRADIENT FRACTIONS 
The radioactivity incorporated into the polypeptides present in 
culture supernatants and sucrose gradient fractions was determined 
using the technique of Bollum (1966). Aliquots of the samples to be 
assayed were applied to 3m filter paper discs which were then given 
3 washes for 10 mins each in 5% TCA followed by 3 x 10 mins washes in 
ethanol/ether 1 : 1 and then air dried. The dried discs containing 
the precipitated protein were placed in vials in which Smls of a 
solution consisting of 0.5% PPO and 0.03% dimethyl-POPOP in toluene 
was added. The radioactivity present in each vial was measured in a 
Packard "Tri-carb" liquid scintilation countirwith a gain setting of 
7% and a window setting of 50 - 1000 giving a counter efficiency of 56% 
for ' A C. 
The presence of NP-40, SDS and sarkosyl (TCA precipitable compounds) 
did not effect the determination of incorported TCA precipitable 
• 	radioactivity. 
SDS POLYACRYLAMIDE GEL ELECTROPHORESIS 
The discontinuous buffer system and acrylamide/bis ratio of 
Laenin ii (1970) were used. Electrophoresis was carried out on 
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15cm x lcm x 0.15cm linear 3% - 20% gradient gels and uniform 
12% gels of the same dimensions at either a constant 30mA for 6 hrs 
at room temperature or a constant l2mA for 16 hrs at room temperature 
for both types of gel. The different running conditions created 
some differences in mobility however each gel contained a track of 
several marker proteins of known molecular weight giving an internal 
measure of mobility on each gel. 
Completed gels or portions of completed gels were stained for 
protein using 0.1% Coomassje blue in 30% (V : V) methanol, 10% (V : V) 
acetic acid, 60% H20 and destained in the same solution without 
Coomassie blue. Those gels or portions of gels containing radioactive 
samples were prepared for fluorography by impregnation
~y ithPPO using 
the technique of Bonner and Laskey (1974). The resultant destained 
or PPO-impregnated gels were dried down under vacuum onto 3rrin filter 
paper. Radioactive components in gels prepared for fluorography were 
visualised by exposing the dried gel to preflashed (Laskey and Mills 
1975) RP X - Omat film at -70 0C for 1 - 4 weeks. Exposed films were 
developed for 4 mins at room temperature in a 1 : 4 aqueous dilution of D19 
developer then fixed, washed and dried. 
THE PREPARATION OF UNFRACTIONATED CELL CULTURE PRODUCTS 
FOR SDS PAGE 
Samples of culture supernatants and cell lysates were prepared 
for SDS PAGE by precipitation in lOx their own volume of acetone on 
ice for 15 mins. The precipitated proteins were pelleted by 
centrifugation at 12 ' 800 	for 2 mins in an Eppendorf microcentrifuge 
° 
	 av 
at 4C and washed 2x under the same conditions. The final pellet was 
air dried and dissolved in SOS PAGE sample buffer. 
SUCROSE GRADIENT VELOCITY SEDIMENTATION 
Samples (300u1) were analysed on 4.5m1 5% 
- 20% linear sucrose 
gradients containing 0.5 PBS and 0.5% NP-40 (other detergents were also 
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used in sucrose gradients, see Results). The gradients were 
centrifuged at 200,000g 	for 4 hrs at 4 °C in a Spinco model Lav 
ultracentrifuge using an SW 50 swing-out rotor at 45,000 r.p.m. or 
in a Sorvall OTD 65 ultracentrifuge using an AH 65 swing-out rotor 
at the same speed. After centrifugation the gradients were divided 
into fractions of approximately 1500 which were collected into the 
flat bottomed wells of a microtest plate. 
Fractions which were to be analysed by the haemaggl uti nation 
inhibition assay for imunoglobulin were diluted 1 1 with 0.5 PBS 
containing 0.5% NP-40 to give an adequate volume for analysis. 
The distribution of radioactivity in sucrose gradients was 
determined by TCA precipitation using 100 samples from each fraction. 
The contents of radioactive fractions were prepared for SOS PAGE by 
precipitation in lOx the fraction volume of ethanol on ice for 1 hr. 
The precipitated proteins were pelleted by centrifugation for 2 mins 
at 12 800 	in an Eppendorf microcentrifuge, washed 3x in 1 ml ofav 
ethanol followed by a similar volume of acetone. The final acetone 
pellet was then air dried and dissolved in SDS PAGE sample buffer. 
THE AMMONIUM SULPHATE FRACTIONATION OF CELL CULTURE SUPERNATANTS 
Salt fractionation of cell culture supernatants (prepared without 
NP-40) was carried out by the addition of a 100% saturated solution 
at 0 0  C of (NH 4)SO4  pH 7.2 to a sample of culture supernatant on ice 
to give the required final concentration of (NH 4)2SO4. Following 
the addition of (NH 4)2SO4 the mixture was allowed to stand on ice, 
with occasional mixing for 30 mins when the precipitate was pelleted 
by centrifugation at 80000 	for 15 mins at 4 °C in a Spinco model Lav 
ultracentrifuge using a No. 4 fixed angle rotor at 35,000 r.p.m. 
The supernatant was discarded and the pellet dissolved in 3001 of 
distilled water containing 0.5% NP-40 for analysis by sucrose gradient 
velocity sedimentation. Pellets from large samples of culture 
supernatant contained too much salt to be layered directly onto a 
sucrose gradient. In this case the pellet was redissolved in 3rnls of 
distilled water containing 0.5% NP-40 and the proteins repelleted 
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from solution by centrifugation under the same condition as above for 
16 -irs. The supernatant was discarded leaving a salt-free pellet. 
THE IMMUNOPRECIPITATION OF CELL CULTURE IMMUNOGLOBULINS 
Several techniques and antisera were evaluated (see Results) 
the conditions described below gave optimal results. 
Ininunoprecipitation was carried out using rabbit antihuman 
heaw'y chain class specific and light chain type specific antisera 
(Behringwerke) together with formalin fixed, heat killed, protein 
A-bearing Staphylococcus aureus bacteria as an imunoadsorbant 
(Kessler 1975). A 0.4m1 sample of radiolabelled culture supernatant 
was incubated with 5i1 of the relevant antihuman imunoglobulin antiserum 
or a similar volume of a control serum at 4°C with mixing in a 
microcentrifuge tube. After 15 mins 500 of a 3x washed 10% (wet cell 
weight : volume) suspension of the Staphylococcal imunoadsorbant was 
added and the mixture incubated in the same way for a further 15 mins. 
The bacteria were then removed from the mixture by centrifugation at 
12 .800 	for 1 min in an Eppendorf microcentrifuge and washed 3x in 
PBS 0.5% NP-40. Imunoprecipitated material was then eluted from the 
washed bacterial absorbant by suspension in 251 of 2x SDS PAGE sample 
buffer and incubating in a boiling water bath for 3 mins. The elute was 
collected by centrifugation at 12800 	for 5 mins at room temperature 
to remove the bacteria. Before applying all or a portion of the eluted 
sample to a gel it was clarified by centrifugation under the same 
conditions for 5 mins. 
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RESULTS 
THE DETECTION OF IMMUNOGLOBULINS 
USING THE HAEMAGGLUTINATION INHIBITION TEST 
The serum coated SRBC described in the Materials and Methods 
Section on the serological detection of imunoglobulins were tested 
for their specificity by assaying them against serial dilutions of 
goat antihuman heavy chain antisera (Technicon) and rabbit antihuman 
light chain antisera (Berhingwerke). SRBC preparations coated with 
samples of human myeloma or macroglobulinaemia serum characteristically 
demonstrated high end points for agglutination reactions with a single 
antiheavy chain antiserum and a single antilight chain antiserum 
(Fig. 5) although occasionally SRBC coated with a particular myeloma 
serum would agglutinate only with an antilight chain antiserum. Similar 
preparations coated with normal human serum showed raised end points 
against anti y and anti K antisera. However, the agglutination titres 
of these preparations were considerably lower against every antiserum 
than those of rnyeloma or macroglobulinaemia serum coated SRBC. 
Inhibition of agglutination of such high antisera titres allows 
the sensitive and specific detection of human ininunoglobulin heavy 
and light chains in the supernatants of cultured human lymphoid cell 
lines (Fig. 6). The sensitivity of this system can be measured by 
assaying dilutions of standardised human serum. In this way I chains 
can be detected in standardised serum (Berhingwerke Standard Human 
Serum batch no. A975) at dilutions of 1 : 106 (V/V in unused culture 
medium) which is equivalent to an IgG concentration of 12.9ng/ml, JJ 
chains atl : 6.4 x 10 (9.28ng 1gM/mi) and a chains at 1 : 64 x lO 
(20ng IgA/ml). K chains can be detected at a 1 	2.5 x 10 dilution 
of the same standard serum and Xchajns at a 1 : 6.4 x 1O 4 dilution. 
By calibrating the test in this way (for a given batch of imunoglobulin 
coated SRBC) one can quantify the amount of imunoglobulin secreted 
by human lymphoid cell lines. Fig. 7 and Table 3 show just such an analysis 
of the imunoglobulin produced in cultures of the cell lines RPM] 8866 
and SM1 . In both cultures, over a period of 5 days, their peak of 
production was about lOi.ig of immunoglobulin/lO cells/24hrs. This is a 
similar figure to that estimated in the same way for several other cell 
lines being maintained under normal conditions. 
Fig. 5 	The_agglutination reactions of serum coated SRBC 
Gluteraldehyde fixed SRBC coated with serum from a Waldenstroms 
Macroglobuljnaemja patient (ODI), serum from a myeloma patient (SNE) 
and pooled normal human serum (NHS) were tested against doubling 
dilutions of antihuman heavy chain antisera and antihuman light chain 
antisera in the presence of unused culture medium in V section microtest 
plate wells. 
Fig 5 
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Fig. 6 	The haemagglutination inhibition assay 
The appearance of microtest plates containing assays using the 
haemagglutination inhibition technique for the presence of p heavy 
chains (a) and K light chains (b) in the supernatants of cultures of 
seven human B lymphoid cell lines. 
Fig  
C/) 













DILUTIONS OF ANTIHUMAN ji ANTISERUM 
4x10 3 	 4x10_6 0 
cc cx ocoox cc 	øccxxx 















DILUTIONS OF ANTI HUMAN K SERUM 
2x1O 	 2x10_6 0 
m 
-Mal 
• A.1 • 11 • ii • rl • ii • 	• Ti • Iry • 
•' f' t 
'4- 
IA A, A AA A  JL4. I 1 	11 Ii 
0000ot  
Fig. 7 	The accumulation of immunoglobulin in the supernatants of 
human B lymphoid cell lines 
The amount of imunoglobulin present, with time, in the supernatants 
of cultures of (a) RPMI 8866 an IgG secretor and (b) SMI 1 an 1gM secretor. 
The IgG and 1gM present in the supernatants is plotted as the relative 
decrease in agglutination end point which is calibrated in Table 3. 
(immunoglobulin in supernatant 0 	, live cell number • 	, viability A 
Table 3 	The quantification of irnmunoglobulin detected in the 
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SCREENING OF HUMAN LYMPHOID CELL LINES FOR SECRETION OF I?1UNOGLOBULINS 
A large number of established human lymphoid cell lines were 
assayed for the secretion of 	, y and P heavy chains and K and A light 
chains by testing culture supernatant in the haernagglutination inhibition 
technique. Each line was assayed on more than one occasion and most 
at least three times. The majority of lines secreted a single heavy 
chain class together with a single light chain type and these are 
summarised in Table 4 (the details of whose contents are given in 
Appendix I). The most common class of imunoglobuljn secreted by 
these cell lines is 1gM. Although this distribution does not hold for 
the small number of cell lines established from individuals with 
infectious mononucleosis it is evident in all the lines established 
from other sources and is particularly striking in those lines from 
cord bloods where no examples of secretion of any other ininunoglobulin 
class but 1gM were found. 
The proportion of K and A light chain secreting cell lines 
appeared similar for each group from which the lines were established 
and within each class of imunoglobulin secreted. The overall ratio of 
K light chain secretors to A chain secretors was 1.3 	1 reflecting 
the relatively similar abundance of K and A chains found in sources of 
human ininunoglobulin. 
Several lines appeared to secrete more than one class of heavy 
chain and/or more than one type of light chain. However this pattern 
was mostly apparent in relatively "young" cell lines and in all cases 
gave way to secretion of a single heavy chain class and light chain 
type on more prolonged culture. 
A second group of cell lines whose imrnunoglobulin secretion pattern 
differs from the majority of established lines are those which secrete 
no detectable immunoglobulin or only a single heavy chain or light chain. 
However, in ccntrast to those lines secreting more than one heavy chain 
or light chain, this group have been in culture for some time, are 
mainly derived from individuals with disorders affecting the lymphoreticular 
system and for the most part the lines have stable and reproducible 
patterns of immunoglobulin secretion. The most common pattern in this 
group, shown by eight lines, is a lack of detectable heavy chains in 
the presence of light chain secretion (see Table 5). Of these lines Jijoye 
has been previously described as secreting yu and K chains and EB 3 as secreting 
TABLE 4 
The number of human B lymphoid cell lines secreting a sin gle class of 
heavy chain and a single class of light chain 
Source of blood lymphocytes Imunoglobulin secretion 
c*ic 	ax 
Cord blood 0 0 0 0 21 19 
Adults* 4 3 10 8 20 16 
Adults with infectious mononucleosis 3 2 4 2 1 1 
Adults suffering from disorders 
of the lymphoreticular system 1 2 4 2 8 3 
*This group consists of normal healthy individuals 
together with those suffering from genetic and chromosomal disorders 
or from malignant disease not affecting the lymphoreticular system 
TABLE 5 






a 	y 	11 	K 	 A 
Daudi M Burkitt lymphoma - - - - - 
FAL 1 F Healthy cord blood - - - - - 
F89 M Subacute lymphatic leukaemia - - - - - 
Raji M Burkitt lymphoma - - - - - 
F137 M Chronic lymphatic leukaemia - - + - - 
[8 2 F Burkitt lymphoma - - - - + 
E8 3 M Burkitt lymphoma - - - - + 
JIM  M Healthy normal adult - - - - + 
Jijoye M Burkitt lymphoma - - - + - 
KAT 1 F Infectious mononucleosis - - - + - 
U266BL M Multiple myeloma - - - - + 
RPMI 8226 F Multiple myeloma - - - - + 
no detectable irmnunoglobulin chains as determined by immunoelectrophoresis 
(Van Furth et al., 1972). However, in common with Evans et al., (1974) 
and using a similar haemagglutination inhibition technique, this 
report classified Jijoye as secreting K chains only and EB 3 A chains 
only. The secretion of A chains only by the human plasma cell line 
RPM1 8226 agrees with the results of Matsuoka et al., (1968) from 
the analysis of culture supernatant by imunodiffusion and 
imunoelectrophoresjs. Although U266BL is described here as secreting 
A chains alone this line is derived from the blood lymphocytes of an 
IgE myeloma patient and has been demonstrated, by imunodiffusion, to 
secrete cheavy chains (Nilsson et al., 1970). However, as the 
assay system used in this project initially to screen for secreted 
immunoglobulin detects only a , y and p heavy chains, any lines 
secreting 6 or c heavy chains remain unidentified at this stage. 
Among the secreted proteins of a single cell line (FB7) only 
a heavy chain (i.') is detectable (Table 5). The detection of p chains 
was far less positive in the supernatants of F137 cultures than the 
detection of light chains in light chain only secreting cell lines 
and the amount of heavy chain detected in F137 supernatants was far 
smaller (of the order of 500x less) than that in other p chain secreting 
cultures. Nevertheless, the result was consistantly reproducible and 
agrees with that of Evans et al., (1974). 
Four human B lymphoid cell lines had no detectable heavy chains 
or light chains in their culture supernatants (Table 5). Of these Raji 
has been reported to secrete p chains only and Daudi K chains only 
(Evans et al., 1974). However, in my hands Raji secretes no 
immunoglobulin and Daudi culture supernatants have been positive for 
K chains only a few times in a large number of assays and then just 
by a matter of 2 or 3 wells of inhibition. Both these lines have been 
classified here as non-secretors. 
The cell lines CCRF, MOLT  and K562 also failed to secrete any 
detectable inimunoglobulin, but, as CCFR and MOLT  are derived from 
T lymphocyte leukaemias (Foley et al., 1965, Minowada et al., 1973) and 
K562 is an erythroleikaemjc cell line (Anderson et al., 1979) i.e. they 
are all non-B lymphid lines, this result is to be expected. 
It is appropriate to also mention here the lines BR18 and BR18T 
for, although they do not show abnormal patterns of imunoglobulin 
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secretion (see Appendix I), they represent a change in secreted 
imrnunoglobulin. BR18 secretes v and K chains and is the parent 
line of BR18T, a spontaneous tetraploid derivative which also secretes 
u heavy chains but together with X light chains. This alteration in 
light chain expression using what should be the same immunoglobulin 
genesmay have implications for genic and allelic exclusion in light 
chain synthesis. 
The effect on iriinunoglobulin production of co-culturing human Blymphoid 
cell lines with I lymphocytes 
Kishirnoto et a]., (1978) claimed that 1gM production could be 
enhanced and IgG production induced in human lymphoblastoid cell 
cultures by normal human T cells. This report led to an attempt to 
repeat these results using the haemaggl uti nation inhibition test to 
detect the imunoglobulin produced. If these observations were repeated 
this system could provide a model in human lymphoid cell lines of the 
heavy chain switch in imunoglobulin synthesis. 
Five different 1gM secreting human B lymphoblastoid cell lines 
(BAR, BR18, G-S, MON and RPM! 1788) were each co-cultured with fresh 
human I lymphocytes from three different donors under exactly those 
conditions described by Kishimoto et a]., (1978). However, using the 
haemaggl uti nation inhibition assay, no increase in 1gM production over 
the control level of that produced by lymphoblastoid cells cultured 
on their own noinduction of IgG production was detected in those lines 
co-cultured with T lymphocytes. The levels of IgG production, of the 
order of lOOiig/ml, claimed by Kishimoto et a]., (1978) would be readily 
detected in the haemagglutination inhibition assay. 
The screening of available human B lymphoid cell lines established 
a single heavy chain, single light chain "monoclonal" pattern of 
immunoglobulin secretion as the norm, with the predominant class of 
immunoglobulin secreted being 1gM. A small number of cell lines have 
been identified which differ from the majority in their pattern of 
immunoglobulin secretion their synthesis of immunoglobulins. However, 
these are independently established cell lines from different clinical 
sources and may not represent true variants or mutants but, for example, 
the "fixing" in culture of cells representing separate stages of 
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B lymphocyte differentiation. In this case the availability of 
cultures from the same line which were respectively normal and 
variant in terms of imunoglobulin production would provide useful 
additional material for studying imunoglobulin synthesis in human 
lymphoid cell lines. 
CLONING AND MUTAGEN TREATMENT 
As indicated at the end of the last section of results a 
comparison of normal and variant immunogl obul i n-synthesi sing cultures 
from the same cell line would be helpful in determining the events 
giving rise to variants and so hopefully to understanding imunoglobulin 
synthesis in general. So, in addition to identifying abnormal 
immunoglobulin secretion among established cell lines, an attempt 
was made to detect variant immunoglobulin synthesising cells within 
a cell line by experiments involving mutagen treatment and cloning. 
The human B lymphoid cell line RPMI 8866 was used in initial 
experiments to determine the cloning conditions as this line has been 
shown previously to grow in semi-solid agarose (Lever and Seegmiller 
1976). It was found that RPMI 8866 would form colonies in two of the 
commercial brands of agarose tested (Table 6) but with a low frequency. 
The low efficiency of colony formation in agarose led initially to 
the use of different forms of semisolid media. The most successful 
of these was collagen, but, although higher cloning efficiencies 
were obtained ( = 25%) in a collagen matrix constructed according to 
Elsdale and Bard (1972), this proved a difficult medium from which 
to remove the cell colonies. Therefore, conditioned media and feeder 
layers were used in an attempt to increase the cloning efficiency in 
agarose. Conditioned media had little or no effect but the inclusion 
of a fibroblast feeder layer, in particular one of human embryonic 
lung fibroblasts, gave a dramatic increase in cloning efficiency 
(Table 7) which was maintained over a wide range of cell densities 
(Table 8). Using these conditions several human B lymphoid lines were 
cloned with a high efficiency, (Table 9). 
Table 6 	Colony formation in different types of agarose 
The cloning efficiency (number of colonies formed expressed as 
a % of the number of cells plated) of RPMI 8866 in different commercial 
forms of agarose. Each result is the mean of 3 petri dishes containing 
100 cells each in agarose. 
Table 7 	The variation in cloning efficiency with culture conditions 
The cloning efficiency of RPMI 8866 in International Enzyme Grade A 
agarose under different culture conditions. Each result is the mean of 
2 petri dishes containing 100 cells each in those conditions. 
Table 8 	The variation in cloning efficiency with cell number 
The variation in cloning frequency of RPMI 8866 with the number 
of cells plated in International Enzyme Grade A agarose over a human 
embryonic lung fibroblast feeder layer. Each result is the mean of 
2 petri dishes at that cell density. 
TABLE 6 
Agarose Cloning efficiency (%) 
May and Baker 0 
Miles 0 
Miles LGT 0 
International Enzymes (Grade A) 5 
Sigma 	(electrophoretic grade) 2 
TABLE 7 
Conditions Cloning efficiency 	(%) 
No feeder layer, fresh medium 6 
No feeder layer, 
fibroblast conditioned medium 9 
No feeder layer, 
lymphoblast conditioned medium 8 
Human embryonic skin 
fibroblast feeder layer, fresh medium 21 
Human embryonic lung 
fibroblast feeder layer, fresh medium 52 
WC38 fibroblast feeder layer, 
fresh medium 20 
TABLE 8 







Table 9 	The cloning efficiencies of several human B lymphoid cell lines 
The conditions are those described in Table 8. Each line was 
plated in duplicate. 
Table 10 Immunoglobulin secretion in clones of RPMI 1788, RPMI 8866 
and a mixed culture of the two 
The cultures were cloned in the conditions described in Table 8. 
In the cases of RPMI 1788 and RPMI 8866 samples of 10 clones each were 
tested and of the mixed culture clones 50 were sampled. 
Table 11 The cytotoxic effect of Meiphalan 
The pooled results of 2 experiments on the viability of 
1 x 106  cells/ml cultures of RPMI 8866 exposed for 24hrs to differing 
concentrations of Meiphalan. The 0 represents the addition of only the 
solvent, propylene glycol, at a final concentration of 0.1% to the culture. 
Each result is a mean of duplicate cultures. 
TABLE 9 
Cell line Cloning efficiency (%) 
RPMI 8866 58 
SMI 1 37 
0R1 1 25 
EB4 30 
RPMI 1788 35 
RPMI 8226 71 
TABLE 10 
Imunoglobul in 
Cloning secreted by sample clones 
Cell 	line efficiency IgG 	1gM 	IgG & 1gM 
RPM! 1788 25 0 10 0 
RPM18866 41 10 0 0 
RPM! 1788/ 
8866 mix 28 12 38 0 
TABLE 11 
Melphalan 	(g/ml ) viable cells after 24hrs exposure 
1 	x 10 88 
2x10 7 93 
4x10 7 28 
6 x 10 11.7 
8 x 10-  5.4 
-6 lxlO 0 
-5 lxlO 0 
0 86 
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In order to detect irmnunoglobulin_secretjng colonies in agarose 
it was intended to employ the "antibody overlay" technique of 
Scharff et al.., (1975) used to identify inhiiunoglobuljn production by 
colonies of mouse rnyeloma cells in agar. However, goat antihuman y chain 
antiserum (Technicon) at concentrations ranging from 1 	10 to 1 : 100 
in a 2m1 0.25 agarose overlay failed to detect inhllunoglobulin 
secretion in 1, 2 and 3 week colonies of RPMI 8866. As an alternative 
all colonies to be tested for ininunoglobuljn production were picked 
from agarose and assayed in microculture by haemagglutinatjon inhibition 
using a reduced range of antisera concentrations. Although far more 
time consuming than antibody overlay this regime did have an advantage 
in that each clone could be tested for secretion of more than one 
inrnunoglobuljn polypeptide. This facility was used to demonstrate the 
accuracy of the cloning technique in producing clones of single cell 
origin in that no clones producing both 1gM and IgG were identified 
among 50 sample clones derived from a mixed culture of RPMI 1788 and 
RPMI 8866 (Table 10) in which both classes of ilmiunoglobulin could be 
detected. 
The effect of a 24hr exposure to increasing concentrations of 
Meiphalan, a mutagen shown to effect iniiiunoglobuljn synthesis in mouse 
myeloma cells, on the viability of cultures of RPMI 8866 is shown in 
Table 11. Using a concentration from the middle of the range, which 
has a visible cytotoxic effect, a 5m1 culture of RPMI at i x 106 cells/ml 
was exposed to 6 x 10 	9/ml of Meiphalan for 24hrs. The surviving 
cells were separated out by centrifugation on 11% hypaque at  500g 
av for 10 mins at room temperature (J. Evans, personal communication) washed 
in medium and samples plated out in 10 petri dishes at 500 cells/dish. 
A similar sample fromn untreated culture of the same cell line was 
plated out in a similar way. A total of 1117 clones were recovered 
from the plated sample of the mutagenised culture and 836 from the 
control culture. However, every one of the mutagen treated and control 
clones secreted both, apparently normal, y and Kchains. In addition 
130 cultures established during other experiments in this laboratory, 
by dilution cloning of the cell lines F137 and YAK  after treatment 
with MNNG or EMS in a manner which has produced several biochemical 
changes (Porey et al., 1973, Arthur et al., 1975, Gardiner et a]., 1977) 
were assayed for secretion of c 
, y , p ,Kand A chains. Each culture 
showed no change in its irrDllunoglobulin secretion pattern from their 
parent line. 
u7 s8~  
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In terms of generating mutant clones the mutagenesis and 
cloning experiments produced negative results. To repeat or extend 
such experiments would be time consuming and, in the light of these 
results, perhaps fruitless. Thus, it was decided to devote the time 
available to further examination of normal lines and the presumptive 
variant lines identified earlier. 
THE ANALYSIS OF RADIOACTIVITY LABELLED PROTEINS SECRETED 
BY HUMAN LYMPHOID CELL LINES 
Following the serological identification of imunoglobulins 
in culture supernatants a more detailed analysis of these molecules 
requires that the proteins synthesised by human B lymphoid cell lines 
can be distinguished from the FCS proteins in which the cells are 
cultured. This distinction can be made by the biosynthetic labelling 
of the cell products using a radioactive precursor. An initial 
assessment of the nature and quantity of proteins labelled in this 
way and secreted into the culture medium was made by the analysis of 
a selection of samples of biosynthetically radiolabelled culture 
supernatants from different cell lines by SDS PAGE. The samples were 
run under reducing conditions which break S-S bonds (Fig. 8) and under 
non-reducing conditions, (Fig. 9) on 3% - 20% gradient gels. 
The more striking feature of these gels is the large number of 
protein bands shown by each cell line supernatant, especially in the 
reduced gel, and the high proportion of bands which appear common to 
all the cell lines including the T lymphoid line CCRF. However among 
the large number of components several are prominent. In the reduced 
gel (Fig. 8) the tracks from several of the imunoglobulin secreting 
cell lines have a conspicuous band corresponding to the size of a light 
chain (22,000 mol. wt.) but this band does seem to vary from line to 
line in its mobility. The reduced track of RPMI 8866 shows a large 
band at 50,000 mol. wt. which possibly represents the secreted y chains 
of that line. The tracks in the same gel of SMI 1 and U2668L both 
show a band not present in other samples at about 70,000 mol. wt. 
Fig. 8 	SOS PAGE analysis of reduced cell line supernatants 
This flurograph shows the SDS PAGE profiles of unfractionated 
14 C valine biosynthetically labelled culture supernatants under reducing 
conditions (i.e. with 5% 2-mercaptoethanol in the sample buffer) on a 
linear 3% - 20% gradient gel. All the samples of culture supernatant 
contained an equal number of TCA precipitable counts and an equal amount 
of total protein. The molecular weights referred in the text are given 
(x10 3 ) on the right and were estimated from the mobility of molecular 
weight markers shown (x10 3 ) on the left. The molecular weight markers 
were; phosphorylase b (94,000), BSA (68,000), IgG heavy chain (51,000), 
IgG light chain (22,000) and RNAase A (13,000). 
Fig. 9 	SOS PAGE analysis of non-reduced cell line supernatants 
This flurograph shows the same analysis as in Fig. 8 but without 
2-mercaptoethanol in the sample buffer. The markers were; IgG (146,000), 
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As SMI 1 is a P K secretor and, although only 	chains were detected 
in U266BL cultures, it has been reported as secreting IgE (Nilsson et al., 
1970) 	these bands may represent w and c chains respectively. The 
diffuse band of about 200,000 mol. wt. present only in the reduced 
track of RPMI 8226 cannot be explained in terms of its known 
imunoglobulin secretion pattern, but, as this is the only line among 
these samples which grows as an attached culture, this band may represent 
a large molecular weight peptide involved in cell adherence. 
The non-reducing gel (Fig. 9) shows a similar group of bands 
around light chains size except in the sample from JIJOYE but here 
there is an additional band about double the light chain molecular 
weight indicating that the light chains may be secreted as dimers in 
this case. In fact similar derbands are present, in addition to 
those of single light chain size,, in the tracks of other imunoglobulin 
secreting cell lines and RPNI 8226 has been reported as secreting light 
chains in a dimer form (Matsuoka et al., 1968). If these bands are 
light chains this indicates that they are free in the cell line supernatant 
yet there are no putative heavy chain bands visible in the non-reducing 
gel and the 150,000 mol. wt. band of RPMI 8866, the 180,000 mol. wt. band 
of U266BL and the large band at the origin in the SMI 1 track indicate 
the presence of entact IgG, IgE and 1gM molecules respectively. This 
raises the possibility that these cell lines may secrete intact 
ininunoglobulin molecules and free light chains. 
However these points are only speculation at this stage. The 
overriding conclusion from this analysis is that human B lymphoid cell 
lines secrete a large number of proteins in addition to imunoglobulins 
and so some fractionation of their secreted proteins is required for 
any further examination of a particular component. 
THE PURIFICATION OF IMMUNOGLOBULINS FROM SECRETED PROTEINS 
The different irnmunoglobulin classes were originally defined by 
their sedimentation velocities and have well characterised sedimentation 
coefficients. Thus, it was considered that sucrose gradient velocity 
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sedimentation could be used in fractionating culture supernatants 
to analyse secreted imunoglobulins. Furthermore, it was thought 
unlikely that there would be many proteins among those secreted by 
human B lymphoid cell lines of the size of 19S pentameric 1gM. Therefore, 
if the 1gM secreted by human B lymphoid cells is in the pentameric 
form, 1gM secreting cell line supernatants should provide useful 
starting material for this approach. 
It was found that the biosynthetically radiolabelled secreted 
proteins of the 1gM secreting cell line SMI 1 could be resolved into 
a fast sedimenting 19S component and a slower component of about 4S by 
sucrose gradient velocity sedimentation (Fig. lOa). Serological 
analysis of the gradient fractions demonstrated that p heavy chains 
were present only in the 19S component (Fig. lob), but K light chains 
were present in both components of the secreted proteins (Fig. lOc). 
These results indicate that intact 19S 1gM molecules are present in 
the proteins synthesised and secreted by SMI 1 . The analysis of the 
radioactivity labelled proteins present in the 19S and slower components 
by SDS PAGE (Fig. 11) showed that the two most abundant polypeptides 
present in the 19S component have similar molecular weights to human 
11 chains and light chains confirming that 19S 1gM is synthesised 
and secreted by this cell line. The presence of a polypeptide in 
the slower component with the molecular weight of a human light chain 
is consistent with the serological analysis of the gradient fractions 
from the same cell line showing the presence of light chains in 
slow components and supports the evidence cited earlier that in 
addition to intact 19S 1gM, free light chains are secreted by SM! 1 . 
All other 1gM-secreting human B lymphoid cell lines whose 
biosynthetically labelled secreted proteins were analysed by sucrose 
gradient velocity sedimentation showed a similar profile to SMI 1 that 
is a 19S and a slower sedimentating component. Several of these are 
shown in Fig. 13. In some of these lines the 19S component represents 
a substantial proportion ( >50%) of the secreted protein. The SOS PAGE 
analysis of the radiolabelled proteins present in these components 
from several lines also confirms the initial results from SMI 1 showing the 
and light chain polypeptides in the 19S components and an additional 
light chain band present, to a varying extent in different cell lines, 
in the slow component (Fig. 14). 
Fig. 10 	Sucrose gradient velocity sedimentation analysis of culture 
supernatant from an 1gM secreting cell line 
0.3mls of secreted proteins from SMI 1 (a u K secreting human B 
lymphoid cell line) were analysed on a 4.5ml 5% - 20% sucrose gradient 
containing 0.5% NP-40 at 200000 	for Ors at 4 °C as described in theav 
Methods section. 
(a) Profile of 14C valine biosynthetically labelled proteins, 
101.11 of each fraction were TCA precipitated and counted. The remainder of 
each fraction was analysed for u chains (b) and K chains (c) by the 
haemagglutination inhibition test. 
The sedimentation velocities were calibrated by analysing, during 
the same run, on an identical gradient a mixed sample of the same volume 
containing diluted serum from a macroglobulinaemia patient and human 
haemoglobin (d). The fractions were assayed for U chains (shown in 
histogram form) to give the position of the 19S serum 1gM and for their 























Fig. 11 	SDS PAGE analysis of sucrose gradient fractions 
A 300 sample of unfractionated SMI 1 radiolabelled culture 
supernatant (UF) and the central fractions from each of the 19S and 
slow components (SC) isolated by the method described in Fig. 10 from 
SMI 1 secreted proteins were analysed by SOS PAGE on 12 gels. The 
flurograph of these gel tracks is shown here together with marker 
proteins run on the same gel. The Coornassie Blue stained portions of 
the gel containing the markers was swollen to the same size as that 
part which was prepared for flurography by incubating in 20X its 
volume of water for lhr after destaining. The molecular weights of 
the markers are: 1gM P chain 72,000; IgG Y chain 51,000; light chains 
22,000 (the differences in mobility are discussed later in the text); 
Phosphorylase b 94,000; BSA 68,000; ovalbumin 43,000; RNAaseA 13,000. 
Fig. 12 	Comparative SOS PAGE analysis of purified iririunoglobulin 
standards and rnyeloma, macroglobulinaemia and normal sera 
Purified IgA, 1gM and IgG, obtained as described in the Materials 
section, were analysed along with samples from two rnyeloma sera, 
GRE (ci A) and SNE (y K), a Waldenstrom's macroglobulinaemia serum 
ODI (P A) and a normal serum. The rnyeloma and macroglobulinaemia sera 
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Fig. 13 	The velocity sedimentation analysis of the secreted proteins 
from different cell lines 
300u1 samples of biosynthetically radiolabelled cell culture 
supernatants from several different 1gM synthesising human B lymphoid 
cell lines were analysed by sucrose gradient velocity sedimentation 
under the conditions described in Fig. 10. lO.l samples from each 
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Fig. 14 	Comparative SDS PAGE analysis of radioactively labelled 
sucrose gradient components from different cell lines 
The central fraction from each of the 19S and slow components (SC) 
from some of the sucrose gradient velocity sedimentation analyses of cell 
line supernatants shown in Fig. 13 together with 30ul samples of 
unfractjonated radiolabelled culture supernatant from the respective cell 
lines were analysed on 12 SDS PAGE gels. Molecular weights are shown 
(x10 3 ) on the right hand side; the markers were phosphorylase b (94,000) 
Ovalbumin (43,000 and RNAaseA (13,000). 
Fig 14 
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An additional feature of these gels where 1gM isolated from 
more than one cell line are analysed together is that the electrophoretic 
mobility of the lightchains is not constant. Furthermore, this 
difference in mobility seems related to light chain type (BAY 1 and 
WEB 1 are ji A secretors and BAY  and CON 1 P K ) so that K chains migrate 
in SDS gels more rapidly than A chains. This observation was also made 
in the SDS PAGE analysis of samples of myeloma and macroglobulinaemia 
sera which had been serologically typed using the haemaggl uti nation 
inhibition test. Samples of these sera were analysed on an SDS gel. 
Purified human IgA, IgG and 1gM were run in parallel with these samples 
since these imunoglobulins had shown a difference in their light 
chain mobilities when they were used as molecular weight standards in 
the analysis of the SMI 1 radiolabelled sucrose gradient fractions 
(Fig. 11). Fig. 12 confirms that the apparent molecular weight of the 
1gM light chain (identified as K by the haemagglutination inhibition 
test) is larger than that of the light chain from the purified human 
IgG and shows that it is also larger than any of the othbands 
identified as light chains. Thus its mobility cannot be explained in 
terms of the difference in K and A chain nobility in SDS gels observed 
in the secreted 1gM of human B lymphoid cell lines. Alternative 
explanations of this and other observed examples of variation in light 
chain mobility will be discussed later. 
The use of detergents in sucrose gradients 
Initial sucrose gradient runs showed very small 19S components 
or no components of this size at all in the analysis of 1gM-containing 
cell line supernatants. In addition, the total TCA precipitable 
radioactivity recovered in the fractions of these gradients was 
considerably less than that in the sample of culture supernatant which 
had been applied to the gradient and a significant amount of TCA 
precipitable radioactivity could be detected by counting the empty 
used centrifuge tube. It was concluded that a portion of the radioactive 
proteins present had adhered to the polypropylene tube in which the 
gradient was run. Centrifuge tubes manufactured from different plastics 
were also found to bind large amounts of radioactive protein from 
the sample of culture supernatant. The use of a detergent was also 
56 
Considered as a means of overcoming this problem. The inclusion 
Of 0.5% NP-90 in the gradient prevented the binding- of proteins to 
the centrifuge tube and dramatically altered the observed profile 
of radioactivity in the gradient fractions (Fig. 15). The apparent 
preferential binding of the 19S component to the centrifuge tube 
in the absence of detergent may be because the 1gM which constitutes 
this component is a heavily glycosylated protein (see Introduction, 
section on imunoglobulin structure, Table 1) or as it moves further 
in the gradient the 19S component is exposed to a greater area of 
the tube and in a lower concentration of protein than the slower 
sedimenting component. 
The use of other detergents such as SDS and sarkosyl also 
prevented the binding of proteins to the centrifuge tube (Table 12) 
and had the same effect on sucrose gradient analysis of culture 
supernatants as NP-40 (Fig. 16), although the 19S component in the 
sarkosyl gradient shown seems less well defined. However unlike the 
non-ionic detergent NP-40 the ionic detergenSDS and sarkosyl were 
both found to affect the haemagglutination inhibition test (presumably 
by disrupting hydrogen bonding) when present in sucrose gradient 
fractions or culture supernatants at concentrations which prevent 
binding of proteins to plastic surfaces. Thus NP-40 was the detergent 
of choice from those tested and was then used not only in gradients 
but in other preparations of culture supernatants to prevent loss of 
the secreted imunoglobulin. 
Analysis of supernatants from presumptive variant cultures by sucrose 
gradient velocity sedimentation 
The ability to detect heavy chains and light chains in sucrose 
gradients can be used to analyse the nature of the irruiunoglobulin 
secreted by those cell lines in which only a heavy chain or light 
chain can be identified serologically in the culture supernatant. 
The immunoglobulin polypeptides secreted by these cell lines could 
be part of a larger molecule whose other heavy or light chains have 
not been identified either because they are 5 or c chains which 
cannot be assayed using the haemagglutination inhibition technique 
in its current form or because they are altered chains which cannot 
Fig. 15 	The comparison of sucrose gradient velocity sedimentation 
in the presence and absence of a detergent 
Two 300p1 samples of biosynthetically radiolabelled culture 
supernatant from the same culture of SMI 1 were analysed by velocity 
sedimentation under the conditions described in Fig. 10 on identical 
gradients except that one contained 0.5% NP-40. 
. Radioactivity in the absence of NP-40 
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Fig. 16 	The effect of different detergents on the sucrose gradient 
velocity sedimentation of radiolabelled culture suoernatants 
Four 3000 samples of culture supernatant from the same 
biosynthetically radiolabelled culture of SMI 1 were analysed by velocity 
sedimentation under the conditions described in Fig. 10 in identical 
gradients except that one contained no detergent (a) and the remaining 
three contained different detergents (b) 0.1% sarkosyl (c) 0.1% SDS 
(d) 0.5% NP-40 
Table 12 	The adherence of cell culture secreted proteins to 
polypropylene centrifuge tubes in the presence of different 
detergents 
The centrifuge tubes from the experiment described in Fig. 16 were 
washed out three times with 5% TCA to remove any remaining free label 
and a further three times with ethanol, dried, immersed in scintilation 



























Detergent content TCA preci pi table radioactivity adhering 
of gradient to the centrifuge 	tube 	(cprn) 
0 13,211 
0.1 	Sarkosyl 1,504 
0.1 	sos 397 
0.5 	NP-40 663 
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be recognised serologically. In these cases the detectable 
polypeptide would show a greater sedimentation velocity than that 
expected for single heavy or light chains. 
In all the supernatants from cell lines apparently secreting 
light chains only which were examined in this way, their respective 
light chain types were all identified as poorly defined components 
present in the sample fractions and in the first one or two fractions 
at the top end of the gradient. A typical profile of this type (from 
the cell line EB 2 ) is shown in Fig. 17. This indicates that these 
light chains are not part of larger molecules and that the largest 
complex they represent would be a light chain dimer which has sedimented 
as far as the top four fractions of the gradient. TheA light chains 
detected in the culture supernatant of U266BL were present in a far 
greater number of fractions extending further into the gradient (Fig. 17). 
This is consistent with the light chains being present in a free of 
dimer form and in addition, also as part of a larger molecule which 
in turn agrees with the interpretation of the analysis of U266BL 
supernatant on SOS gradient gels. U266B1 has been characterised as 
a secretor of c chains and A chains (Nilsson et al., 1970). c chains 
cannot, at this stage, be identified by the haeniagglutination inhibition 
test. 
The cell line F137 has been identified in this project as 
secreting p chains only but in the analysis of a sample of F137 supernatant 
by sucrose gradient velocity sedimentation no P chains could be detected 
in any of the gradient fractions. This may be because theu chains 
secreted by F137 are normally present at a low level in any case and 
samples are always subject to some dilution in the gradient. Normal 
and radiolabelled samples of F137 culture supernatant concentrated by 
ammonium sulphate precipitation also gave negative results when tested 
both for detectable u chains in the haemagglutination inhibition test 
and for a radiolabelled 19S component by sucrose gradient sedimentation. 
These findings contrast with those for other u secreting cell lines whose 
19S components could be enriched by this proceØdure (Fig. 18). This 
ind1cates that the p chains of F137 are not secreted as part of a large 
1gM-like molecule. 
Sucrose gradient velocity, sedimentation analysis of culture 
supernatant has demonstrated that 1gM is secreted by human B lymphoid 
Fig. 17 	The analysis of culture supernatants from presumptive variants 
of immunoglobulin secretion by velocity sedimentation 
0.4ml samples of culture supernatants from the lines to be analysed 
were fractioned by velocity sedimentation as described in Fig. 10. Each 
fraction was analysed for the heavy or light chain normally detected in 
the culture supernatant. The resulting gradient profiles of U266BL and 
EB2  are shown (the presence of A chains is expressed as the relative 
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cell lines as complete 19S molecules which in some lines represents 
a large portion of the total secreted protein; this is revealed 
particularly when steps are taken to avoid losses of imunoglobulin 
on handling. This analysis has also shown that in addition to complete 
1gM molecules free excess light chains are also secreted to a 
varying extent in different cell lines. The investigation of 
presumptive variant inlnunoglobulin-synthesising cell lines using this 
technique has shown that with the exception of U266BL the single heavy 
chains or light chains identified in the supernatants of these cell 
lines are secreted as such and not as part of a larger molecule 
whose other constituant polypeptides are not recognised serologically. 
As this is the case, even although the resolution of their sedimentation 
velocities could be improved by running different gradients and under 
different conditions, it is unlikely that free heavy or light chain 
polypeptides could be isolated in this way as the bulk of the other 
secreted proteins sediment around the same 4S size. Thus, although 
sucrose gradient velocity sedimentation can provide information on the 
form in which the imunoglobulin chains of presumptive variant lines 
are secreted, this technique cannot be readily used in investigating 
the nature of the polypeptides themselves. 
THE ISOLATION OFIMMUNOGLOBULINS 
FROM CELL LINE SUPERNATANTS BY IMMUNOPRECIPITATION 
As the secreted imunoglobulins of human B lymphoid cell lines 
can be readily identified serologically in the haemagglutination inhibition 
test it was considered that it might be possible to purify them on a 
serological basis. Isolation of the secreted imunoglobulins of human 
B lymphoid cells in this way would be particularly useful in analysing 
the products of the presumptive variant lines which would be difficult 
to purify by physical means. The most popular technique in this 
field is immune- or immuno-precipitation. However, this technique 
has several limitations, the principal one being speci fi city,which 
depends largely on the antisera used. In many of the published results 
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using immunoprecipitation for the successful isolation of ininunoglobulins 
from cell lines, antisera prepared and purified by the authors 
themselves have been used (see for example Singer and Williamson 1979). 
The time available does not permit the raising of antisera in this 
Project and so commercial preparations must be employed. For this 
reason - and because there are several methods of imunoprecipitation - 
it was decided initially to evaluate this technique in the isolation 
of imunoglobulins from human B lymphoid cell line supernatants. It 
has been demonstrated that 1gM can readily be isolated physically from 
cell culture supernatant, so this provides a useful standard against 
which to compare invTlunoprecipitated imunoglobulins from the same 
source. 
Fig. 19 compares, by SOS PAGE, inlllunoprecipitates formed by 
three different methods, all using the same primary antisera with 1gM 
isolated by velocity sedimentation from the same radiolabelled sample 
of culture supernatant. All three methods show isolation of the 
relevant heavy chains and light chains in comparable purity to those 
from 19S component. However the classical indirect irmiunoprecipitation 
using a second anti-immunoglobulin antiserum uses more primary antiserum 
and takes longer to complete than the other two techniques where the 
second antiserum is replaced by two different protein A imunoabsorbants. 
In the two protein A-based techniques the staphylococcal imunoabsorbant 
forms a far smaller pellet on removal from the sample of culture 
supernatant by centrifugation than the much larger protein A coupled 
sepharose beads. This allows for a more efficient elution of 
precipitated material in a smaller volume of sample buffer making the 
fixed Staphylococcus aureus organisms a more convenient immunoabsorbant. 
A striking feature of the analysis shown in Fig. 19 is that 
in each immunopt-ecipitation method, although the control non-immune sera 
precipitated nothing, anti y' and anti ii antisera both precipitated p chains 
and light chains from the supernatant of  p K secreting cell line. This 
brings into question the specificity of the antisera. The more pronounced 
light chains in the imunoprecipitated samples in comparison to the 19S 
component. although both were isolated from the same volume of culture 
supernatant, suggests that the lack of specificity in this case was 
due to anti light chain activity in the antisera supplied as anti - chain 
and anti P chain specific. 
Fig. 19 	Evaluation of inlnunoprecipitat -jon 	A comparison of different 
methods 
0.3m1 aliquots from the same sample of radiolabelled S?11 1 culture 
supernatant were imunoprecipitated using non-immune rabbit serum, 
rabbit anti human Y chain (Miles) and rabbit anti human 	chain (Miles). 
These primary sera were precipitated using a second goat anti-rabbit 
imunoglobulin anti-serum (Miles) or either of two irirnunoadsorbants 
which were fixed staphylococcus aureus organisms or protein A coupled 
sepharose beads. Where a second precipitating anti - serum was used lOiji 
of the primary antiserum was incubated with the sample of supernatant 
for lhr at 4°C followed by 200 of the precipitating antiserum and 
incubation overnight at 4 °C. The precipitate was then spun down at 
12,800g 
av  for 15 mins washed three times in PBS 0.5% NP-40 and dissolved 
in SDS PAGE sample buffer. The irmnunoprecipitatjon protocol described 
in the Methods section was used when an inriunoadsorbant was employed in 
place of a second antiserum with the substitution of 15mg of protein A-Sepharose 
per sample for the staphylococcal iuinunoadsorbant. Where the inruno-
adsorbants were used additional control samples containing only the 
ininunoadsorbant were set up and processed as ininunoprecipitates to detect 
any direct binding of secreted proteins to protein A. The ininuno-
precipitates and controls together with a 19S component, isolated as 
previously described, from an identical sample of supernatant were 
analysed on a 12% SDS PAGE gel, a flurograph of which is shown opposite. 
The primary serum or antiserum used is indicated directly above the 
relevant track and above that the second antiserum or ini.unoadsorbant. 
Fig 19 
Goat an'i Protein A Fixed 
rabbit coupled staphylococcus 
immunoglobin sepharose aureus 
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Following this observation, several different commercial antisera 
were evaluated for their specificity in this way. The SDS PAGE 
analysis of imunoprecipitates, from a radiolabelled p K secreting 
cell line supernatant, using different anti heavy chain and anti 
light chain antisera (Fig. 20) demonstrates that there is considerable 
variation in specificity among those antisera tested. The Behringwerke 
anti A track is empty and the anti K track shows the expected polypeptides 
whereas the anti Y antiserum from the same supplier appears to precipitate 
a small but detectable amount of the same protein recognised by its 
anti ij equivalent. The Technicon anti y and anti p antisera and the 
anti IgG Fc and anti 1gM Fc each show results in keeping with their 
claimed specificities. However the anti y and anti p from the Scottish 
Antibody Production Unit both precipitate polypeptides with the 
characteristics of 1gM constituents. 
Protein A has a high affinity for rabbit antibodies and antisera 
raised in rabbits are generally used in protein A dependent techniques. 
However, the analysis shown in Fig. 20 uses antisera which are also 
derived from different species and demonstrates that, despite their 
reported lower affinity for protein A, antibodies from sheep and goats 
(sources of many commercial antisera) can also be successfully used in 
immunoprecipitation with Staphylococcus aureus protein A inuiunoadsorbent. 
The analysis of secreted chains from the presumptive variant immunogiobulin 
synthesising cell lines byimunoprecipitation 
The SOS PAGE analysis of imunoprecipitates, formed with the 
relevant antisera, from the radiolabelled supernatan1of EB 2 , EB 3 , JIM1, 
and U266BL showed single components which all had the molecular weight 
(22,000) characteristic of light chains. This indicates that these 
light chains are secreted as such and, with the exception of U266BL, 
is consistant with the earlier analysis of the same supernatants by 
velocity sedimentation. The velocity sedimentation analysis of U266BL 
suggested that a portion of the secreted A chains may be part of a 
larger molecule and this is in keeping with its description as an IgE 
secretor (Nilsson et al., 1970). The remaining A chains by being 
present in excess and/or by having a greater affinity for the anti A 
antibodies may account for the absence of an c  heavy chain in the 
imniunoprecipi tate. 
Fig. 20 	Evaluation of immunoprecipitation : A comparison of different 
anti sera 
0.3m1 samples of SMI 1 radiolabelled culture supernatant were 
immunoprecipitated using the staphylococcal imunoadsorbant technique 
described in the MethodsSection with a range of different antisera. The 
resulting irnmunoprecipitates were analysed on a 12% SOS PAGE gel a 
flurograph of which is shown opposite. The tracks relating to the use 
of the different antisera are as follows: 
a 	No serum 
b Rabbit non-immune serum 
c 	Rabbit anti BSA 
d Rabbit anti human A (Behringwerke) 
e 	Rabbit anti human K (Behringwerke) 
f Rabbit anti human y (Behringwerke) 
g 	Rabbit anti human P (Behringwerke) 
Ii Goat anti human r (Technicon) 
i 	Goat anti human P (Technicon) 
j Sheep anti human Y (SAPU) 
k 	Sheep anti human u (SAPU) 
1 Goat anti human IgG Fc (North east) 
m 	Goat anti human 1gM Fc (North east) 
Fig 20 
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The characteristic light chain molecular weight of the 
imTflufloprecjpjtaed components from these cell lintes indicates that the 
secreted light chain polyptides have a normal structure. However, 
immunoprecipitated K light chains from Jijoye radiolabelled supernatant 
have an apparently larger molecular weight of about 30,000 (Fig. 21) 
suggesting that they are structurally abnormal. Components of the 
same size are present in the anti K ilrinunoprecipitate from K.AT 1 and 
the anti A from RPM! 8226 which are also shown in Fig. 21. However 
these components are Co-precipitated with a polypeptide of normal 
light chain molecular weight. It is unlikely that the larger component 
is derived from the apparently normal light chain polypeptide which has 
been so altered in its aminoacid structure as to show a large change in 
Charge or number of residues as this would require the synthesis of two 
different light chains from the same cell or that the cultures concerned 
are biclonal with respect to their light chain synthesis. A more 
probable explanation would be that the light chains synthesised by KAT 1 
and RPM! 8226 are homogeneous in each line with respect to their aminoacid 
sequence but they are differentially glycosylated.. Efficient glycosylation 
of the secreted light chains of Jijoye could also explain their similar 
slow mobility. There are other explanations for variation in light chain 
size but these will be considered later. Alternatively of course, the 
CO- precipitated larger component from KAT 1  and RPM! 8226 need not be 
a light chain at all but, for example, an N-terminal heavy chain fragment. 
The imunoprecipitation with anti human u chain antisera of a 
relatively large volume of F137 radiolabelled supernatant failed to 
demonstrate any p chain polypeptides in analysis of the imnlunopt-ecipjtate 
by SDS PAGE (Fig. 22). At the same time a 0.2n,l radiolabelled sample of 
G-S (a relatively low producer of 1gM, See Fig. 13) diluted to the same 
volume and treated in the same way could be shown to contain polypeptides 
characteristic of j.i chains and light chains. This situation is in 
keeping with previous experiments where the constant but weak detection 
of ii chains in the supernatant of F137 cultures by haemagglutination 
inhibition has failed to yield to further analysis. This suggests that 
the initial detection of v chains in the supernatant of F137 is an 
artefact, perhaps caused by the secretion of some other protein or the 
interaction of a secreted protein and components rom the culture medium. 
Fig. 21 	Analysis of immunoprecipitates from radiolabelled supernatants 
of Jijoye,KAT 1 and RPMI 8226 
The immunoprecipitates from 0.3ml samples of supernatants from 
radiolabelled cultures of the above cell lines together with untreated 
30l aliquotes from the same supernatant samples (UT) were analysed on 
a 12% SDS PAGE gel, a flurograph of which is shown opposite. The 
anti sera used are indicated directly above the relevant track and the 
origin of the supernatant samples above that. Molecular weight mobilities 
are shown on the right (xlO 3 ) and the markers were; phosphorylase b 
(94,000), ovalbumin (43,000) and RNAase A (13,000). 
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Fig. 22 	Analysis of imunoprecipitates from G-S and F137 radiolabelled 
culture supernatants 
Immunoprecipitates from 2.5ml samples of radiolabelled supernatant 
from F137 and a 0.2m1 radiolabelled supernatant sample from G-S diluted 
to the same volume in used medium were analysed together with 30i1 samples 
of untreated radiolabelled culture supernatant (UT) from the same cell lines 
on a 12% SDS PAGE gel a flurograph of which is shown opposite. The antisera 
used are shown above each track and above that the origin of the supernatant 
samples. Molecular weight mobilities (xl0 3 ) are shown on the right, the 


















Alternatively the ii chains may in fact be present but derived from 
some source other than normal secretion such as the shedding of cell 
surface immunoglobulin or the spillage of intracellular imunoglobulin 
from dead or dying cells. In this case the proteins concerned may be 
unstable and so they are onlyreadily detected in samples taken from 
continuous cultures where their extracellular concentration will be 
maintained. 
THE SEROLOGICAL ANALYSIS OF INTRACELLULAR 
AND CELL SURFACE IMMUNOGLOBULIN IN HUMAN B LYMPHOID CELL LINES 
Ininunoglobulins are not only secreted proteins but can also be 
expressed on the surface of cells and their synthesis for either secretion 
or surface expression requires the intracellular presence of 
inimunoglobulins. Lack of secretion of ininunoglobulins, therefore, does 
not imply lack of their synthesis. This is particularly relevant to 
the study of those cell lines whose imunoglobulin synthesis appears 
deficient or abnormal on the basis of the heavy chains or light chains 
identified among their secreted proteins. Therefore experiments were 
conducted to determine whether intracellular or surface immunoglobulins 
were present in and on human B lymphoid cell lines. These experiments 
were directed particularly at those cell lines which secrete no detectable 
immunoglobulin or only a single type of ininunoglobulin polypeptide but 
also included a selection of normal iniTiunoglobulin secreting lines as 
controls. 
The presence of intracellular imunoglobulin was determined 
simply by assaying a lysate of washed cells in the haemagglutination 
inhibition test (the details are described in the Methods section). The 
lack of any effect of NP-40 on the serological detection of imunoglobulins, 
discovered in the sucrose gradient velocity sedimentation experiments, 
and the ability of NP-40 to lyse cells but not their nuclei prompted this 
assay. However, the use of a detergent meant that cell surface proteins 
would also be present in the lysate. As the cell surface ininunoglobulins 
were also being assayed, the true cellular distribution of the 
iffinlunoglobulins could be deteruiined by a comparison of the two results. 
Despite contamination by cell surface irnmunoglobulin this adaptation 
of the haemagglutination inhibition assay represents a more convenient 
and rapid method of determining the presence of cellular imrnunoglobulin 
than 	conventional immunofl uorescence microscopy. 
Cell surface immunoglobulin was identified using an i125 protein A 
binding assay which was adapted from the method of Cohen (personal 
comunicaion) as a measure of the binding of various antihuman heavy 
and light chain antisera to the cell surface and the details of which 
are described in the Methods section. Behringwerke class specific 
rabbit antihuman heavy chain antisera were used in this assay despite 
the previously discussed suspicion of their specificity in inuhiunoprecipitation. 
This was because the goat antihuman heavy chain antisera which showed 
the greater specificity in irnmunoprecipitatjon appeared not to bind 
significant levels of protein A in the cell surface assay. This contrasts 
with the binding of these antisera by protein A bearing fixed 
Staphylococcus aureus organisms and indicates that the immunoglobulin 
binding properties of protein A vary depending upon its presence in the 
staphylococcal membrane or in free solution. However the specific 
positive binding of antisera in the cell surface imunoglobulin assay was 
clearly discernable by showing a five fold or greater increase in 1 125 
protein A bound over control values and a four fold increase over negative 
experimental values. (Table 13). The assay results showiin Table 13 
are summarised, together with those results from analysing cell lysates 
in the haemagglutination-inhibition test for the presence of 
immunoglobulin, in Table 14. In addition the previously established 
immunoglobulin secretion patterns are also included in Table 14 for 
comparison. 
The T lymphoid line CCRF, as one might expect, does not synthesise 
immunoglobuljn therefore secretes no immunoglobulin and has no cell surface 
imunoglobulin. The normal irrrlunoglobulin-.synthesising B lymphoid lines 
ODY 1 , RPMI 8866 and SMI 1  each synthesise a single heavy chain class and 
light chain type, secrete the same heavy chains and light chains and 
have them present on the cell surface although whether they are incorporated 
into the structure of the membrane or merely "in passage" as part of the 
secretion process cannot be determined. However, the intracellular, 
surface and secreted heavy chains and light chains of the other cell 
lines analysed demonstrated several combinations of synthesis and expression 
Table 13 	The identification of cell surface immunoglobulins in human 
B lymphoid cell lines 
Values for the binding of i125  protein A (cpm) to similar samples 
of cells from different cell lines in the presence of different rabbit 
antihuman inuiunoglobulin antisera (Behringwerke) are shown. 	The 
different cell lines are given at the left hand side of each row and 
the various human imunoglobulin chains against which the antisera were 
directed are indicated at the top of each column together with columns 
showing the results obtained when non-irTrJne rabbit serum was used and 
when no serum or antiserum was present (C). These values represent 
the pooled results from three experiments; 2 covering together the heavy 
chains and a third the light chains. In each of the heavy chain 
experiments non-immune and 0 controls were present but in the light chain 
assays only non-immune controls were used having established that none 
of the cell lines spontaneously bound large amounts of i 125  protein A. 
The non-immune values, therefore, a mean from the heavy chain and light 
chain assays. 




a y 11 K A immune 0 
Daudi 775 218 4181 5276 632 274 267 
EB2 238 157 2269 470 2201 232 202 
ES 3 195 197 462 453 8085 314 218 
FAL J 264 291 279 440 512 288 213 
F89 173 196 275 385 412 248 156 
F137 715 388 2568 428 882 229 212 
Jijoye 185 199 277 3200 522 236 153 
JIM  286 189 1851 559 2604 228 191 
KAT 1 352 183 1735 1881 470 194 188 
Raji 404 215 1314 353 659 252 215 
RPMI 8226 284 188 272 637 1665 228 170 
ODY 1 2329 230 915 464 1412 331 528 
8866 223 1504 347 2636 604 257 167 
SMI 1 417 219 1553 1829 664 293 204 
CCRF 250 239 166 368 545 171 162 
Table 14 	Intracellular, surface and secreted imunoglobulins of 
Human B lymphoid cell lines 
The results of assaying cell lysates from different lines in the 
haemaggl uti nation inhibition test for the presence of  -y and ii heavy 
chains and Kand A  light chains are shown. In addition a summary of 
the radio binding assay results for cell surface immunoglobulin is 
given together with the previously determined pattern of secreted 
immunoglobulins for comparison. 
TABLE 14 
Lysate Surface Secreted 
FAL 1 p - - 
F89 p - - 
F137 p p (u) 
Raji Ii p - 
Daudi PK PK 
EB2 pA pA A 
JIM 1 pA pA A 
KAT 1 K JJK K 
EB3 A A A 
Jijoye K K K 
RPM! 8226 A A A 
ODY 1 ciA ciA ciA 
SMI 1 1.1K Plc PK 
RPM! 8866 K YK 
CCRF - - - 
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of ininunoglobulins: FAL 1  and F89 synthesise only a heavy chain which 
is not secreted nor expressed on the cell surface; Raji and F137 
synthesise a heavy chain which is expressed on the cell surface but 
not secreted; Daudi synthesises a heavy chain and light chain which 
are both expressed on the cell surface but not excreted; EB 2 , JIM  and 
KAT 1  synthesise a heavy chain and a light chain both of which are 
expressed on the surface but only the light chain is secreted; EB 3 , 
Jijoye and RPMI 8226 synthesise only a light chain which can be 
detected on the cell surface and is secreted. In these "variant 
combinations of imunoglobuliri synthesis and expression, ji chains 
are the only heavy chains present and where they are synthesised in 
the absence of light chains they are not secreted. In contrast to 
this pattern of heavy chain secretion in all cases where light chains 
are synthesised they are secreted whether heavy chains are present or 
not. This might suggest that although there is no requirement of 
heavy chains for light chain secretion there is a dependence on light 
chains for heavy chain secretion. However, EB2 , JIM 1 and KAT 1 synthesise 
heavy chains and light chains but secrete only the light chains showing 
that heavy chain secretion is not dependent only upon light chain synthesis. 
Other possible mechanisms underlying these observations and their 
relevance to immunoglobulin synthesis and expression in B lymphocytes 
will be discussed later. 
65 
nicriiccir 
The pattern of imunoglobulin synthesis in established human B 
jyiphoblastoid cell lines 
The overall pattern of inununoglobulin expression seen in this 
survey of human B lymphoid cell lines is "monoclonal' that is one 
heavy chain class and a single light chain type. This is the 
established format in these cell lines (Nilsson 1971, Evans et al., 
1974) as it is in B lymphoid lines from other species and in normal 
lymphocytes. Occasionally reports have been made of human 
lymphoblastoid cell lines which have the capacity to produce two 
different heavy chains. Takashi et a]., (1969) claimed to have 
demonstrated cichain and y chain production in the same cells of 
a lymphoblastoid cell line by immunofluorescence and Bloom et al., 
(1971) reported the secretion of both r and .' chains in two 
lymphoblastoid cell lines detected by ininunodiffusion of concentrated 
culture supernatant. Cloned cultures of human lymphoid cell lines 
have been reported as expressing multiple heavy chain classes 
(Hinuma and Grace 1967) detected by cell surface ininunofluorescence. 
The same technique has also been used to demonstrate multiple 
expression of Y chain subclasses in IgG synthesising human 
lymphoblastoici cell lines, (Simmons et al., 1979). As previously 
mentioned, Kishimoto et al., (1978) claimed to induce concurrent 
IgG synthesis in IgM-synthesising human lymphoblastoid cell lines by 
co-culturing with I lymphocytes using a radioiniiiune assay to identify 
the two classes of immunoglobulin. The results of Kishimotoet al., 
(1978) could not be repeated in this project using the haemagglutination 
inhibition assay and there appears to have been no confirmation of 
any of the reports of dual or multiple heavy chain expression cited 
above nor structural analysis of the heavy chains involved. Structural 
analysis in the form of SDS PAGE of radiolabelled imunoprecipitates 
was used to differentiate between the concurrently expressed secreted 
IgG and cell surface 1gM of a human lymphoblastoid cell line 
(Premkumar et a]., 1975). However the synthesis of the two different 
heavy chains was not demonstrated in clones of the line in which they 
were initially detected. 
T. 
Methodological errors stemming from the specificity of 
serological reagents, the polyclonal nature of cell lines and their 
possible contamination by other cultures or the accuracy of cloning 
techniques could explain the various observations of multiple heavy 
chain expression. However, the possibility exists that there are 
genuine cases of cells which synthesise more than a single heavy chain 
class. In dual heavy chain expression if both heavy chains were being 
transcribed from the same allelic set of heavy chain genes, that is 
from the same chromosome this would confound the current models 
of heavy chain switching by gene deletion (see Introduction, Genetics 
section) because cells clearly cannot go back to express a gene which 
has been deleted. Alternatively if two heavy chain genes were being 
synthesised by the same cell it could be as a result of the expression 
of both allelic sets of heavy chain genes. This, however, would 
represent a breakdown of allelic exclusion which is currently thought, 
from work on mouse myeloma cells, to be maintained by there being 
only one functionally rearranged ininunoglobulin heavy chain gene 
per cell (see Introduction, Genetics section). The most probable 
combination of heavy chains simultaneously expressed by human lymphoid 
cell lines would be p and 5 as the majority of IgD bearing human 
lymphocytes are also positive for 1gM (Rowe et al., 1973) and the 
presence of IgD is considered to be a marker for B lymphocytes in 
an intermediate phase of differentiation (Vitetta and Uhr 1977). A 
report has been made showing the detection of multiple imunoglobulin 
classes including IgD on the cell surface of human lymphoid cell lines 
by immunofluorescence (Van Boxel and Buell 1974). However, no other 
reports of IgD expression by human lymphoid cell lines have been made. 
Neither surface nor secretory IgD were assayed for in this project. 
In any case the transient simultaneous expression in vivo of 1gM and 
IgD could be explained within the deletion model of heavy chain 
switching simply by the stability of imunoglobulin mRNA. In this 
case dual production could not persist through multiple cell divisions 
and therefore could not be present in continuously cultured cell lines. 
Alternatively if 1gM and IgD synthesis could be maintained through 
multiple cell divisions, because of the specialised developmental 
nature of IgD expression the underlying mechanisms need not necessarily 
be related to later switches to the major classes of secreted immunoglobulin. 
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Apart from a single instance in the results of Van Boxel 
and Buell (1974) there have been no reported cases of dual light 
chain production in human lymphoid cell lines and none have been 
observed in this project. However, the production of A chains by BR18 
and K chains by BR8T the tetraploid derivative of BR18 represents 
a situation similar to the synthesis of both light chain types by 
a single cell line. The normal expression of only one light chain 
type in B lymphocytes (genic exclusion) and allelic exclusion in 
light chains are thought to be controlled by mechanisms limiting 
the number of rearranged functional light chain genes to one per 
cell (see Introduction, Genetics section). However, production of 
both light chain types by a single cell line, which has been reported 
at the mRNA level in mouse myeloma cells (Storb et al., 1977), would 
suggest that other mechanisms in addition to those involving gene 
rearrangement control light chain expression. Furthermore, an order 
of gene rearrangement has been proposed in light chain genes such 
that A genes are only rearranged following unsuccessful initial 
rearrangement in the K alleles. The derivation of a K synthesising 
human lymphoid line from a A secreting parent, a situation which 
BR18 and BR18T would appear to represent, indicates that such a 
hierarchy may not be present in human light chain expression. Any 
inferences made from these two human lymphoid lines depend, of course, 
upon how similar BR18 and BR18T actually are. 
The monoclonal pattern of immunoglobulin production observed 
in human lymphoid cell lines reflects that of normal blood lymphocytes; 
however the overall predominance of 1gM synthesis does not. Steel 
et al., (1977) have argued that only 1gM synthesising cell lines are 
derived from EB virus transformation of cord blood lymphocytes, an 
observation confirmed in this study (see Results section, Table 3) 
because there is selective transformation of those cells which are 
actively secreting iniTlunoglobulin. This is in keeping with what is 
known about immunoglobulin synthesis in the human neonate where, 
although the proportions of 1gM and IgG-bearing lymphocytes are 
similar to those of adults (Froland and Natvig 1972), 1gM is the only 
class of circulating immunoglobulin synthesised by the infant's cells, 
as distinct from that transported across the placenta from the maternal 
plasma (Lawton et al., 1972). In contrast to Steel et al., (1977), 
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Rosen et al., (1977) view the EB virus as a polyclonal B cell 
stimulator which can infect and activate the majority of resting 
B lymphocytes to immunoglobulin secretion. However, using EB virus 
as a B lymphocyte activator in cord blood Bird and Britton (1979) 
observe exclusive 1gM synthesis by the activated B lymphocytes and 
explain the lack of activation of IgG or IgA surface bearing lymphocytes 
in cord blood as representing a functional immaturity in this 
lymphocyte subset. Active immunoglobulin secretion is, of course, 
a definative marker of functional maturity in B lymphocytes. 
Predominant, although not exclusive, secretion of 1gM by 
"EB virus activated" B lymphocytes from healthy adult peripheral blood 
lymphocytes and peripheral blood lymphocytes from individuals with 
infectious mononucleosis (an in vivo EB virus infection) has also 
been demonstrated (Bird and Britton 1979). These observations are 
both regarded as normal responses by the authors and indeed the 
in vitro stimulation of human blood lymphocytes with polyclonal 
B lymphocyte activating substances usually results in the development 
of a majority of 1gM secreting lymphocytes (Ringden et al., 1979). In 
comparison to B lymphocyte activation, 1gM synthesis is relatively 
over-represented among the cell, lines derived from healthy adults and 
under-represented among those lines from infectious mononucleosis patients 
(see Results, Table 3) which agrees with (and extends) the findings of 
Steel et al., (1977). This suggests that the populations of lymphocytes 
from which the transformed lines are derived are not the same in these 
two groups. Furthermore, as infectious mononucleosis is characterised 
by raised serum imunoglobulin of all classes the proportion of circulating 
immunoglobulin-secreting B lymphocytes is likely to differ from the 
norm. Thus the difference between the imunoglobulin secretion pattern 
of lines derived from infectious mononucleosis patients and those 
derived from healthy adults, (a phenomenon which is not observed among 
'resting' B lymphocytes which have been activated in vitro), can be 
attributed to differences in the cells showing active iriiiiunoglobulin 
secretion in vivo. 
The pattern of immunoglobulin secretion in human lymphoid cell 
lines derived from individuals with disorders of the lymphoreticular 
system closely resembles that of cell lines derived from the blood 
lymphocytes of healthy adults (see Results, Table 3). This suggests 
that in the majority of cases the cell lines are derived not from 
the malignant cells characteristic of the disorder but from EB virus 
transformation of lymphocytes from the normal 'background' population. 
Exceptions, of course, are those lines derived from Burkitt's Lymphoma 
patients where the proliferating cells are also those carrying the 
EB virus genome. However, other exceptions are few as can be judged 
by the comparative rarity of EB virus nuclear antigen-negative B lymphoid 
cell lines. 
The argument that EB virus acts upon those lymphocytes already 
secreting imunoglobulin (mature plasma cells are evidently insusceptible, 
Nilsson et a]., 1971) defines that subpopulation of circulating 
lymphocytes as those which can be transformed. If there are no other 
restrictions on the transformable population this implies that the 
distribution of imunoglobulin classes secreted by human lymphoblastoid 
cell lines established from healthy peripheral blood lymphocytes reflects 
the relative frequences of the different inuilunoglobulin-secreting 
lymphocytes in healthy peripheral blood. Most of the published data 
on imunoglobulin secretion by cultured blood lymphocytes have been 
derived using mitogen stimulation. Recently, however, Freijd and 
Kunovi (1980) have reported the frequencies of the different 
spontaneous immunoglobulin-secreting cells from healthy adult human 
blood. These show a far higher proportion of 1gM-secreting lymphocytes 
than IgG secretors which agrees with the imunoglobulin secretion patterns 
of normal human lymphoblastoid cell lines. Freijd and Kunori (1980) 
also report that the number of IgA secreting lymphocytes exceeds both 
IgG and 1gM secretors. IgA secreting cell lines, however, are not 
as frequently established as 1gM and IgG lines. 
In order to define clearly the nature of those human lymphocytes 
which are susceptible to EB virus transformation it would be necessary 
to isolate and characterise all the subpopulations of circulating 
B lymphocytes but most importantly, those actively secreting immunoglobulin. 
Any selection for the growth of cells producing a particular 
class of ini'nunoglobulin during the establishment or culturing of 
lymphoblastoid cell lines or any instability of immunoglobulin 
production in culture would greatly influence arguments concerning normal 
B lyiiphocytes and drawing on immunoglobulin secretion by human 
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lymphoblastoid cell lines. However, the observation in this laboratory 
that subcultures taken from an early stage of establishment of a cell 
line secreting two different immunoglobulin molecules give rise to 
approximately equal numbers of clones secreting each of the parental 
imunoglobul ins argues against selection in culture. In addition, 
as discussed below, imrnunoglobulin secretion appears to be a particularly 
stable feature of human lymphoblastojd cell lines and human lymphoid 
cell lines in general. 
The level of irTrur1oglobulin production 
The haemagglutination inhibition test used to detect imunoglobulins 
produced by human lymphoid cell lines is also a semi-quantitative assay. 
Human type I collagen (Sykes and Solomon 1978) and chicken lense 
specific crystalins (de Pomevai and Clayton 1978) have been identified 
and assayed quantitatively using haemagglutination inhibition techniques 
similar to (and in the latter case derived from) that used in this 
project for imniunoglobulins. Therefore, having discussed the nature of 
the immunoglobulins normally produced by human B lymphoid cell lines the 
level of ininunoglobulin production can also be commented upon. 
The figure of 	101.1g/24hrs/106 cells given in the Results section 
for the production of secreted imunoglobulin from human lymphoblastoid 
cells appears higher than the previously reported rate of 1 - 4ug/24hrs/ 
i06  cells (Nilsson and Ponten 1975). However, the level of imunoglobulin 
detected by the haemagglutination inhibition assay increases by doubling 
amounts so that given the limits of accuracy of this technique, the 
values are in reasonably good agreement. Imunoglobulin secretion at 
this level represents an output greater than the 1.5ug/10 6 cells/7 days 
of IgG (Mannrotti et al., 1980) or 2.9iig/10 6 cells/7 days of 1gM 
(Koopman and Schrohenloher, 1980) secreted by mitogen stimulated human 
blood lymphocytes and not much less than the 10 - 20iig/10 6cells/24hrs 
reported for the two human myeloma lines RPMI 8226 (Matsuoka et al., 1968) 
and U266BL (Nilsson 1971a). These figures, however are lower than 
the output reported for mouse myeloma cells in culture (Laskov and 
Scharff 1974) which approaches lOOi.ig of immunoglobulin/10 6 cells/24hrs. 
The level of imunoglobulin production in the human plasma cells may 
be lower than their murine equivalents as,of the two human cell lines 
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assayed RPM! 8226 secretes only light chains and U266BL synthesises 
IgE which is not one of the major classes of secreted imunoglobulin. 
These human rr!yeloma cell lines were not quantitatively assayed in 
this project as neither of them secretes one of the major classes 
of imunoglobulin although their output could have been measured 
knowing the concentration of total imunoglobulin in the reference 
serum and estimating the proportion of imunoglobulin molecules 
having K or A chains. However they K secreting cell line ARH 77 
which was established from a multiple myeloma patient and has been 
described as a plasma cell line (Burk et al., 1978) was assayed 
for its level of secreted imunoglobulin. ARH 77 secreted consistently 
less ininunoglobulin than some of the more rapidly secreting human 
lymphoblastoid cell lines and since the establishment of this line 
it has been found to carry the EB virus nuclear antigen indicating 
that it is inftact a lymphoblastoid cell line (Minowada, personal 
communication; confirmed in this laboratory also). 
The proportion of total secreted protein which immunoglobulin 
represents in human lymphoblastoid cultures has been reported as 
varying from 3% - 10% though a single extreme value of 50% has been 
reported (Hutteroth et al., 1973). The sucrose gradient analysis of 
radiolabelled culture supernatants from 1gM secreting cell lines also 
showed contributions of approximately 10% by 19S 1gM to the total 
secreted protein in most instances. However cell lines where the 19S 
1gM accounted for 50% more of the secreted proteins appeared quite 
common. In fact when the secreted excess light chains are also 
taken into consideration the total proportion of secreted protein giv'?n 
over to iminunoglobulin of one kind or another must exceed 70% in 
some lines. This is borne out by SDS PAGE analysis of unfractionated 
radiolabelled cell line supernatants together with sucrose gradient 
fractions (see Results, Fig., 14) where the polypeptides in the 
unfractionated sample which co-migrate with the u chains and light 
chains are by far the most abundant components in that track. This 
rmarkable level of immunoglobulin production may be explained in 
some part if these lines contain a larger proportion than usual of 
more differentiated cells. It has been noted that cultures of human 
lymphoblastoid cell lines contain a number of cells which appear 
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morphologically more differentiated than the normal lymphoblast cell 
type (de Harven 1967, Ben-Bassat et a1., 1977). It is reasonable 
to assume that a more differentiated B lymphoid cell would synthesise 
more imunoglobulin so that the presence of a significant number of 
these cells could markedly increase the amount of imunoglobulin 
secreted by a cell line culture. 
Not all of these cell lines consistently produce such a high 
proportion of imunoglobulin over a long period of time. This 
inconsistency may be related to culture conditions which have been 
shown to affect imunoglobuljn production (Nilsson 1971a). Certainly 
it was noticed during the course of this project that in some lines 
inlnunoglobuljn synthesis and protein synthesis in general was 
disturbed during changes in the batches of FCS used in the laboratory. 
Nevertheless, the high levels of imunoglobulin production shown by 
human lynphoblastojd cell lines in this project indicate that these 
lines synthesise more iminunoglobulin than perhaps is generally thought 
to be the case. Although they are considered to be "second class" 
cells in terms of irrinunoglobulin synthesis,human lymphoblastoid cells 
can produce a significant amount of irrinunoglobulin and in a relatively 
pure form so that in the absence of a range of suitable human plasma 
cell lines they may provide a useful alternative for the formation of 
human/human hybrids in monoclonal antibody production. 
Although the levels of immunoglobulin detected in the lysates 
of human B lymphoid cell cultures were not accurately quantified, it 
can be reported that samples from normal imunoglobulin_secreting 
cell lines showed complete or near complete inhibition of agglutination 
across the twelve wells of the microtitre plate. This would normally 
indicate an average immunoglobulin concentration for the three major 
classes assayed of 	51ig/ml at least. As the lysate was prepared 
using 5 x lO6cells/ml of lysis buffer, 5 x lO 6cells must contain on 
average at least 5g of immunoglobulin. This in turn gives a figure 
Of 10 - 10 molecules per cell which would include both intracellular 
and surface immunoglobulin. McC onahey et al., (1971) have measured 
surface imunoglobulin on human lymphoblastoid cells at 2 x lO molecules 
per cell ar,1 Litwin et al., (1974) have reported a figure of 1 - 5 x lO 
molecules/cell for surface imrnunoglobulin alone. By comparison with the 
estimate of total cellular inlnunoglobuljn from the lysates these figures 
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suggest that the greater portion of cellular immunoglobulin is 
present on the cell surface which is the expected situation in 
an actively imunoglobulin secreting B lymphocyte of intermediate 
differentiation, (Nilsson 1978). 
The absence of variant or mutant immunoglobulin secreting human 
Blymphoid cells in cloning and mutagenesis experiments 
In experiments involving the mutagen treatment and cloning of 
a human lymphoblastoid cell line no variants of imunoglobulin 
production were detected, yet a large number of mouse myeloma cell 
line clones which synthesise abnormal irTinunoglobulins or which have 
lost the capacity to synthesise ininunoglobulin have been described 
arising spontaneously or after mutagen treatment. These variant 
or mutant mouse myeloma cells occur with a high frequency which 
has been estimated at 10 5/cell/generatjon for spontaneously occurring 
structural mutants of irmiunoglobulin polypeptides (Adetugbo et a]., 
1977), at 1 - 2 x 10 3/cell/generation for spontaneously occurring 
loss of synthesis or secretion of one or both polypeptides (Coffino 
et al., 1972) and as high as 6.5% of the surviving cells for loss of 
ininunoglobulin synthesis or secretion after mutagen treatment 
(Scharff et al., 1975). In contrast to these rates, drug resistance 
in mouse myeloma cells has been estimated as arising with a frequency 
of 106 - 10 7/cell/generation (Baumal et al., 1973) which is many 
orders of magnitude lower than the spontaneous instability of 
imunoglobulin production and approaches the 10 8/cell/generation 
figure for spontaneous variation in other mammalian cell systems 
(Sharp et al., 1973, Chasin et al., 1974). This kind of evidence has 
led to the general consideration that imniunoglobulin genes and their 
expression are abnormally labile, a phenomenon which, it has been 
implied, may have some bearing on somatic mutation theories on the 
generation of antibody diversity, (Adetugbo et al., 1977). 
In this project the analysis of over 2 x 10 untreated and 
mutagenised clones of human lymphoblastoid cell lines for the production 
of more than one immunoglobulin polypeptide, making a total analysis of 
over 4 x 10 	clonal products of immunoglobulin genes, did not lead 
to the detection of any variation in inhiiunoglobulin production. A 
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relatively small number of MNNG and EMS-treated clones of YAK  
and F137 were screened for iniiunoglobulin production. The vast 
majority of untreated and mutagenised clones, however, were derived 
from the cell line RPMI 8866 which has been successfully used by 
other workers in mutagenesis experiments (Lever and Seegmiller 1976). 
"Meiphalan" with which the cells were treated belongs to the 
phenylalanine mustard group of chemicals and is an established mutagen 
(McCann and Ames 1978). The treatment of mouse myelorna cells, using 
the same dose of Meiphalan (6 x 10 7gJml) as the human lymphoblastoid 
cells were exposed to in this project, produced loss of ininunoglobulin 
synthesis or secretion in 1.86% of the clones derived from the 
surviving cells (Scharff et al., 1975). Furthermore, Melphalan is 
used in the treatment of human multiple myeloma and following treatment 
with the drug patients have been reported to show an increase on the 
amount of light chain produced, changes in the structure of the 
myeloma protein or complete loss of its synthesis (Hobbs 1971). This 
suggests that Melphalan has an effect, in vivo on human irrinunoglobulin-
synthesising cells. 
Against this background of information the absence of any 
variant clones of human lymphoblastoid cells especially after treatment 
with Melphalan makes it tempting to conclude that the imunoglobulin 
genes and their expression in human lymphoblastoid cells are very 
stable and particularly so in comparison to the irmiunoglobulin genes 
of mouse myelorna cells. The stable nature of immunoglobulin synthesis 
in human lymphoblastoid cells is borne out by the lack of reports in 
the literature of loss of synthetic activity or changes in the 
immunoglobulins synthesised by these cell lines. However it is 
questionable if this result can be used in a comparative sense. First, 
because only a single mutagen and a single cell line were investigated 
in detail. Second, and more importantly, the cloning and mutagenesis 
experiments were carried out, perhaps naively, for the most part 
to generate variants and not to compare rates of variation so that a 
mouse myeloma cell line was not included in these experiments. Therefore, 
strictly speaking, as a mouse myelonia cell line was not treated and 
analysed in the same system with a human lymphoblastoid cell line a 
true comparison of the rates at which variants arise in the two cell 
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types cannot be made. Nevertheless, in addition to the findings in 
this project it has been reported that cloning experiments with human 
lymphoblastoid cell lines over a long period of time have failed to 
detect non-producing cells and that treatment of the human plasma 
cell line U266BL with Meiphalan has failed to demonstrate any changes 
in iniliunoglobulin secretion in cloned sublines (Nilsson 1978). Such 
results support the notion that the invnunoglobulin genes of human 
lymphoid cell lines are more stable than those of rrnouse myeloma cells. 
If this is the case it represents an important and fundamental 
difference between the two systems and suggests that the labile nature 
of the immunoglobulin genes in mouse myeloma cells is not a property 
of that class of genes but is related to the nature of the mouse myeloma 
cell. This, in turn, might indicate that the rearrangement, erroneous 
rearrangement and deletion of immunoglobulin genes may not have so 
prominant a role in imunoglobulin gene expression In normal B lymphocytes 
and plasma cells as has been implied from their frequent occurrence 
in mouse rnyeloma cells (see Introduction, Genetics section). 
Excess light chain synthesis by human B lymphoid cell lines 
The analysis of unfractionated biosynthetically radiolabelled 
culture supernatants by reducing and non-reducing SDS PAGE suggested 
that, in addition to intact imunoglobul'in molecules, free light 
chains may also be present in the culture supernatants of human 
B lymphoid cell lines. This was confirmed by the serological and 
SOS PAGE analysis of radiolabelled culture supernatants, from 1gM 
synthesising cell lines, fractionated by sucrose gradient velocity 
sedimentation which provided convincing evidence that human lymphoblastoid 
cells do synthesise and secrete free excess light chains. 
Despite this evidence, the presence of light chains in excess 
could be explained by the cultures being mixtures of cells secreting 
intact molecules and other cells secreting only light chains. However, 
this biclonal explanation appears unlikely when excess light chains 
have been observed to varying degrees in all the normal immunoglobulin- 
synthesising cell lines examined, whereas human lyrniphoblastoici cell lines 
secreting only light chains have been comparatively rare in this project. 
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Furthermore, these lines have been in culture for some time, are 
monoclonal in other aspects of their phenotypes and one line SMI 1 
which has been assayed in detail and secretes significant amounts 
Of free light chain had been physically cloned from a single cell. 
A second alternative explanation to account for these results is 
that free light chains in the culture supernatant could be produced 
by the degradation of secreted 1gM in such a way that the heavy chains 
are degraded far more rapidly than the light chains. This possibility 
could be experimentally tested, using the techniques which demonstrated 
the presence of excess light chains in this project, by incubating 
radiolabelled 19S 1gM in non-radioactive culture supernatant then 
analysing this mixture for radiolabelled 19S 1gM or its degraded 
products. However, although FCS probably contains proteolytic activity 
and one might expect some proteolytic enzymes to be liberated or 
secreted from dead or dying cells within cultures, it is unlikely that 
specific preferential degradation of heavy chains over light chains 
would occur in what would be such a broad spectrum proteolytic 
environment. Therefore, the most rational explanation of the presence 
of free light chains in culture supernatants of these cell lines is 
that, together with intact molecules, human lymphoblastojd cell lines 
secrete free excess light chains. 
Excess light chains have been serologically identified in the 
culture supernatants of other human lymphoblastoid cell lines (Litwin 
et al., 1974) and of the human plasma cell line U266BL (Nilsson 1978a). 
Human rnyeloma tumours produce excess light chains (Zolla et al., 1970) 
and this observation has been frequently made in mouse myeloma tumours 
and in the in vitro cultured mouse myeloma cell lines, (Baumal and 
Scharff 1973a). One view of this phenomenon is that it represents an 
abnormal imbalance of heavy chain and light chain synthesis (Parkhouse 
1977) symptomatic of the neoplastic nature of the myeloma cell. This 
view stems from the opinion that the most economical way for cells to 
assemble and produce immunoglobul ins should be by synthesising 
equimolar amounts of heavy and light chains and from descriptions of 
instances of apparently balanced heavy and light chain synthesis 
(tskonas and Williamson 1967). On the other hand normal human serum 
contains free light chains (Berggard and Edelman 1963) and while the 
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synthesis of heavy chains and light chains can be balanced in mouse 
tissues, including myeloma cells, this is comparatively rare; and 
much more commonly there is some excess light chain produced 
(Baumal and Scharff 1973). These observations, together with the 
consistent finding of excess light chain synthesis in immature human 
B lymphocyte neoplasms (Gordon et al., 1978) suggest that this is 
a pattern of irrrnunoglobulin synthesis related to normal cells. The 
demonstration in this project of excess light chain synthesis in 
non-malignant human B lymphoblastoid cells derived from normal B 
lymphocytes is consistent with the view that excess light chain 
synthesis is related to a normal pattern of immunoglobulin production. 
If an excess of light chains is a normal feature of irrinunoglobulin 
synthesis the question then arises of its role in this process. A 
plausible explanation is that an excess of light chains is maintained 
in order that light chains combine immediately with newly synthesised 
heavy chains to prevent the formation of large, relatively insoluble, 
heavy chain complexes which would be crippling, if not lethal, to the 
cell. This argument gains some support from observations which are 
compatible with the idea that synthesis of predominantly or only 
heavy chains is toxic to the cell. These observations come from 
studies of mouse myeloma cells and suggest that loss of heavy chain 
expression is a frequent event which precedes loss of light chain 
expression (Coffino and Scharff 1971). The rarity of variant mouse 
myeloma cell line clones synthesising heavy chains only in comparison 
to those synthesising only light chains (Scharff et al., 1975) and 
the preferential loss of heavy chain synthesis in mouse hybridoma lines 
containing different numbers of heavy and light chain genes (Kohler 1980) 
also indicate that the producticnof free light chains could be lethal 
to the cell. 
Several of the human B lymphoid cell lines whose patterns of 
immunoglobulin synthesis have been described in this project could be 
used to clarify further excess light chain synthesis and its role in 
controlling imunoglobulin biosynthesis. For example, a comparison of 
the rates of incorporation of a radioactive precursor into the secreted 
heavy chains and light chains of a cell line secreting little or no 
excess light chain e.g. BAY  (see Results, Fig. 14) with a cell line 
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Secreting a significant amount of excess light chain e.g. CON  
(see Results, Fig. 14) would demonstrate whether the secreted light 
chains represent the only source of excess light chains or whether 
there is an intracellular pool of excess light chains. The four 
human B lymphoid cell lines described in this project as synthesising 
only heavy chains are obviously also of interest in this area. If 
the role of excess light chain synthesis is to prevent the formation 
of heavy chain complexes then heavy chains synthesised in a low 
concentration of light chains or, as in these cell lines, in the 
absence of light chains should be abnormal or present as intracellular 
complexes larger than dimers. Thus an analysis of the state of the 
heavy chains synthesised by human B lymphoid cell lines in the absence 
of light chains could provide evidence consistent with or contradictory 
to the idea of excess light chains preventing the formation of heavy 
chain complexes. In those mouse myeloma cell lines where heavy chains 
are the only immunoglobulin polypeptides expressed they appear always 
to be defective heavy chains (Conan et al., 1974, Wilde and Milstein 1980). 
and the same is true of the variant human heavy chain disease proteins 
which are synthesised in the absence of light chains (Buxbaum et al., 
1978). However, the human B lymphoid cells described in this project 
which synthesise only heavy chains are not plasma cells (as these 
other examples are) and may represent stages of B lymphocyte differentiation 
even earlier than the lymphoblasts, when immunoglobulin synthesis is 
not so rapid and normal heavy chains can be safely synthesised. 
parent variations in light chain molecular weight. 
The mobility of human imunoglobulin light chains analysed by 
SDS PAGE in this project has not been constant. However in several 
cases the differences in migration appeared to be consistent and to 
be related to light chain type in that K chains migrated more rapidly 
than x chains. Similar observations have been described for light 
chains from normal human serum (Virella and Coelho 1974), and in the 
analysis of light chains from the surface imunoglobulin of human 
lymphoblastoid cells (Singer and Williamson 1980). The migration of 
polypeptides in SOS preparations is determined by their molecular 
weight (Shapiro 1967) and yet human K and xchains have identical 
molecular weights (Edelman and Gall 1969). In this case differential 
binding of SDS seems likely to account for the phenomenon. Indeed, 
the amount of SDS bound by a polypeptide can depend upon its nature 
as well as its size (Nelson 1971) and so the differences in the amino 
acid composition of the constant regions of K and A chains must give 
rise to different affinities for SOS and thus to the type specific 
mobilities observed. There appear to be no specific studies of 
normal light chain mobilities in other species, but comparative 
analyses of the ininunoglobulins secreted by mouse hybridornas show 
type specific mobility in murine light chains (Wilde and Milstein 1980, 
Kohler and Shulman 1980). The difference in mobility here, however, 
is the reverse of that found in human light chains, that is murine A 
chains migrate more rapidly in SOS PAGE than K chains. This observation 
may initially seem strange when greater amino acid sequence homology 
exists within light chain types between species than between types 
within species (Nisonoff et al., 1975). However, there is no reason 
to expect that those sequences which have been conserved during evolution 
are those which are important in determining the affinity of a 
polypeptide for SOS. 
Not all the light chains analysed by SOS PAGE in this project 
showed variations in mobility which could be accounted for by type 
specific variation. The K chains secreted by Jijoye migrate far more 
slowly than normal K or A chains and have an apparent molecular weight 
of 	30,000 (see Results, Fig. 21). The same analysis showed that 
anti-light chain precipitable components of the same apparent molecular 
weight were synthesised by KAT 1 , a K chain secretor, and RPMI 8226 
a x chain secretor in addition to components of a normal light chain 
size. Purified human 1gM obtained from the American Red Cross also 
had an apparently large K light chain (see Results, Fig. 11). Previous 
reports of abnormal light chains either secreted by mouse myeloma cells 
(Birstein et al., 1977) or present as human myeloma proteins 
(Franklin et al., 1979) have been of polypeptides showing a much reduced 
molecular weight and have been classified as structural mutants containing 
deletions. Out-sized light chains on the other hand cannot be so 
readily explained. The presence of carbohydrate would increase the total 
molecular weight of these polypeptides which then as glycoproteins 
would show anomalous binding of SOS (Grefrath and Reynolds 1974) and 
glycosylation has been discussed as a possible mechanism to explain these 
observations, (see Results, The analysis of secreted chains from the 
presumptive variant immunoglobulin synthesising cell lines by 
immunoprecipitation). There are, however, other possible explanations 
involving additions of amino acid residues to the polypeptides which, 
if less probable than the addition of carbohydrate are of more interest 
and potential significance. These explanations would be least likely 
to account for the large light chain in the purified serum 1gM sample 
as the presence of additional peptides would be likely to disrupt the 
initial hydrogen bonding of light and heavy chains and so prevent 
subsequent disulphide bond formation and assembly of an intact 1gM 
molecule. In contrast to this, Jijoye, KAT 1 and RPM! 8226 do not secrete 
complete immunoglobulin molecules therefore, there would appear to 
be no such restrictions on the structure of their secreted light chains 
whose synthesis as well as structure can be further studied. Mouse 
myeloma light chains have additional N-terminal amino acids in their 
"precursor" form. These are tte"signal peptides", which determine 
the membrane bound synthesis and eventual secretion of light chains 
and which are subsequently cleaved from the light chains during or 
immediately after their entry to the endoplasmic reticulum (see Introduction, 
Biosynthesis of imunoglobulins). Similar N-terminal signals have not 
yet been demonstrated in the biosynthesis of human light chains but 
it is reasonable to assume that a similar mechanism applies. Although 
the signal is required for secretion into the endoplasmic reticulum 
it has not been demonstrated that the cleavage of the signal from the 
polypeptide is an essential part of the process. In at least one 
protein, ovalburnin, the signal is not cleaved during secretion (Lingappa 
et al., 1979). Therefore these large light chains could be normal 
peptides which have been secreted with their signals intact. In this 
case Jijoye would represent a variant of the process by which proteins 
are secreted across membranes lacking the membrane endopeptidase 
activity which is part of that mechanism. K.AT 1 and RPMI 8226 would 
possess inefficient forms of that activity and so they would produce 
a mixture of processed and unprocessed light chains to give the observed 
two anti-light chain precipitable components. As yet, little is known 
about the membrane bound apparatus of the endoplasmic reticulum which 
recognises and cleaves secretOry signals and so variants of this 
type would be valuable in studying these processes. 
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A second explanation for the abnormally large light chains, 
which also involves an addition to the polypeptide content of normal 
light chains, is the mechanism by which it is considered the 
immunoglobulins have evolved, that is, duplication of the domain 
pseudosubunits. However, it would be unlikely that KAT 1 and RPMI 
8226 could express both a semi-duplicated and normal light chain 
simultaneously. This leaves only Jijoye to fit this explanation 
and even here the apparent increase in light chain molecular weight 
might not be enough to encompass an extra domain. Nevertheless, the 
discovery of split genes and the direct relationship between 
immunoglobulin domains and exons (see Introduction, The Genetics 
of Immunoglobulins) make the immunoglobulins an excellent model for 
the predicted generation of novel proteins by changes at the exon/domain 
level (Gilbert 1978). Infact the transfer and exchange of domains 
between immunoglobulin genes appears to have been a major part of 
their evolution (Miyata et al., 1980). Therefore, any examples of 
such events may help to understand the mechanisms involved at the 
molecular level in the evolution of immunoglobulins and proteins in 
general. 
The nature of the presumptive variant irnunoglobulin synthesising 
cell lines and the significance of their patterns of imniunoglobulin 
synthesis and expression 
Those cell lines analysed during the course of this project 
which have not shown the normal pattern of synthesis, surface expression 
and secretion of a single heavy chain class and a single light chain 
type (see Results, Table 14) have been referred to as "presumptive 
variants". As this description suggests, one explanation of their 
patterns of immunoglobujin synthesis and expression is that these 
cell lines are variants or mutants blocked at different stages of 
irnmunoglobulin synthesis and secretion. EB 3 , Jijoye and RPMI 8226 
fit this description well as they synthesise and secrete only light 
chains so that, as mutants, they would be expected to have non-functional 
heavy chain genes which is a common occurrence within our current 
understanding of immunoglobulin genetics. In the other cell lines 
which secrete only light chains, EB 2 , JIM1 ,and KAT 1 the situation 
becomes more complex as they also synthesise, but do not secrete, 
i-i heavy chains. As mutants these lines would have a fault affecting 
heavy chain secretion. However, the heavy chains concerned behave 
normally regarding the signal hypothesis as they are expressed on the 
cell surface and to get there they must pass into the endoplasmic 
reticulum. Therefore, a previously unknown step in secretion has to be 
invoked at which these heavy chains are blocked. It may be relevant 
that mutations not affecting the signal peptides of mouse light chains 
have been reported to prevent their secretion (Mossman and Williamson 
1980). On the other hand there are structurally distinct membrane 
bound and secretory p chains which are transcribed differently from 
the same single gene (see Introduction, Biosynthesis of immunoglobulins, 
transcription of immunoglobulin genes). Thus a similar effect would 
be achieved if the mutation in these lines affected p chain nuclear 
RNA processing such that the splicing pattern of the primary transcript 
could produce only mRNA coding for p chains with plasma membrane 
binding C-termini and so no u chains would be actively secreted. Of 
the other presumptive variant lines, none of which secrete iniriunoglobulins, 
Daudi synthesises p heavy chains and K light chains and expresses both 
on the cell surface. A description of a mutation event which could give 
rise to this phenotype would be similar to the argument already outlined 
for the restriction of synthesised p chains to surface expression. In this 
case the light chains are also restricted to the cell surface and as there 
are no known cell surface membrane binding light chains specific structures, 
all light chains synthesised by Daudi must be bound to membrane specific 
heavy chains. The remaining non-secreting cell lines FAL 1 , F89, F137 
and Raji synthesise only p heavy chains. Thus, if their phenotypes 
are mutant, they must have completely non-functional light chain genes. 
The p chains of F137 and Raji are expressed on the cell surface, but, 
as previously mentioned, not secreted. Therefore, a second genetic 
lesion affecting primary transcript splicing, in a manner already 
described, must also be postulated in these lines. FAL 1 and F89 do 
not express their P chains on the cell surface and the prevention of 
P chain secretion across the membrane of the endoplasmic reticulum by, 
for example, a mutation in the region coding for the p chain signal 
peptide would account for their lack of surface or secretory expression. 
Therefore, it is possible within our current understanding of 
the events of immunoglobulin synthesis to describe these presumptive 
variant lines as mutants of normal irrmiunoglobuljn synthesis. As 
such they would provide useful information on further investigation 
about the stages of synthesis at which they are blocked and also 
perhaps outline previously unknown steps in Imunoglobulin synthesis 
and secretion. 
Alternatively, the patterns of inrunoglobulin synthesis and 
expression shown by several of the presumptive variant cell lines may 
represent different stages of B lymphocyte differentiation. That is 
to say these cell lines may not be mutants of normal cells but 
different fixed stages of B cell ontogeny. This is an initially 
attractive hypothesis not least because the classical descriptions 
of mutant immunoglobulin synthesising cells come from the many studies 
of spontaneous and mutagen-induced variant clones of the plasma cell 
mouse myeloma lines (Milstein et al., 1975, Scharff et al., 1975) 
whereas most human lymphoid lines do not represent plasma cells but 
intermediately differentiated B lymphocytes and have far more stable 
immljnogjobulin synthesising phenotypes, as has been previously 
discussed. Indeed, if those cell lines synthesising or secreting 
only a single type of immunoglobulin chain were mutants, their 
frequent occurrence - even including the hundreds of cell lines 
screened in this laboratory at one time or another - is incompatable 
with the lack of variant or mutant cells in mutagenesis and cloning 
experiments, unless there is extreme selection for variant cells during 
the establishment and culture of cell lines. Furthermore, the re-occurrence 
of the same relatively complex phenotype e.g. in EB 2 , JIM 1 and 
KAT 1  and the repeated requirement for the same type of mutation affecting 
the splicing of the ii chain primary transcript make the mutation 
argument seem over-elaborate and clumsy. However, apart from the 
shortcomings of the mutation hypothesis what strengthens the B lymphocyte 
differentiation argument is the continuum of imunoglobulin synthesis 
that is apparent when the presumptive variant lines are looked at from 
the point of view of representing different stages of B lymphocyte 
ontogeny. This pathway is outlined in Table 15. According to this 
scheme, imunoglobulin synthesis begins during B lymphocyte differentiation 
with the synthesis of P heavy chains which are not expressed on the 
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TABLE 15 
SEVERAL OF THE PRESUMPTIVE VARIANT CELL LINES 
REPRESENTING DIFFERENT STAGES OF B LYMPHOCYTE DIFFERENTIATION 
Imunoglobulin expression 	Representative cell lines 
Intracellular 	Surface 	Secretory 
L = Light chain 
cell surface or secreted, as represented by ininunoglobuliri expression 
in FAL 1  and F89. The next step, shown by F137 and Raji, is the 
surface expression of the i chains followed by the synthesis of 
light chains which are also expressed on the cell surface as in Daudi 
and presumably as intact surface 1gM molecules. At this stage in 
B lymphocyte ontogeny the cell surface antibodies bind antigen and 
stimulate the lymphocyte to proliferate and produce more imunoglobulin. 
Thus as ininunoglobulin synthesis accelerates light chain synthesis 
increases first and remains in excess to accommodate the subsequent 
increase in heavy chain synthesis which otherwise might be toxic to 
the cell, as previously discussed. These events are indicated by the 
cell lines EB 2 , JIM 1 and KA1 1  which synthesise and express on the 
cell surface p chains and light chains but secrete only light chains. 
As p chain synthesis increases so B lymphocytes switch from the 
synthesis of predominantly surface bound p chains to secretory i-i chains 
giving rise to the pattern of immunoglobulin expression shown by the 
vast majority of human B lymphoblastoid cell lines. 
There is evidence from other sources to support the claims 
of some of these cell lines as examples of early B lymphocyte differentiation. 
There have been several reports from studies of murine foetal liver 
hybridomas (Burrows et al., 1979). Abelson murine leukaemia virus 
transformed mouse bone marrow cells (Siden et al., 1979) and isolated 
murine and human pre- B cells (Levitt and Cooper 1980) that pre- 
B lymphocytes synthesise P chains and no light chains which is the 
same irrinunoglobulin synthesis pattern shown by FAL 1 and F89. However, 
unlike F137 and Raji, none of the pre-B cells described in these 
reports express their ii chains on the cell surface and in one report 
(Levitt and Cooper 1980) the pre- B cell p chains are freely secreted. 
Although F137 may put some p chains into the culture medium it could 
not be described as freely secreting p chains, as previous analysis 
has shown. The ininunoglobulin phenotype of Daudi is well established 
as one which represents an intermediate stage of B lymphocyte 
differentiation (Nilsson 1978) and the shift in synthesis from membrane 
bound imunoglobulin to secreted irrinunoglobulin is also a well 
documented step in B lymphocyte ontogeny. Athough there is evidence 
both from this project and elsewhere that light chains are synthesised 
in excess of heavy chains there appear to be no other reports of 
B lymphoid cells which, like, EB 2 . JIM  and KAT 1 synthesise both 
heavy chains and light chains but secrete only light chains. 
The hypothesis that these cell lines represent relatively 
undifferentiated B lymphocytes raises the point of their origins 
especially as it has been argued earlier that human B lymphoblastoid 
cell lines are normally derived from B lymphocytes actively 
secreting irruunog1obu1in. All the cell lines in question carry the 
EB virus nuclear antigen (Steel, personal communication). However 
the majority are derived from Burkitts Lymphoma which makes credible 
their establishment as earlier B cells than lymphoblasts. The 
exceptions are F89, F137, FAL 1 , JIM  and KAT 1 . Of these F89 and F137 
were established from leukaemias which are also sources of clonal 
expansion of B lymphocytes in early stages of differentiation. 
FAL 19 JIM  and KAT 1 on the other hand, were established from a normal 
cord blood, normal adult blood and blood from an infectious mononucleosis 
patient respectively. Bearing in mind the large number of normal, 
ininunoglobulin secreting B lymphoblastoid cell lines derived from 
these sources they do not seem likely origins for relatively 
undifferentiated B lymphoid cell lines. However support for the 
possibility that EB virus transformed lines representing early 
cells in B lymphocyte ontogeny can be established from a non-malignant 
source comes from a recent report by Fu et al., (1980) that pre- B 
cell-like lines can be established using EB virus from the bone marrow 
of X-linked aganinaglobulinaemia patients. 
The possibility exists then that here is a group of cell lines 
which represent fixed stages of human B lymphocyte differentiation in 
finer detail than ever before as regards the onset and development of 
imunoglobulin synthesis. If this is the case these cell lines show 
that i.i chain synthesis precedes light chain synthesis in human B 
lymphocyte ontogeny. The significance of this asynchromous onset of 
ininunoglobulin chain synthesis, as suggested by Burrows et al. (1979) 
from murine data, may be that by not expressing light chains immature 
B lymphocytes are free to expand the number of individual cells expressing 
a specific VH gene without the external regulation that might accompany 
the presence of an 1gM surface receptor. It is equally interesting that 
these results suggest that immature B lymphocytes express free j. chains 
on the cell surface as I lymphocyte receptors may resemble or have the 
conformational properties of VH  domains, Eichman and Rajewsky (1975). 
These two pieces of information raise the attractive hypothesis that 
the surface u chain V  domains in immature B lymphocytes have a role 
in the lymphocyte interactions which modulate the humoral response. 
Further structural studies of the imunoglobulin polypeptides 
and their relevant N-terminal and/or C-terminal additions synthesised 
by the above cell lines should give an insight into the mechanisms 
which underly the control of the various patterns of immunoglobulin 
synthesis and expression. In addition structural studies will also 
determine whether or not the imunoglobulin chains synthesised by 
these putative immature B lymphocyte lines are analogous to those 
found in the more mature normal B lymphoblastoid cell lines. If 
this is not the case the status of these lines as representing earlier 
stages in differentiation would be questionable. In addition to 
analysis of their ininunoglobulin phenotypes the presumptive immature 
B lymphocyte cell lines represent a valuable source for the study 
at the DNA level of the structure and organisation of imunoglobulin 
genes either in early or in variant human B lymphocyte development. 
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Human B lymphoid cell lines secreting a single heavy chain class and a single light chain type 
Cell lines were established from blood lymphocytes unless otherwise indicated and with 
the exception of cord bloothall donors were adult unless otherwise stated. Donors, other than 
infectious mononucleosis patients were considered to have had no recent infection. 
Cell 	line Sex 
Donor 
Condition 
Pattern of irwnunoglobulin 
secretion 
Y 	P 	K 	A 
AIR 1 M Bladder cancer + - - + - 
ALE2 M Bladder cancer + - - - + 
ALP 1 F Normal + - - + - 
BUR2 F Infectious mononucleosis + - - + - 
DUN 1 M Infectious mononucleosis + - - - + 
FLE 1 M Infectious mononucleosis + - - - + 
HUT  M Manic depressive + - - - + 
ICH 2 F Manic depressive + - - - + 
MAR  M Infectious mononucleosis + - - + - 
NAY 2 M Waldenstroms Macroglobulinaemia + - - - + 
Cell line I 	Sex 
ODY 1 M Waldenstroms Macroglobulinaemia 
ROS 1 F Normal 
SHA 1 F Acute lymphatic leukaemia 
SIG  M Achiasmate 
TON  F Infectious mononucleosis 
ALF3 M Bladder cancer 
co 
CD 
ARH 77 F Multiple myeloma 
ART  F Chronic myeloid leukaemia 
BEC-11 F Tonsilitis 	(established from tonsil 	lymphoid cells) 
BRI-7 M Normal adult 
CAN  F 15/7 translocatjon 
COL  M Aortic incompetence 
DEW  F Infectious mononucleosis 
EB4 F Burkltt lymphoma 
GEF 1 M Normal 
HUC 1 M Normal 
ICH 1 F Manic depressive 
Pattern of immunoglobulin 
secretion cx 	 P 	K 	A 
+ - + 
+ - + 
Donor 
Condition 
Cell 	line Sex 
Donor 
Condition 
Pattern of immunoglobulin 
secretion 
ci 	y 	p 	K 	A 
JOE M Normal - + - - + 
LOR 1 F Infectious mononucleosis - + - - + 
LYN2 F XY - + - + - 
MAZ 1 F Trisomy 21 - + - + - 
MEK 1 F Trisomy 21 - + - + - 
MICH F Idiopathic thrombocytopaenia 
(established from spleen cells) - + - + - 
0R1 1 F Normal - + - - + 
PAR  M Infectious mononucleosis - + - - + 
POS 3 M XX - + - - + 
PRA  M Infectious mononucleosis - + - + - 
RIC 1 F Thorotrast treated patient - + - + - 
RIL 1 F Normal - + - - + 
ROS 2 F Normal - + - - + 
RPMI 8866 F Acute myelogenous leukaemia - + - + - 
TAB  F Hurlers syndrome - + - - + 
TIL 1 M XXXXY - + - + - 
I- 
Cell 	line Sex 
Donor 
Condition 
Pattern of immunoglobulin 
secretion 
K 	X 
WAL 1 F Infectious mononucleosis - + - + - 
WIK1 M Infectious mononucleosis - + - + - 
ANA  11 Cord blood - - + - + 
ANA  M Cord blood - - + - + 
ARD 1 F + l5pH - - + + - 
ARO 1 F Aortic incompetence - - + + - 
ARY 1 M Manic depressive - - + - + 
BAK 1 M XXV - - + - + 
BAX 1 F Cord blood - - + - + 
BAY  F Cord blood - - + + - 
BAY  F Cord blood - - + - + 
BAY  F Cord blood - - + + - 
BAY  F Cord blood - - + + - 
BAY  F Cord blood - - + + - 
BET  M Cord blood - - + + - 
BET  M Cord Blood - - + + - 
I- 
Cell 	line Sex 
Donor 
Condition 
Pattern of imniunoglobulin 
secretion 
11 K 	A 
BET  M Cord blood - - + + - 
BLA 1 M Acute leukaemia - - + + - 
BLA4 M Acute leukaemia - - + + - 
BOB  M Cord blood - - + - + 
BOK 1 F Cord blood from known 
chromosomal mosaic - - + + - 
BON  F Cord blood - - + + - 
BR18 F Normal - - + - + 
BR18T F Tetraploid derivative of BR18 - - + + - 
BUR 1 F Infectious mononucleosis - - + - + 
CAR 1 F Chronic myeloid leukaemia - - + + - 
CHU 1 M Acquired agamaglobul i naemi a - - + - + 
CLA 1 F Cord blood - - + + - 
CLA4 F Cord blood - - + - + 
COA F Myel of i brosi s - - + + - 
CON  F Cord blood - - + + - 
CR0 1 M Cord blood - - + + - 
Cell 	line Sex 
Donor 
Condition 
Pattern of irnmunoglobulin 
secretion 
K 	A 
EB 1 F Burkitt lymphoma - - + + - 
GAL  M Normal - - + + - 
GAL  M Normal - - + + - 
GAL  M Normal - - + + - 
G-S F Chronic lymphatic leukaemia - - + + - 
HIL 1 F Cord blood - - + - + 
HOL 1 M Cord blood - - + - + 
HUC2 M Normal - - + + - 
JED 1 M Small 	V - - + + - 
KEL 4 F Cord blood - - + + - 
KIT  F Manic depressive - - + - + 
LAX  M XX - - + - + 
LID  F Normal - - + + - 
MAC  F Cord blood - - + + - 
MON 1 M Cystic fibrosis 	(child) - + - + 
MUN 1 F Normal - - + + - 
c) 
I- 
Cell 	line Sex 
Donor 
Condition 
Pattern of immunoglobulin 
secretion 
K 	X 
NAMALVA F Burkitt lymphoma - - + - + 
NOR M Manic depressive - - + - + 
OCH 1 F Bladder cancer - - + + - 
PAL  F Cord blood - - + - + 
PRA  M Infectious mononucleosis - - + + - 
POS 1 M XX - - + + - 
RAF  M Trisomy 21 - - + - + 
RHE M 2110 translocation (child) - - + - + 
RIC 2 F Normal - - + - + 
RIC 3 F Normal - - + - + 
Rh 1 F Manic depressive - - + + - 
RPMI 	1788 M Normal - - + - + 
RUS 1 M Leukaemia 	(Acute myeloblastic ?) - - + + - 
SAR2 F Manic depressive - - + - + 
SEB 3 F+M Pooled cord bloods - - + + - 
SEC  F+M Pooled cord bloods - - + + - 
1 
Cell 	line Sex 
Donor 
Condition 
Pattern of imunoglobulin 
secretion 
OL 	y 	11 	K 	 X 
SEC  F+M Pooled cord bloods - - + - + 
SEC  F+M Pooled cord bloods - - + + - 
SEC  F+M Pooled cord bloods - - + + - 
SEC  F+M Pooled cord bloods - - + - + 
SEC  F+M Pooled cord bloods - - + - + 
SEY 2 M Normal - - + + - 
SIM 1 M Aypogamaglobulinaemia - - + + - 
SOB  M XX - - + + - 
SMI 1 F Cord blood - - + + - 
SM! 2 F Cord blood - - + + - 
SM! 4 F Cord blood - - + - + 
SLiT 1 M Cord blood - - + - + 
TAF 1 M Ataxia telanglactasia (child) - - + + - 
TAF 2 M Ataxia telangiactasia (child) - - + + - 
TAF 3 M Ataxia telangiactasia 	(child) - - + - + 
yEN 1 M Acute lymphatic leukaemia - - + + - 
Lt) 
Cell 	line Sex 
Donor 
Condition 
Pattern of imniunoglobulin 
secretion 
CE 	 Ii 	K 	A 
WAD  F Normal - - + + - 
WAM 1 M C-band heterozygote - - + - + 
WAR  M Acute lymphatic leukaemia (child) - - + - + 
WEB  F Cord blood - - + - + 
WEB  F Cord blood - - + - + 
WES 1 M Cord blood - - + - + 
WHE M Cord blood - - + - + 
WIG M Cord blood - - + - + 
YAK  M Cord blood - - + - + 
XER 1 F Xeroderma pigmentosim - - + + - 
XER2 F Xeroderma pigmentosim - - + + - 
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Possibility of EB virus preferentially 
transforming a subpopulatioa 
of human B lymphocytes 
PERMANENT lymphoblassoid cell lines can be established by 
transformation' of human lymphocytes with EB virus 12 The 
lines secrete immunoglobulin (Igj in ruro 3 ' and rcprcsenL 
morphologicaily, an intermediate stage beeween the resting lym-
phocyte and the fully developed plasma cell' • It has been 
suggested that the EB rtits stimulates inactive B lymphocytes to 
secrete immunoglobulin and that the virus is behaving, in this 
respect, like a polyclonal B cell mitogen. The evidence comes from 
observations that most iposaibly all) human B lymphocytes carry 
surface receptors for ES vu-si?. that an increase in Ig secretion is 
detectable within a few days of adding the virus to a culture of 
lymphocytes' and that in the earls stages ol'growth, lympboblas-
told lines established in this way secrete multiple classes 01 If 
heavy and light chaini in It seems. however, that only a fraction 
of te, of lymphocytes in an ES virus-infected culture respond 
esther by lg synthesis or by proliferation and furthermore that the 
two events occur simultaneously The possibility therefore 
remiins that EB virus does not stimulate If synthesis de noco but 
selectively transforms (that is. induces to proliferate) that minor 
population of B cells which has already begun to secrete 1g. This 
alternative is supported by our analysis of the major classes of It 
heavy and light chains secreted by lymphoblastoid cell limes 
(derived from peripheral blood lymphocytes) in relation to the age 
and clinical status of the donors. 
The data are set out in Table I. The most striking finding is that-
of fifty unselected lines derived from cord bloods. forty-nine 
secrete only 1gM This is at variance with the expected outcome o( 
polyclonal stimulation of resting B cells, since the ability to 
synthesise cytoplasmic If of differing heavy chain classes in 
response to a polyclonal B cell rnitogen seems to be acquired 
earlier in ontogeny than the class and subclass segregation of cell  
surface immunoglobulin determinants that is already well estab-
lished among the circulating lmphoesses of the human foetus 
many weeks before birth1 3,i .A,hough 1gM -secreting cells have 
been shown to predominate among poke-weed-stimulated human 
cord lymphocytes, lgG secretor's form is substantial proportion in 
most samples and, in some cases at lease IgA-producing cells are 
also readily found" It therefore seems incompatable with this 
mode of action of EB virus that no or a heavy chains could be 
detected in the supernatants of any of ow cord blood lines even 
when tested repeatedly during the carts weeks following their 
establishment in i'uro and even though potyclonal composition 
could still be demonstrated by the presence of both kappa and 
lambda light chains. Conversely. our findings are in keeping with 
the view that EB virus induces proliferation in those rare cells 
which are actively secreting immunoglobulin since, for the first 
few weeks after birth, the healthy human infant synthesises Ig 
exclusively of classM (ref. 6). 
Adult blood lymphocytes stimulated unh pokeweed mitogen 
typically contain populations of B cells secreting 1gM. IgG and 
IgA respectively, in the approximate proportions of 2: h refs 15 
and 17). Bcompanson. 1gM s'etors sesem to be relatively over-
represented among the monoclonal limes deri'.ed from healthy 
adults and under-represented ang thaw from infectious mono-
nucleosis patients (Table I). The difference between the two 
groups is ticult to explain if the lines are derived from resting 
blood B ceih, but since infectious mono.uctcosis is characterised 
by a substantial increase in serum If of all three major classes' 5 . 
the population of lg.secreting cells in the circulation is likely to be 
markedly disturbed. If this is the population which gives rise to 
lymphoblassoid lines, a deviation from the normal distribution of 
G.M and A secretors would not be unexpected. It would also 
provide a rational explanation for the observation that lyrnpho-
blastoid lines can be established exceptionally easily from the 
blood of patients in the acute or earl's convalescent phase of 
infectious mononucleosis' and other virus infections tm2 ' 3 . 
when the absolute number of IS-'aecretin cells in the circulation is 
abnormally high. 
Tiele I 	Patterns of Ig secretion by human lympboblastoid cell lines 
Ig secret 
Source of No. of cell lines 
blood (no of different donors) Heas'i chain Light chain 
Lymphocytes 6 A 	M Nones K L None 
Cords Total 50(25) 
Monoclonal lg secretors 39(2O) * 0 0 	49 I 30 29 I 
0 0 	39 - 20 19 - 
Adults Total 9(62) 
no recent Monoclonal lgsecretorshól59l 31 tO 	49 0 54 40 3 
infncuon)l 
20 9 	38'1 0 39 27 0 
Adults Total 191 16) 
(infectious Monoclonal Ig iecretos 17(15) 9 5 	7 0 14 7 0 
mononucleosis) 
5 7 5 	5 I) 11 0 
• Alt cord bI 3od lines, all infectious mononucicosis-densed lines and at but two of the lines from other adult donors were established in our laborator 
'PIg secretion was detected be a highly sensitive and reproducible haensagglutination-'in)uoition technique'. In moss cases si.,Oerisiaialsts had been tested 
on several occasions 
.One cord-derived line FAL 1 i has consistently failed to secrete any detectible Ig 'ret' 4). Morphologically it is invastinguishable from other 
lvmphoblastoid lines, and complete EB virus particles were seen in electron rn,crovcope 'rrparations The cells have surface lg '4K determinants b 
indireci immunoiluorescence( and react strongly .iih a rabbit antiserum spes, -ific for human B lymohoid cells. 
§Althoueh described as 'adilts . three of ihesc donors were below he aim of (P r. The zr-cup comprised healthy ,ndisiduaas and those suffering from 
genetic (including cytoeenetic. disorders or from malignant disease not ct'ecting he lymph. - reticular system 
. Lines were considered monoclonal when only a single class of lii heas chain and uncle cuss at light chain could be detected in the supernatant. 
The difference between these two itroupsin the protortion of monoc'onal lines mecretins 4 heavy chain is significant 14- 	43, p <005i There are 
no significant differences between any group in the proportion ollines vecreting K or L light chains. 
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Arguments based on the studs of Ig secret-ion by monoclonal 
lymphoblastoid lines would, of course, be invalid if there was any 
suspicion of a selective advantage for the growth of cells produc-
ing Ig ofa particular class, or if the commitment ofa given cell and 
its progeny to secrete a particular class of heavy chain were 
unstable in the conditions of culture. On the first point- our 
experience has been that when multiple aliquots of 10-100 cells 
are taken, at an early stage of growth. from a line which is 
secreting comparable amounts of two immunoglobulin molecules 
(distinguished by heavy and or light chain class), the subcultures 
ultimately give rise to approximately equal numbers of clones 
secreting each of the parental I  species Selection of the dominant 
clone from a newly established line therefore seems to be a 
random process with respect to class of Ig secreted- On the second 
point. in spite of one contradictory, report". it seems that 
lymphoblastoid cell clones secreting more than one class oi'heavy 
and or tight chain are exceptionally rare' 1 . while stability of the 
commitment to secrete a particular class of Ig is one of the most 
sinking features of human lymphoblastoid luses 36 We have been 
unable to detect any change in the pattern of Ig synthesis among 
several hundred clones derived from lines exposed to a variety of 
physical and chemical rnutagens. although a considerable number 
of other biochemical changes have been induced' 
The distribution of monoclonal heavy and light chains ul-
timately produced by lines from a particular set of donors is 
therefore likely in be a valid index of the relative proportions of 
their blood lymphocytes secreting (or committed to secrete) each 
class of Ig and susceptible to ES virus 'transformation 
It is important to an understanding of the mechanism of ES 
virus transformation to know whether the stage of differentiation 
of the host B lymphocyte is  critical factor Our conclusion, that 
there is preferential. if not exclusive, transformation of those cells 
already secreting Ig in iit'o i though mature plasma cells are 
evidently insusceptible 15 ), seems to be more compatible with the 
available data than the proposition that EB virus acts as a 
poLcional B cell mitogen If the subpopulation of Ig-secreting 
blood lymphocytes can be isolated—for example. by velocity 
gradient sedimentation—the question may be resolved. 
We thank Mrs Marilyn Woodward, Mrs Jane Jenkins. Mr 
Gordon Martin and Mr Ross Maynard for aance. and Mr J. 
Davies for advice on statistical analysis. 
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